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Traumatic brain injury (TBI) is a worldwide epidemic as the number of victims living with the 
resulting cognitive and physical impairments continues to rise, principally due to limited 
treatment options which fail to address its multifaceted sequelae.  By approaching TBI therapy 
from a molecular standpoint, we have the opportunity to develop a better understanding of the 
mechanisms which prevent effective recovery.  With this information, we can move toward the 
identification of novel therapeutic treatments which target specific molecules to improve patient 
outcome following TBI.  Here, we focused on the therapeutic potential of osteopontin (OPN), an 
extracellular matrix (ECM) protein which is a substrate of several matrix metalloproteinases 
(MMPs), and capable of acting as both a cytokine and modulator of axonal outgrowth during 
synaptic recovery.  The ECM and its components are of particular interest with respect to 
selecting novel TBI therapeutics since this network has been implicated in neuronal plasticity 
 xvi 
 
during both development and following central nervous system (CNS) insult.  In this dissertation 
study, the temporal and spatial profile of OPN expression, its protein and transcript localization 
within reactive glia (IBA1 positive microglia or GFAP positive astroglia), and its interaction 
with the cytoarchitectural protein microtubule associated protein 1B (MAP1B) after injury were 
each compared under conditions of deafferentation induced synaptogenesis in the rat.  Two TBI 
models were employed: one exhibiting adaptive synaptic plasticity (unilateral entorhinal cortex 
lesion, UEC), and the other generating maladaptive synaptic plasticity (central fluid percussion 
injury followed by bilateral entorhinal cortex lesions, TBI+BEC), in each case targeting 1, 2, and 
7d postinjury intervals.  In addition, we examined the potential for converting the adaptive 
response to one of maladaptive plasticity by attenuating immune reactivity through acute 
administration of the tricyclic antibiotic minocycline, utilizing a dosing paradigm previously 
demonstrated to reduce inflammation.  To more clearly confirm that OPN has a role in successful 
synaptic regeneration, we developed a colony of OPN knockout (KO) mice which were used to 
profile synaptic structure and functional outcome under conditions of UEC-induced 
synaptogenesis.  
In Chapter 2, we report that full length OPN responds robustly in the acute (1-2d 
postinjury) degenerative period following UEC and TBI+BEC.  After UEC, time-dependent 
differences were observed for two alternative MMP-processed OPN forms, including early 
increase in a RGD-containing 45 kD, integrin binding fragment (1d), and delayed increase in a 
C-terminal 32 kD OPN peptide (7d).  OPN transcript was also elevated acutely after UEC, a 
finding which was pronounced in enriched dentate molecular layer (ML) fractions.  Parallel 
immunohistochemistry (IHC) and in situ hybridization localized OPN protein and transcript to 
reactive glia following UEC.  This localization was concentrated within microglia which 
 xvii 
 
delineated the border between the intact and deafferented ML, a pattern which was less 
pronounced in maladaptive TBI+BEC animals.  The timing of this glial movement suggests that 
OPN regulates microglial migration and, potentially, could act as an astrokine to recruit activated 
astrocytes to influence subsequent synaptic regeneration.  MAP1B staining confirmed dendritic 
loss during axonal degeneration and dendritic atrophy, with a reemergence during collateral 
axonal sprouting.  However, OPN colocalization with MAP1B was minimal, suggesting a minor 
role for OPN in reorganization of dendritic/axonal cytoarchitecture in this model of 
deafferentation.  Minocycline reduced acute OPN protein response 2d after UEC, and caused a 
more random OPN positive glial distribution, similar to that of the maladaptive TBI+BEC.  The 
role of OPN in the inflammation-directed degeneration of terminals is supported by reduced 
MMP-9 activity which is temporally correlated with the reduction of MMP-generated OPN lytic 
fragments (45 kD).  Interestingly, this reduction of integrin-binding OPN peptide also matched 
the impaired removal of presynaptic terminals, evidenced by diminished synapsin 1 clearance in 
animals which received postinjury minocycline.   
In Chapter 3, we sought to more precisely evaluate the role of OPN following 
deafferentation utilizing wild type (WT) C57BL/6 and OPN knockout (KO) mice subjected to 
UEC, comparing the spatio-temporal injury response between WT and KO.  To do this we 
profiled several outcome measures which assessed OPN role in different aspects of recovery: 1) 
expression of select proteins important in various stages of synaptic recovery, 2) glial response, 
3) cognitive recovery, and 4) MMP enzymatic activity.  Compared to WT mice, OPN KO mice 
did not show significant differences in the acute injury-induced alteration of proteins important 
to cytoarchitectural reorganization (MAP1B) or stabilization of the synaptic junction (N-
cadherin).  However, both Western blot and IHC analyses showed OPN KO mice had impaired 
 xviii 
 
presynaptic terminal clearance, supported by attenuated synapsin 1 breakdown, a result quite 
similar to that of the minocycline-treated rats with OPN reduction in Chapter 2.  This impaired 
degeneration in OPN KO mice at 2d postinjury correlated with IHC evidence for altered 
microglial morphology, and hippocampal function assessed by the novel object recognition 
(NOR) task.  Our NOR results confirmed cognitive dysfunction in OPN KO mice during the 4-
21d period of synapse reorganization after UEC.  In addition, OPN KO decreased MMP-9 
activity, an effect associated with reduced MMP-9-bound lipocalin 2 (LCN2), a persistently 
activated form of that MMP.  These latter findings further support the hypothesis that MMP 
processing of OPN contributes to effective regenerative response after injury.   
  Collectively, the studies presented in the two chapters of this dissertation provide 
evidence that OPN is a critical element in the acute immune response following injury-induced 
CNS deafferentation.  They suggest that the cytokine can be produced by reactive microglia, may 
mediate cell migration and acute degenerative clearance, potentially serves as an astrokine to 
recruit those glia to sites of synaptic repair, and disrupts these processes when it is either reduced 
or ablated.  Interestingly, this OPN role in synaptogenesis appears to involve ECM interaction 
with MMP-9, possibly regulated by LCN2.  Most importantly, OPN involvement seems to affect 
the time-dependent progression of synaptic repair, an effect which can be measured by efficacy 
of functional outcome
 1 
 
CHAPTER 1 
 
INTRODUCTION
 2 
TRAUMATIC BRAIN INJURY 
Impact, Epidemiology, and Classification 
Traumatic brain injury (TBI) is a serious global health issue with an estimated 10 million 
new incidents a year (Hyder et al., 2007), 1.7 million of which occur in the United States alone 
(Faul et al., 2010).  TBI affects people of all backgrounds and geographic locations, culminating 
in a vast number of incidents which exceed that of spinal cord injury (SCI), HIV/AIDS, breast 
cancer and multiple sclerosis (MS) combined (Brain Injury Awareness Association).  Further 
compounding the impact of new injuries are the lasting effects of TBI, including long term 
cognitive and motor deficits.  These impairments often require victims to undergo extensive 
psychological and physical therapy (Hyder et al., 2007; Asikainen et al., 1998; Faul et al., 2010; 
Weightman et al., 2010), nearly tripling (5.3 million) the number of Americans who currently 
live with the effects of TBI.  Together, the subsequent cost of rehabilitation and loss of 
productivity has resulted in a large financial burden in excess of $60 billion annually (Langlois et 
al., 2006; Finkelstein et al., 2006; Rutland-Brown et al., 2006).  While these estimates are limited 
to the direct effects of TBI, the economic and social impact may be even greater, up to $221 
billion, when factoring in lost quality of life (Coronado et al., 2012). 
TBI is defined as any process that damages the brain following trauma such as a blow to 
the head, penetrating injury, or merely rotational forces which involve rapid acceleration and 
deceleration (Silver et al., 2005).  While everyone is susceptible to TBI, the most vulnerable 
cohorts are men, young individuals, and the elderly.  Those 0-4 years, adolescents, and seniors 
over 75 years comprise the largest portion of TBI-related injuries each year (Langlois et al., 
2006).  The leading cause of TBIs is falls, while motor vehicle accidents and blows to the head 
comprise the majority of all other annual incidents (Langlois et al., 2006).  Due to the varied 
 3 
nature in which TBI is acquired, it presents an assorted constellation of symptoms and signs 
(Saatman et al., 2008) which manifest in an estimated 52,000 deaths, 275,000 hospitalizations, 
and 1.3 million emergency room visits each year (Rutland-Brown et al., 2006).  Further, TBI is a 
silent epidemic due to the high incidence of cases which are undetected and/or untreated, a 
number which remains unknown (Goldstein, 1990; Coburn, 1992).  In addition to civilian injury, 
recent attention has focused on the impact of TBI on military personnel returning from combat.  
In 2009 alone, 28,000 soldiers were diagnosed with a TBI, many whom suffer long term co-
morbidities alongside other psychological and psychiatric symptoms of war (Department of 
Defense 2013).  Given the expanding societal impact of TBI, this epidemic requires improved 
diagnostics for more specific treatments that lead to better functional recovery and outcomes.  
TBI classification is considered one of the greatest barriers to effective TBI therapeutics due to 
the inherent heterogeneity of this disease (Saatman et al., 2008).  Clearer criteria to improve the 
classifications of TBI would greatly assist in the development of individual TBI therapies for 
improved outcome.   
Currently, TBI is classified into broad categories of severe, moderate, and mild.  These 
groups are based on clinical scores utilizing the Glasgow Coma Scale (GCS) which assesses 
brain function and alertness through eye opening, motor response to pain, and verbal responses.  
Patients with a GCS score of 8 or less are considered to have a severe injury, while those with a 
score of 9-12 have a moderate injury, and those with a GCS 13 or greater are considered to have 
a mild injury.  Unfortunately, the GCS does not account for the pathophysiological or 
pathoanatomical features of head injury sequelae, placing importance on molecular assessments 
which may further define additional biological markers key to future therapeutic management 
(Andriessen et al., 2010; Saatman et al., 2008).  This approach is particularly important in the 
 4 
treatment of mild traumatic brain injury (mTBI) which may occur with minimal loss of 
consciousness (LOC) or lack of LOC altogether, often permitting this type of injury to go 
unnoticed.  Acute medical consequences from TBI can range from motor impairment to 
cognitive dysfunction, and may include disruption of sensory perception, psychiatric 
disturbances (Hurley and Taber, 2002; Bryant et al., 2010), sleep disorders, post-traumatic stress 
disorder (PTSD), and seizures (Annegers et al., 1998; Benedictus et al., 2010; Greenwald et al., 
2012) however, there is limited knowledge regarding the symptoms and long term outcome of 
mTBI (Senathi-Raja et al., 2010; Shenton et al., 2012; Vanderploeg et al., 2005).  Clinical 
evidence indicates that the effects of TBI are not only acute, but victims are at increased risk for 
a myriad of long term neurological and psychiatric diseases (Rogers and Read, 2007; Halbauer et 
al., 2009; Bryant et al., 2010) including depression (Rapoport, 2012), epilepsy (Annegers et al., 
1998; Ferguson et al., 2010; Frey, 2003), and Alzheimer disease (Mortimer et al., 1985; 
Fleminger et al., 2003; Sivanandam and Thakur, 2012).  Given the potential for a number of long 
term complications related to TBI, and recognition that mTBI may often go undiagnosed and 
untreated, a number of studies have investigated the role of repeated concussive or 
subconcussive injury in athletes or military personnel.  Interestingly, these patients did not have 
profound acute or intermediate symptoms, but suffered from a progressive dementia, chronic 
traumatic encephalopathy (CTE) (Goldstein et al., 2012; Saulle and Greenwald, 2012; McKee et 
al., 2009).  Given recent evidence that neurodegenerative disease can manifest years after the 
initial TBI insult, and the importance of using pathoanatomical features in the classification of 
TBI, it is clear that understanding the molecular mechanisms which underlie TBI pathobiology 
and recovery must be investigated to improve the detection and treatment of TBI which improve 
functional recovery (Saulle and Greenwald, 2012; Goldstein et al., 2012; Saatman et al., 2008).  
 5 
Pathophysiology 
         As previously stated, TBI is a heterogeneous process which includes a wide range of events 
including skull fracture, cerebrovascular injury, and synaptic damage.  TBI pathology may be 
categorized as focal or diffuse, while the molecular processes which determine patient outcome 
are classified as primary or secondary.  Primary injury includes mechanical damage that occurs 
at the moment of impact, while secondary insults are characterized by downstream processes 
(Werner and Engelhard, 2007).  During a blow to the head or rapid acceleration and deceleration, 
the brain contacts the hard skull, creating focal brain injury injuries on opposite sides of the 
brain, also known as coup and contrecoup (Silver et al., 2005; Andriessen et al., 2010).  These 
focal injuries often include laceration, contusion, and hemorrhage, the latter of which induce 
brain damage best studied in models of ischemia and stroke (Lin et al., 1993).  While gross 
damage is a factor in TBI outcome, current therapies are focused on the molecular pathobiology 
which underlies the lasting impairment seen in TBI patients (Povlishock and Katz, 2005; Silver 
et al., 2005; Smith et al., 2013).  Specific to TBI, brain movement within the rigid skull induces 
mechanical injury which causes a number of events such as cell membrane damage and 
subsequent excitatory amino acid (EAA) release.  Also, there is often breakdown of the blood 
brain barrier (BBB), further exacerbating the brain’s vulnerability to neuroexcitotoxicity 
(Schmidt and Grady, 1993; Farkas et al., 2006; Habgood et al., 2007; Povlishock et al., 1978) 
and cytokine/chemokine distribution, inducing yet another level of chemical neurotoxicity.  In 
contrast to focal insult, these chemical imbalances and stretching of axons or the shearing of 
fibers against the cranial vault can also result in a diffuse axonal injury (DAI) (Strich, 1961; 
Gennarelli et al., 1982; Adams et al., 1991), pathology characterized by hallmark axonal bulb 
swellings (Povlishock et al., 1983; Povlishock and Kontos, 1985).  While DAI is a classic injury 
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used to confirm TBI in postmortem brains of trauma patients, this pathology also leads to 
downstream events of synaptic deafferentation and neuronal cell death as axonal transport and 
targeted synapses become interrupted and damaged (Povlishock et al., 1992; Povlishock and 
Katz, 2005). 
 
Neuroexcitation Following Traumatic Brain Injury 
 While many deleterious processes occur during TBI, one of the first to occur is the 
release of multiple neurotransmitters, EAAs, and cytokines.  Neurotransmitters have been well-
documented in synaptic transmission and intracellular cell function (Campbell, 1983; Young, 
1992; Tymianski, 1996; Tymianski and Tator, 1996), and have been hypothesized in the 
regulation of neuronal dysfunction underlying human TBI (Hayes et al., 1988; Lyeth et al., 1988; 
McIntosh et al., 1988; Faden et al., 1989; Miller et al., 1990). This excitotoxic hypothesis was 
first proposed in 1983 by Rothman and Olney based on the neurotoxic potential of glutamate 
binding to NMDA receptors (NMDAR) (Rothman and Olney, 1986; Rothman and Olney, 1987; 
Bullock et al., 1998).  Following TBI, ionic dysregulation not only occurs within the axon, but 
within astrocytes, and throughout the brain, and is characterized by an early release of multiple 
EAAs, and a rapid increase in extracellular aspartate and glutamate (Faden et al., 1989; Hayes et 
al., 1992).  Excessive neurotransmitter release as a consequence of dysfunctional glutamate 
receptor binding has been described in conflicting reports which cite location-specific reduction 
of EAA binding to NMDAR within the hippocampus (Miller et al., 1990), as well as prolonged 
activation of glutamate receptors in injury-induced receptor function (Hayes et al., 1988).  The 
classic hypothesis of increased EAA receptor activation is comprised of two components where 
the first phase involves an alteration in Na
+
 and Cl
-
 concentrations inducing immediate cell 
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swelling and cell death, while the second phase is Ca
2+
-dependent cell degeneration (Arundine 
and Tymianski, 2004).  Specifically, increased Ca
2+
 induces downstream neurotoxic cascades 
including mitochondrial dysfunction and stimulation of calpains, nitric oxide synthase (NOS), 
and other kinases known to play a role in structural damage (Arundine and Tymianski, 2004).  
Isolated studies have shown that mechanical cell deformation alone is responsible for altered 
glutamate receptor function (Zhang et al., 1996) and Na
+
/Ca
2+
 exchange in cortical astrocytes 
(Floyd et al., 2005), and neuronal stretch enhances AMPA receptor-medicated currents (Goforth 
et al., 1999).  Further, evidence in experimental models of mTBI have demonstrated the 
excessive release of acetylcholine and other EAAs in the hippocampus (Gorman et al., 1989; 
Katayama et al., 1989), and also show that treatment blocking these neurotransmitter receptor 
subtypes can decrease long term cognitive deficits (Hayes et al., 1986; Lyeth et al., 1988).  This 
detrimental release of EAAs is exacerbated by breakdown of the BBB (Tanno et al., 1992; 
Shapira et al., 1993), an event which further induces the release of cytokines (Das et al., 2012) 
and other plasma proteins (Hoshino et al., 1996).  Together this cytotoxic cascade compounds 
TBI insult, manifesting in vasogenic edema presenting as elevated intracranial pressure (ICP) in 
the clinic which leads to further secondary injury when left untreated (Klatzo, 1987; Bullock et 
al., 1998; Schilling and Wahl, 1999). 
 
Traumatic Brain Injury Inflammatory Response 
 Mechanisms underlying BBB breakdown are currently unknown, however reduced BBB 
integrity after TBI is likely due to altered NOS-mediated release of nitric oxide (NO), a molecule 
key in the regulation and maintenance of cerebral blood flow and ionic membrane flow (Janigro 
et al., 1994; Kobari et al., 1994; Cobbs et al., 1997; Lu et al., 2001).  BBB disruption is 
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detrimental as this structure normally provides a stable neurochemical environment, essential for 
optimal central nervous system (CNS) function (Saunders et al., 1999; Habgood et al., 2007).  
When intact, the BBB harbors numerous intercellular tight junctions which prevent the 
transmission of large molecules (Ek et al., 2003; Ek et al., 2006), but following injury, permits 
potentially toxic molecules to enter the CNS, and impair normal function (Habgood et al., 2007).  
Certain molecules which pose such a threat are cytokines and chemokines released during post-
traumatic CNS inflammation involving glial cell activation and the recruitment of leukocytes 
(Morganti-Kossmann et al., 2001; Ziebell and Morganti-Kossmann, 2010).  In models of closed 
head injury (CHI), studies indicated an increase in tumor necrosis factor-α (TNF-α), a cytokine 
important in the inflammatory immune response during injury and repair, (Hofman et al., 1989; 
Shohami et al., 1994), IL-6, a cytokine secreted by CNS cells, reportedly elevated following 
human TBI (Breder et al., 1988; Spangelo et al., 1990; Young et al., 1992; Frugier et al., 2010), 
and IL-1, a prototypic inflammatory cytokine which acts in the brain to regulate the acute 
immune response (Rothwell and Luheshi, 2000).  In addition, even diffuse TBI models show a 
neuroinflammatory response as early as 6 hours postinjury, characterized by microglial 
activation localized to injured axons (Kelley et al., 2007). 
While the inflammatory response is likely initiated in attempt to promote neurological 
repair mechanisms (Correale and Villa, 2004; Lucas et al., 2006), it remains to be determined 
whether TBI-induced inflammation plays a protective or deleterious role (Shohami et al., 1999; 
Morganti-Kossmann et al., 2002) as cytokines have the ability to promote both neurotoxicity and 
neuroprotection (Morganti-Kossmann et al., 2007).  The initiation of early inflammatory 
activation is thought to be induced by several factors including reactive oxygen species (ROS) 
and NO, and is supported by both resident microglia (Juliet et al., 2008) and astroglia which have 
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the ability to secrete cytokines after monitoring the injured environment (Singhal et al., 2002; 
Cederberg and Siesjo, 2010).  Microglial response is instrumental in the removal damaged 
neurons and cellular debris, necessary for the progression of effective tissue remodeling.  During 
this process, however, microglia are also responsible for the release of ROS, NOS, and 
glutamate, which, as previously mentioned, may be detrimental to neuronal recovery 
(Kreutzberg, 1996; Ziebell and Morganti-Kossmann, 2010).  Similar to EAA release, cytokines 
can be responsible for trauma-induced edema in the brain, subsequent increased ICP (Yamasaki 
1992), and potentially contribute to delayed neuronal damage (Lucas et al., 2006; Cederberg and 
Siesjo, 2010).  Initial studies evaluating inflammatory response after TBI indicated a deleterious 
role as IL-1 was found to exacerbate neuronal injury (Rothwell, 1999).  Additional animal 
studies support the damaging effects of inflammatory cytokines by showing an improved post-
TBI neurological outcome when the acute inflammatory response is attenuated by over-
expressing interleukin-1 receptor antagonist (IL-1ra) (Relton and Rothwell, 1992; Loddick and 
Rothwell, 1996; Tehranian et al., 2002; Lucas et al., 2006) or pharmacologically inhibiting TNF-
α (Shohami et al., 1997).  More recent studies utilizing S-nitrosoglutathione, a metabolite of 
NO/glutathione reaction which nitrosylates proteins as a protective strategy show increased 
neurological repair after TBI, protecting the CNS against excitotoxicity, inflammation, and ROS 
(Khan et al., 2011).  Further, anti-inflammatory treatments aimed at developing therapy for 
human TBI have demonstrated transient neuroprotection after injury.  
Minocycline, a tetracycline derivative capable of inhibiting the immune response and 
inactivating microglia, has been used to test inflammatory role after TBI.  There is published 
evidence that it is neuroprotective in instances of SCI (Stirling et al., 2004; Teng et al., 2004), 
excitotoxicity (Tikka and Koistinaho, 2001; Tikka et al., 2001) and ischemic injury (Arvin et al., 
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2002; Wang et al., 2003; Xu et al., 2004; Morimoto et al., 2005), components of heterogeneous 
TBI insult.  Until recently, the positive effects of attenuating the early immune response with 
minocycline were largely understudied.  Original studies by Sanchez Mejia indicated a decrease 
in IL-1β was linked to improved neurological function and decreased lesion volume following 
CCI (Sanchez Mejia et al., 2001).  More recently the neuroprotective effects of acute 
minocycline administration has been replicated in studies of CHI (Bye et al., 2007), including 
evaluation of reduced cognitive and anxiety states (Siopi et al., 2012) and long term locomotor 
recovery (Homsi et al., 2009; Homsi et al., 2010).  Together, these studies suggest the positive 
effects of immune regulation in fostering functional recovery following TBI.   
Contrary to evidence that the inflammatory response produces deleterious effects, 
additional reports indicate cytokines may also be neuroprotective during the acute immune 
response.  Anti-inflammatory cytokines such as IL-10 provide neuroprotection following TBI 
(Knoblach and Faden, 1998; Csuka et al., 1999; Kremlev and Palmer, 2005) whereas deficiency 
in pro-inflammatory IL-6 is detrimental to recovery (Penkowa et al., 2000).  Studies utilizing 
TNF or TNF receptor KO mice indicated transgenic animals had exacerbated injury 
characterized by extensive BBB damage and impaired neurological function compared to wild 
type (WT) mice (Scherbel et al., 1999; Sullivan et al., 1999).  Finally, studies in cuprizone 
models of demyelination found that TNF-α promoted proliferation of oligodendrocytes to 
conduct remyelination within the corpus callosum (Arnett 2001), supporting the hypothesis that 
there are alternative cytokine receptors which facilitate opposing deleterious and protective roles 
(Correale and Villa, 2004).  The complexity of this immune response is seen with reported 
studies in chronic inflammatory neurodegenerative disease, which suggest that chronic 
inflammation (Wirths et al., 2010) and activation of microglia (von Bernhardi, 2007; Block et al., 
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2007) may underlie the long term detrimental effects of the immune response (Holmin and 
Mathiesen, 1999; Bartfai et al., 2007; Ramlackhansingh et al., 2011).  During TBI recovery, the 
combination of EAA toxicity (Miller et al., 1990; Arundine and Tymianski, 2004), BBB 
breakdown (Habgood et al., 2007), and excessive cytokine and chemokine release (Shohami et 
al., 1994; Morganti-Kossmann et al., 2002) may also lead to swelling and neuronal cell death 
(Dietrich et al., 1994; Raghupathi, 2004; Katayama et al., 1990), a process which also occurs as a 
result of apoptotic processes (Belousov et al., 2012; Dietrich et al., 1994; Kermer et al., 1999; 
Raghupathi, 2004).  Together, this suggests further studies must be completed to understand the 
mechanisms by which cytokines and their receptors interact in specific environments to induce 
neurodegenerative or neuroprotective processes after TBI.   
 
Traumatic Brain Injury Induces Neuronal Cell Death 
 Following TBI in both humans and experimental animal models, a degree of cell death is 
exhibited among neurons, oligodendrocytes, and astrocytes.  Certain areas within the brain are 
particularly vulnerable to cell death, namely the hippocampus, cortex, cerebellum, and thalamus 
(Adams et al., 1985; Kotapka et al., 1992; Ross et al., 1993).  In experimental animal models of 
TBI, injured neurons begin to swell, and can exhibit neurodegeneration as early as minutes to 
hours after initial insult (Sutton et al., 1993; Dietrich et al., 1994; Hicks et al., 1996).  It has been 
postulated that injured cells undergo a spectrum of cell death mechanisms ranging from 
apoptotic to necrotic pathways (Raghupathi et al., 2002; Portera-Cailliau et al., 1997; Nicotera et 
al., 1999).  Apoptotic mechanisms in the injured brains of rodents have been observed following 
mild lateral fluid percussion injury, particularly in subcortical white matter and cortical neurons 
(Raghupathi et al., 2002).  Interestingly mechanisms such as caspase- and calpain-mediated cell 
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death have been shown to play a role in both necrosis and apoptotic pathways (Squier et al., 
1994; Wang, 2000).  While both mechanisms appear to affect cell death after TBI, it appears that 
apoptosis is prominent in ischemic mechanisms of injury (Du et al., 1996), while necrosis 
potentially plays a large role in cell death after moderate to severe TBI (Conti et al., 1998; 
Newcomb et al., 1999).  Independent of the mechanism behind cell death, it is a large component 
of the consequences of TBI and may even manifest in delayed or chronic neuronal degeneration 
over time (Hicks et al., 1996; Conti et al., 1998). 
 
Traumatic Brain Injury-Induced Axonal Injury 
In addition to cell death, injury to the axonal compartment also occurs.  Current literature 
has demonstrated that even mTBI induces diffuse axonal injury (DAI) without loss of 
consciousness (Browne et al., 2011), and may be responsible for long term cognitive damage 
(Molgaard et al., 1990; Hillier et al., 1997; Asikainen et al., 1998) or predisposition for other 
neurodegenerative disorders (Graves et al., 1990; Fleminger et al., 2003).  DAI is a major 
component underlying the morbidity and mortality linked to TBI, and as a result has been the 
focus of multiple imaging, biomarker, and high throughput studies in attempt to generate novel 
therapeutic TBI treatments (Smith et al., 2013).  Rapid acceleration and deceleration of the head 
subjects the brain to mechanical forces, deforming the axons which become particularly 
vulnerable in such situations (Gennarelli et al., 1982; Meaney et al., 1995; Smith et al., 1997; 
Smith and Meaney, 2000).  DAI is a condition where damaged axons manifest local axonal 
swellings that appear like a beaded string, injury most commonly found in white matter tracts 
such as the corpus callosum, parasagittal white matter, internal capsule, and thalamus (Graham et 
al., 1988; Adams et al., 1989; Adams et al., 1991; Graham et al., 1995; Gultekin and Smith, 
 13 
1994).  The diffuse nature of DAI is characterized by the integration of both damaged and intact 
axonal fibers, a term utilized only in humans and large gyrencephalic animal models.  This is 
opposed to rodent TBI models which have less widespread axonal damage, but rather focal fiber 
damage termed traumatic axonal injury (TAI) (Smith et al., 2013). 
Original postmortem histological identification of human DAI utilized hematoxylin and 
eosin, silver staining, the Palmgren technique, and/or myelin staining to locate axonal and 
preterminal swellings, as well as the histological confirmation of Wallerian degeneration (Strich, 
1961; Adams et al., 1989; Rand and Courville, 1946).  These techniques, however, have been 
replaced by amyloid precursor protein (APP) staining in both humans and experimental animal 
models (Gultekin and Smith, 1994; Sherriff et al., 1994; Gentleman et al., 1993; Gentleman et 
al., 1995; Grady et al., 1993; Graham et al., 2004; Ng et al., 1994; Christman et al., 1994).  APP 
staining is now the gold standard in identifying DAI/TAI due to the easily identifiable APP 
pooling at local swelling following injury-induced disruption of anterograde axonal transport 
(Povlishock, 1992; Povlishock and Christman, 1995).  APP antibody detection of axonal injury 
has been a cornerstone development, paving the way for subsequent studies which have extended 
the knowledge regarding persistent traumatic injury and its role in the late development of 
neurodegenerative disorders (Chen et al., 1999; Chen et al., 2004; Johnson et al., 2012a; Johnson 
et al., 2012b).  APP staining can be identified in two types of TBI pathology: as retraction bulbs 
in disconnected axons, and axonal varicosities in intact axons (Adams et al., 1989; Smith and 
Meaney, 2000; Povlishock et al., 1983; Povlishock and Kontos, 1985; Povlishock and Becker, 
1985; Povlishock and Katz, 2005).  Reactive axonal swelling in injured axons often progress to 
axonal disconnection, supporting development of partial transport interruption at multiple 
locations (Tang-Schomer et al., 2012).  Pathologically, these reactive axonal swellings appear as 
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early as a few hours postinjury, and began to enlarge within the first 2d after injury.  Further, 
more severe injury induces Ca
2+
 dysregulation, contributing to the disruption of the spectrin and 
ankyrin network which occurs concurrently with mitochondrial and cytoskeletal damage, sealing 
off the distal end of the swelling resulting in the hallmark axonal bulb (Povlishock et al., 1983; 
Povlishock and Kontos, 1985; Povlishock et al., 1992; Povlishock and Katz, 2005).  Importantly, 
this chemical imbalance has been found to be the key in triggering the cytoskeleton breakdown 
and progressive swelling which leads to cognitive and neuronal impairment (Povlishock, 2000; 
Stone et al., 2004; Marmarou et al., 2005; Buki and Povlishock, 2006).  Together, 
neuroexcitation and the inflammatory process which incite neuronal swelling, as well as 
subsequent neurodegeneration and axonal swelling, ultimately induce complete axotomy similar 
to that of Wallerian degeneration (Povlishock et al., 1992).  This process leads to downstream 
degeneration of axon terminals and synaptic deafferentation, pathology which occurs in both 
human injury and experimental models of TBI (Grady et al., 1989; Kotapka et al., 1992; 
Steward, 1989; Erb and Povlishock, 1991). 
 
NEUROPLASTICITY AND RECOVERY FROM TRAUMATIC BRAIN INJURY 
Deafferentation-Induced Synaptogenesis 
Following traumatic insult, the CNS undergoes inherent cell death and a loss of synaptic 
connections as a result of axonal damage and deafferentation (Erb and Povlishock, 1991; 
Povlishock and Katz, 2005).  Restoring neuronal function requires the synaptic networks to 
transition from injured synapses to initiating the synaptic recovery process.  Despite initial 
theories describing the adult CNS as a hard-wired structure, neuronal plasticity in mature 
systems has become an accepted theory since the first description of experience-dependent 
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plasticity describing the modification of synapses following activation (Hebb, 1949; Keyvani and 
Schallert, 2002).  After traumatic injury, early studies within the spinal cord (Liu and Chambers, 
1958), brain stem (Goodman and Horel, 1966), septal nuclei (Raisman, 1969),  superior 
colliculus (Lund and Lund, 1971), and the hippocampal dentate gyrus (Steward, 1976; Lynch et 
al., 1976; Scheff et al., 1977; Christman et al., 1997; Hulsebosch et al., 1998; Harris et al., 
2010a) have demonstrated that the CNS is a plastic structure with the capacity to rewire lost 
connections, and does so in time-dependent stages.  As previously described, traumatic insult to 
the CNS induces a number of pathophysiological cascades, DAI, and subsequent deafferentation, 
processes which then initiate reactive synaptogenesis.  This recovery following injury occurs in 
well-defined phases within the local extracellular matrix (ECM).  Recovery is mediated through 
several cell types, and depends upon a variety of molecules, such as cytoskeletal proteins, cell 
adhesion molecules (CAMs), growth factors, matrix proteins, and matrix enzymes like the matrix 
metalloproteinases (MMPs) to effect synaptic reorganization of dendritic and somatic synaptic 
contacts.  To further understand this process of injury-induced reactive synaptogenesis, both 
human TBI victims and experimental TBI models which express the deafferentation underlying 
clinical deficits have been used to evaluate the specific cellular and synaptic players following 
traumatic injury (Cotman and Nadler, 1978; Grady et al., 1989; Steward, 1989; Phillips and 
Reeves, 2001).  
As noted above, several areas of the brain are particularly vulnerable to TBI-induced 
damage including the cortex, cerebellum, thalamus, and hippocampus (Adams et al., 1985; 
Kotapka et al., 1992; Ross et al., 1993).  Given the importance of these structures in key brain 
functions, these locations serve as useful models to study the process of synaptic and neuronal 
recovery after injury.  Specifically, studies utilizing rodent models of synaptic deafferentation 
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Figure 1.1  Stages of Reactive Synaptogenesis.  Following deafferentation normal synapses 
(A) first undergo a degenerative phase (1-5d postinjury; B) characterized by reactive glia (gl) 
which remove degenerating terminals (d).  Next, synapses enter the regenerative phase (6-15d 
postinjury; C) where sprouting of new axons occurs (arrows) before maturing during 
stabilization (15d+ postinjury; D) (Steward et al., 1988a). 
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have documented time-dependent stages of synaptic recovery after injury in the dentate gyrus 
(DG) (Loesche and Steward, 1977) (Fig. 1.1).  The DG receives the main afferent pathway into 
the hippocampus, and serves as a structure involved in memory and cognition, often affected in 
TBI patients.  During deafferentation, there is a loss of synaptic input, inducing the death of 
affected axonal projections and terminals (Cotman et al., 1981).  Early after injury (1-5d 
postinjury) affected synapses enter a degenerative phase where lesioned axon terminals and 
debris are removed from the site of injury.  The next stage is an intermediate stage (6-15d 
postinjury) when new synapses form by collateral axonal sprouting and terminal generation 
innervates reorganized postsynaptic sites (Lynch et al., 1976; Steward, 1976; Deller et al., 2007; 
Frotscher et al., 1997) .  Finally, in the third stage, the newly repaired synapses undergo 
stabilization (15d+ postinjury) where synapses mature and are strengthened both structurally and 
functionally (Steward and Vinsant, 1983).  These specific stages of synaptic reorganization are 
integral to understanding how synaptic networks recover from injury, and can be further studied 
to ascertain which molecular players permit effective synaptic reorganization within the local 
ECM.  
During the acute postinjury degenerative period, neurons become deafferented, and their 
synaptic structure undergoes altered morphology.  One of the key features contributing to lasting 
CNS impairment seen in TBI patients is the early loss of synaptic input characterized by initial 
changes in dendritic shape and spine density, as well as axonal degeneration (Matthews et al., 
1976a; Adams et al., 1982; Kim et al., 2006).  Underlying these changes in dendritic number and 
morphology are proteins which likely interact with structural components such as microtubules 
and intermediate filaments.  Recent evidence indicates alterations in microtubule associated 
proteins (MAPs) which decrease after ischemia (Tanay et al., 2006), but conversely increase 
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after axotomy of the trochlear nerve (Book et al., 1996) as well as following optic nerve crush 
(Dieterich et al., 2002).  Although these results show opposite effects, they provide evidence for 
the potential use of MAPs in identifying injured synaptic structures.  Further, MAPs may play a 
role in synaptic recovery as they are important in axonal outgrowth during development and 
cortical wiring (Gordon-Weeks and Fischer, 2000; Yamanouchi, 2005) as well as after injury 
(Ma et al., 2000; Ramon-Cueto and Avila, 1999).  Dendritic reorganization also involves 
microtubule plasticity (Tortosa et al., 2011), and is an equally important component in the 
process of trauma-induced synaptic reorganization demonstrated in several models of CNS 
deafferentation (Cotman et al., 1981).  
 
Inflammation, Neuroglia, and Synaptic Plasticity 
During this early phase of dendritic morphological changes and synaptic terminal loss, 
the inflammatory response is one of the first cellular pathways to respond (Martino et al., 2011; 
Marchetti and Pluchino, 2013).  Acute response after injury and subsequent synaptic recovery is 
dependent on these early mechanisms which permit the effective conditioning of the ECM.  
After trauma, the afore mentioned damage to synapses and neurons is significant, requiring the 
interaction of multiple cell types and molecules such as glia, neurons, and cytokines to repair the 
injured terminals (Aloisi et al., 1992; Aloisi, 2001).  One of the first inflammatory cell types to 
arrive at the site of injured synaptic terminals in the inflammatory cascade are microglia.  
Microglia are well known for their function in inflammatory immune response through 
their secretion of cytokine and chemokine signals (Aloisi, 2001).  In addition to secreting these 
molecules, microglia are also often the target of these signals through both autocrine and 
additional paracrine signaling with neurons, astrocytes, and immune cells (Polazzi et al., 2001; 
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Hanisch, 2002).  Microglia can also act as sensors of their environment (Nimmerjahn et al., 
2005) and are often the very first responders to trauma regardless of the organ system involved 
(Kreutzberg, 1996).  Although inflammation is a mechanism for repair, it can also serve as a 
damaging insult.  In lipopolysaccharide-induced inflammation, the site is surrounded by 
activated microglia which can induce neurodegeneration compared to controls (Ekdahl et al., 
2003).  Prevention of this neurodegeneration was effected through blockade of microglial 
response, implicating microglial activation in inflammatory neurodegeneration.  These glia may 
also regulate cell death through apoptosis (Piani et al., 1991).  Microglia-induced apoptosis, 
however, can be extremely variable regarding the mechanisms involved.  For example, various 
studies have reported microglial apoptosis through different pathways, including cathepsin B in 
hippocampal and cerebellar neurons (Kingham and Pocock, 2001), as well as ROS (Colton and 
Gilbert, 1987), NO, and interleukin 1β (IL-1β ) (Chao et al., 1992; Tikka and Koistinaho, 2001). 
In addition to modulating neuronal cell death, microglia can affect neuronal survival 
through the release of anti-inflammatory factors, and secretion of trophic factors (Polazzi et al., 
2001).  Initial descriptions of microglial role in synaptogenesis came with cortical development 
in the early weeks of postnatal life, when maximum microglial numbers correspond with high 
levels of synaptogenesis in nervous tissue (Steward and Falk, 1986). Temporal correlation of this 
microglial surge and synaptogenesis in development implies a potential role for microglia in 
synaptic reorganization after injury.  Microglial mechanisms of reorganization are supported by 
evidence that these cells are capable of secreting many proteins involved in synaptogenesis and 
neural plasticity, such as brain derived neurotrophic factor (BDNF) and thrombospondin 
(Chamak et al., 1995; Binder and Scharfman, 2004; Christopherson et al., 2005; Bessis et al., 
2007; Lipsky and Marini, 2007).  BDNF in particular can be expressed by microglia after TBI 
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(Nagamoto-Combs et al., 2007) and focal ischemia (Madinier et al., 2009).  Studies indicate that 
interruption of the inflammatory response after focal brain ischemia decreases microglial 
activation.  This decrease in microglial activation results in a decrease in BDNF and 
synaptophysin expression, known markers of synaptogenesis and neuroplasticity (Madinier et al., 
2009; Valtorta et al., 2004).  Decreased levels of neurotrophic factors and synaptic markers in the 
absence of microglial activation indicate that microglia are essential for synaptogenesis.  In 
addition to microglial role in synaptogenesis after ischemia, Moller and colleagues describe 
microglial secretion of thrombospondins after axotomy of the facial nucleus (Moller et al., 1996).  
Although it may seem contradictory that these cells appear to have the ability to induce both 
neurodegeneration and neurogenesis, evidence that not all microglia express the same proteins 
(Ellison et al., 1998) suggests there are multiple microglial subpopulations exhibiting different 
roles in neuronal survival or neuronal cell death (Byrnes et al., 2006; Ekdahl et al., 2009).  
Furthermore, Ekdahl and colleagues (2009) contend that microglial role in neurodegeneration 
and neurogenesis is dependent on the surrounding pro- and anti-inflammatory molecules. This 
largely implies that synaptogenesis is sensitive to its environment, and no single molecule 
inherently plays a defined role in synaptic survival or loss.  Overall, this data points to complex 
repair mechanisms involving microglial surveillance of the injured environment. 
As resident macrophages of the brain, microglia play a direct role in the degenerative 
phase of synaptic reorganization by engulfing debris, degenerating terminals, and damaged 
synaptic structures (Colton and Gilbert, 1987; Chao et al., 1992; Ramlackhansingh et al., 2011; 
Bechade et al., 2013; Bessis et al., 2007).  Despite the fact that a majority of the microglial 
literature focuses on their ability to take up and process cell debris, microglia actually have a 
diverse set of functions as they are able to secrete and interact with a number of molecules.  For 
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example, microglia are also capable of inducing superoxide anions and NO in apoptotic 
pathways (Colton and Gilbert, 1987; Chao et al., 1992), potentially contributing to the reshaping 
of injured synapses during trauma-induced reorganization (Ramlackhansingh et al., 2011; 
Bechade et al., 2013; Bessis et al., 2007).  As an immune response cell, many microglia are also 
capable of secreting and interacting with a number of cytokines and chemokines (Hanisch, 
2002).  As early mediators of inflammation after trauma, microglia are instrumental in 
establishing regenerative boundaries of synaptic plasticity by interacting with a number of ECM 
molecules (Takeuchi et al., 1998).  Other types of molecules which are secreted by microglia and 
function in the first phase of reactive synaptogenesis are the ECM proteoglycans and MMPs.  
The MMPs play a major role in the degenerative phase as they have the ability to target multiple 
substrates to break down structural components of the local ECM around synapses (Ethell and 
Ethell, 2007; Ding et al., 2009; Dziembowska and Wlodarczyk, 2012; Harris et al., 2009).  While 
microglia are key to debris clearance during the acute recovery phase, they are also instrumental 
in the next phase of reactive synaptogenesis, regeneration (Graeber et al., 1998).  The modulation 
of neurogenesis and synaptogenesis during this regenerative phase is not restricted to microglia, 
but involves reactive astroglia, which have the ability to modify functional synapses both directly 
and indirectly (Bechmann and Nitsch, 2000; Christopherson et al., 2005; Ekdahl et al., 2009; 
Bechade et al., 2013). 
 Like microglia, astroglia can secrete cytokines (Semple et al., 2010), however their role 
in recovery after trauma has been traditionally described in terms of glial scar formation, as 
exemplified with SCI (McKeon et al., 1991).  Historically, astrocytes have been considered 
physiologically important in the maintenance of CNS homeostasis, supporting neurons through 
nutrition, recycling neurotransmitters, and maintaining the integrity of the BBB (Abbott, 2002; 
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Pellerin and Magistretti, 2004; Wilhelmsson et al., 2006).  Recent studies have further described 
the importance of astrocytes in neuronal repair, showing their ability to direct synaptic plasticity 
(Ullian et al., 2001; Christopherson et al., 2005) .  Following injury, astrocytes undergo reactive 
astrogliosis as they respond with a number of morphological and physiological changes, 
principally increased GFAP supporting hypertrophy and/or thickening and elongation of cellular 
processes (Amaducci et al., 1981; Baldwin et al., 1996; Wilhelmsson et al., 2006).  As a result of 
their reactive morphology, astrocytes become involved in the neuronal repair and recovery 
process by first forming a glial scar (Bignami and Dahl, 1976) .  While reactive gliosis in the 
glial scar has often been described as an inhibitory to axonal regeneration, serving as barrier to 
axonal sprouting (Matthews et al., 1976a; Liuzzi and Lasek, 1987; Silver and Miller, 2004; 
Goldshmit and Bourne, 2010), it is now thought to also serve a positive role in preventing the 
spread of injury to neighboring intact tissue (Matthews et al., 1979; Sofroniew, 2005; White and 
Jakeman, 2008).  While such barrier formation may be part of the astrocytic role after TBI, 
reactive astrocytes also serve an important role in repair through their interaction with a number 
of ECM proteins and growth factors to facilitate effective neuronal recovery (Laird et al., 2008). 
 
EXTRACELLULAR MATRIX AND NEUROPLASTICITY 
The ECM is the lattice network of multiple proteins and molecules which help organize 
the structure of the brain, as well guide the development, maturation and growth of synapses 
(Ruoslahti, 1996a; Venstrom and Reichardt, 1993; Dityatev and Schachner, 2003).  The ECM is 
the major structural component providing stability among cells and tissues, however this 
complex network of neurons and glia appears to play a dominant role in plasticity within the 
CNS.  While it is often described as less organized in the CNS compared to other organ systems, 
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this may be due to the extensive amount of proteolysis it undergoes during the continuous 
remodeling necessary for development and the maintenance of ongoing plasticity (Pittman and 
Buettner, 1989; Romanic and Madri, 1994).  Moreover, the ECM in the brain contributes to 
neuronal homeostasis, and its diffuse distribution of proteins mediate interactions among CNS 
cellular components (Jones, 1996; Yong et al., 1998).  For example, integrins are glycoproteins 
expressed on the cell surface of CNS neurons, glia, meningeal, and endothelial cells which signal 
cell-cell and cell-ECM interactions (Hynes, 1992; Milner and Campbell, 2002).  Several integrin 
binding proteins, including cytokines and chemokines, are released into the ECM to mediate 
such cellular signaling.  Structurally, integrins consist of mixed dimers from α- and –β subunits, 
which introduces another level of variability for ECM interaction, and the ability to affect a 
number of physiological processes such as cellular organization and synaptogenesis during 
neuronal development (Miyagoe-Suzuki et al., 2000; Benson et al., 2000; Graus-Porta et al., 
2001). 
 As ECM proteins play a large role in the synaptogenesis during development, they also 
influence the success of synaptic reorganization following traumatic insult.  Throughout reactive 
synaptogenesis, there are a number of cell types and molecules which act in concert to promote 
the regeneration of functional synapses.  Cells such as microglia (Giulian et al., 1989; Chao et 
al., 1992; Bessis et al., 2007; Ekdahl et al., 2009), astroglia (Christopherson et al., 2005), and 
olfactory ensheathing cells (OECs) (Barnett, 2004) are critical players in this process as they 
have the ability to interact with a number of ECM molecules to direct the different phases of 
synaptic reorganization  (Steward, 1989; Ullian et al., 2001).  Specifically, microglial response to 
injury is characterized by the secretion of a number of molecules including cytokines (Hanisch, 
2002), MMPs (Gottschall et al., 1995), and proteoglycans (Yokoyama et al., 2006).  In addition, 
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microglia also interact with these cytokines and matrix molecules to facilitate reshaping of ECM 
protein structure during the acute degenerative phase (John et al., 2003; Ethell and Ethell, 2007).  
Following deafferentation-induced degeneration, there is often an increase in reactive astrocyte 
interaction with synapses, suggesting that the acute immune response may also serve to recruit 
astrocytes and induce their secretion of growth factors (Goss et al., 1998; Madathil et al., 2013) 
and MMPs (Wells et al., 1996; Muir et al., 2002) to direct sprouting of new terminals during 
synapse regeneration (Falo et al., 2008; Warren et al., 2012).  With regard to synaptic recovery, 
these matrix molecules interact with glial cells to establish the integrity and structure of 
synapses, as well as promote their stabilization and function (Dityatev and Schachner, 2003; 
Dityatev and Schachner, 2006; Busch and Silver, 2007; Frischknecht and Seidenbecher, 2008).  
For example, growth factors secreted by astrocytes are well-documented to influence axonal 
sprouting and neurogenesis after CNS injury (Nieto-Sampedro and Bovolenta, 1990; Deller et 
al., 2006; Thau-Zuchman et al., 2010).  Secreted MMPs can convert pro forms of these 
molecules into active growth factors, as well as mediate their interaction with other glia-secreted 
ECM molecules such as proteoglycans and CAMs important for synapse regeneration.  Both 
microglia and astroglia are sources of various proteoglycans and CAMs (Bandtlow and 
Zimmermann, 2000; Redies, 2000),  and in vitro studies show that astrocyte cultures can be 
easily induced to increase their secretion of certain proteoglycans (Snyder et al., 1996; Canoll et 
al., 1996; Dobbertin et al., 2003).   
 
Proteoglycans and Cell Adhesion Molecules Influence Synapse Formation 
Proteoglycans are a diverse group of glycoproteins important in forming the structural 
integrity of the ECM around synapses, and are found in both secreted and transmembrane forms 
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(Harris et al., 2009).  This family of proteins can be subdivided into different groups based on 
their glycosaminoglycan (GAG) sidechains: chondroitin/dermatan sulfate (CSPG/DSPG), 
heparan sulfate (HSPG), and keratan sulfate.  CSPGs and HSPGs have been studied the most in 
the context of synaptic plasticity due to their role in synaptic development and proximity to the 
synapse (Bandtlow and Zimmermann, 2000).  One HSPG, agrin, can affect synaptic plasticity 
through its binding to growth factors and CAMs, inducing growth of shorter, branched axons 
important for postsynaptic targeting, as well as increased vesicles at pre-and post-synaptic 
densities (Mantych and Ferreira, 2001).  Agrin was first discovered in the ECM of the Torpedo 
electric organ at the neuromuscular junction (Godfrey et al., 1984), and postulated to be a 
neuronally secreted protein to direct formation of the postsynaptic membrane at the 
neuromuscular junction (NMJ).  Subsequent cloning of the agrin gene in various systems 
including the rat (Rupp et al., 1991) and chicken (Tsim et al., 1992) led to the development of 
agrin KO mice.  These agrin-deficient mice failed to form the NMJ, supporting this proteoglycan 
as a key molecule in synaptic organization (Gautam et al., 1996).  Other studies have focused on 
the acetylcholine receptor (AChR) aggregating properties of agrin, demonstrating its function 
during the window of development when synaptogenesis occurs (Ma et al., 1994; Stone and 
Nikolics, 1995; Li et al., 1997).  Further, agrin is present in high amounts in areas of adult 
synaptic plasticity such as in the cortex, hippocampus (O'Connor et al., 1994), and within 
interneuron synapses (Mann and Kroger, 1996; Gingras and Ferns, 2001; Hoover et al., 2003; 
Ksiazek et al., 2007).  In addition to playing a role in postsynaptic development, CSPGs can 
promote axonal outgrowth.  The CSPG family consists of versican, neurocan, phosphacan, 
brevican, and NG2, each of which contain a protein core with a GA side chain, but differ in the 
level of sulfation (Morgenstern 2002).  Although CSPGs were initially viewed as inhibitory to 
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axonal outgrowth during plasticity (Snow et al., 1990; Oohira et al., 1991; Grumet et al., 1993), 
recent evidence suggests certain types of CSPGs are integral during axonal sprouting following 
TBI (Harris et al., 2010b), often interacting with CAMs and growth factors during trauma 
induced-plasticity (Faissner et al., 1994; Bicknese et al., 1994; Sakurai et al., 1997; Schafer et al., 
2008).  Specifically, versican mRNA was increased within the glial scar 4-14 days following 
CCI, while decreased protein expression of all CSPGs was evident between 1-14d postinjury.  
CSPG reduction was concentrated within the pericontusional area, highlighting the importance of 
spatial and temporal parameters in the evolution of plasticity following TBI (Harris et al., 2009).  
Further studies support a strict window of spontaneous cortical sprouting, a process which was 
maximal at 6-14d in pericontusional regions and absent at 28d postinjury (Harris et al., 2010a).  
In addition to guiding axonal outgrowth, CSPGs functional domains interact with other 
ECM molecules near the synaptic junction to permit effective synaptic plasticity (Miyata et al., 
2004; Harris et al., 2011), including CAMs which are known to affect brain connectivity during 
development and throughout life (Doherty and Walsh, 1992; Benson et al., 2000).  One CAM 
family important in synaptic plasticity during both development and after trauma are the 
cadherins, a subset of Ca
2+
-activated cell to CAMs present at the synaptic junction (Beesley et 
al., 1995; Shapiro and Colman, 1999; Redies, 2000).  Specifically, cadherins are active in the 
hippocampus where they are present within extended filopodia and mature synapses (Takeichi 
and Abe, 2005), likely regulating postsynaptic dendritic morphology (Togashi et al., 2002).  
While there are 80 different types of cadherins, roughly 20 of these are so-called ‘classic’ 
cadherins, distinguishable from the remaining protocadherins, and have been extensively studied.  
The classic cadherin nomenclature is derived from the tissue of their original discovery location: 
E-cadherin (epithelial), N-cadherin (neural), P-cadherin (placental), and R-cadherin (retinal) 
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(Huntley et al., 2002).  Of importance to synaptic plasticity is N-cadherin, a CAM family 
member which has been localized to optic axons during arborization (Yamagata et al., 1995), as 
well as in both pre-and post-synaptic sites, and the synaptic cleft of hippocampal synapses 
(Fannon and Colman, 1996; Bozdagi et al., 2000).  While there is evidence that N-cadherins play 
a key role in the sprouting and synapse reorganization after trauma (Warren et al., 2012), it is not 
known whether the acute immune signals generated by TBI alter their response during periods of 
synaptic recovery. 
 
Matrix Metalloproteinases and Synaptogenesis 
Another group of molecules secreted into the ECM by glia are MMP family members, 
enzymes which can modify the local matrix around the synapse, and interact with growth factors, 
proteoglycans, and CAMs to facilitate reactive synaptogenesis.  The MMPs belong to a family of 
over 20 secreted Zn
2+
/Ca
2+
-activated proteolytic enzymes which have the ability to modify 
and/or degrade the ECM in both physiologic and pathogenic conditions (Romanic and Madri, 
1994; Asahi et al., 2001a).  These proteases are capable of activating and inactivating receptors, 
adhesion molecules, and growth factors during embryonic development, wound healing, and 
angiogenesis (Van Hove et al., 2012; Verslegers et al., 2013).  Relevant to CNS plasticity, 
MMPs may act to condition the ECM during the early stages of reactive synaptogenesis, 
facilitating synaptic recovery after trauma (Wee Yong, 2010).  While all MMPs have a similar 
structural organization, including a signaling peptide and catalytic domain, they may be further 
subdivided by their substrate specificity into the collagenases, gelatinases, stromelysins, 
matrilysins, and membrane-type MMPs (MT-MMPs) (Nagase et al., 2006).  MMPs are initially 
produced as inactive zymogens (pro-MMPs) and become active following cleavage of the 
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propeptide domain, which releases the regulatory Zn
2+
-cysteine bond at the catalytic site,   
permitting functional activity (Van Wart and Birkedal-Hansen, 1990; Becker et al., 1995).  MMP 
proteolytic activity can also be indirectly regulated by a number of mechanisms, including cell 
compartmentalization, post-translation modification, and endogenous tissue inhibitor of matrix 
metalloproteinases (TIMPs) which non-covalently bind to MMPs (Baker et al., 2002; 
Chakraborti et al., 2003).  
 Considerable attention has been focused on these proteinases and their molecular 
substrates as effectors of reorganization during synaptic plasticity (Yong et al., 2001; Lo et al., 
2002; Dityatev and Schachner, 2003; Yong, 2005; Wlodarczyk et al., 2011).  In the CNS, these 
enzymes are also capable influencing axonal growth, mediate synaptic modification (Szklarczyk 
et al., 2002; Vaillant et al., 1999; Fredrich and Illing, 2010), and critical to synaptic recovery 
following injury (Yong et al., 2001; Dityatev and Schachner, 2003).  As previously mentioned, 
these modulators of synaptic plasticity may be secreted by glia, and stimulate process outgrowth 
or cell signaling pathways by activating surface receptors (Oh et al., 1999; Giraudon et al., 1997; 
Sternlicht and Werb, 2001).  Prior studies in our laboratory have linked aberrant MMP activity to 
disrupted synaptic reorganization following hippocampal deafferentation.  Membrane type 5-
matrix metalloproteinase (MT5-MMP) and a disintegrin and metalloproteinase-10 (ADAM-10), 
both cleave N-cadherin, a CAM instrumental in synapse stabilization.  Contrasting models of 
adaptive and maladaptive plasticity indicate persistent ADAM-10 expression during maladaptive 
plasticity is correlated with attenuated N-cadherin production and reduced functional recovery 
(Warren et al., 2012).  Further, time-dependent MMP inhibition can reduce ADAM-10 and shift 
N-cadherin expression toward that seen during adaptive synaptic recovery, highlighting the 
significant impact that MMPs can have on synaptic reorganization.  Our laboratory and other 
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groups have identified the stromelysins (MMPs-3,-10,-11) and gelatinases (MMP-2,-9) to be of 
critical importance in the pathophysiology of CNS injury and disease.  While MMP-3 and the 
gelatinases were initially thought to be detrimental proteases, disrupting the BBB and promoting 
further injury (Rosenberg et al., 1998; Van Hove et al., 2012), more recent studies support 
beneficial effects of these MMPs in CNS injury and disease.  MMP-3, for example, has been 
linked to successful axonal outgrowth following sciatic nerve crush (Demestre et al., 2004; 
Shubayev and Myers, 2004), and MMP-9 mediates dendritic remodeling during long term 
potentiation (LTP), a cellular model for learning and memory (Bozdagi et al., 2007; 
Dziembowska and Wlodarczyk, 2012).  Together, these studies implicate MMPs, particularly 
MMP-3 and the gelatinases as players in synaptic reorganization following TBI. 
 
Stromelysin-1 (Matrix Metalloproteinase-3) and Synaptogenesis 
              MMP-3, also known as stromelysin-1, has simple structure consisting of a hemopexin 
domain attached to the catalytic domain of the base MMP structure (Handsley et al., 2005).  
While typically found in neurons and glial cells, MMP-3 is capable of acting both intracellularly 
in dopaminergic neurons (Choi et al., 2008; Shin et al., 2012), as well as extracellularly, cleaving 
a number of substrates including ECM proteins, growth factors, CAMs, chemokines, and 
cytokines (Van Hove et al., 2012).  Although MMP-3 has been localized to various cell types, it 
is largely confined to neurons (Wetzel et al., 2003) within the developing healthy CNS, as well 
as expressed in high amounts during embryonic axonal outgrowth (Pauly et al., 2008).  
Additional studies detected MMP-3 in most areas of the adult brain, particularly within 
peripheral cell bodies and axons (Nordstrom et al., 1995), and functional activity confirmed via 
in situ zymography in the neocortex (Gonthier et al., 2007).  Further, MMP-3 KO mice exhibit 
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balance and hind limb motor deficits as adults, implicating this proteinase as key molecule in 
proper synaptogenic development (Van Hove et al., 2012).  MMP-3 has been demonstrated a 
number of studies to play an important role in CNS development, specifically during neurite 
extension (Machida et al., 1989) and axonal growth cone guidance and extension (Gonthier et al., 
2007).  Its role in synapse formation between granule cells and Purkinje cells in the mouse 
cerebellar cortex (Van Hove et al., 2012) further supports a role for MMP in proper CNS 
development, a process which may be achieved through the lytic activation of laminin (Okada et 
al., 1986), tenascin (Imai et al., 1994), or BDNF (Lee et al., 2001), molecules important in 
synaptic function.  In addition, MMP-3 may regulate myelination during development, given the 
elevated expression in oligodendrocytes and Schwann cells, and ability to promote insulin 
growth factor (IGF) release (Del Bigio and Jacque, 1995; Muir et al., 2002).  
MMP-3 functional role in synaptogenesis and reorganization however is not limited to 
the developing CNS, but has been shown to be important in plasticity within the adult brain.  
This MMP is of particular interest due to its increased postinjury expression in neurons and 
reactive astrocytes, and its targeting of ECM proteins important in axonal and synaptic growth 
(Imai et al., 1995; VanSaun and Werle, 2000; Muir et al., 2002).  Important to synaptic 
stabilization in the adult mammalian brain are the perineuronal nets (PNNs) comprised of a 
number of CSPGs, and their binding partners which act in concert to support dendrites and map 
synaptic contact organization within the ECM.  Essential to plasticity, is cleavage of the PNNs, a 
function accomplished by MMP-3 as evidenced by numerous studies showing that it cleaves all 
CSPGs (Muir et al., 2002; Durigova et al., 2011).  Further, MMP-3 is localized to PNNs during 
remodeling suggesting MMP-3 may direct synaptic plasticity in the adult brain (Baig et al., 
2008).  MMP-3 has also been localized to the NMJ in the PNS, and its cleavage of agrin and 
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intracellular adhesion molecule 5 (ICAM5) suggests an association with synaptic sprouting and 
dendritic spine maturation respectively (Van Hove et al., 2012).  Finally, transient MMP-3 
elevation is associated with learning during hippocampal-dependent tasks and inhibition of 
MMP-3 elicited learning deficits during passive avoidance training together implicate MMP-3 in 
effective hippocampal learning (Olson et al., 2008).  Given that MMP-3 expression and 
functional activity plays a role in proper synapse development through a number of cellular and 
molecular pathways during development, it may play an important role in immune regulation of 
synaptic regeneration following disease or trauma.  
 While MMP activity appears to play a beneficial role during development, evidence of a 
role regarding CNS disease and trauma has mixed results.  MMPs are elevated in all forms of 
neurological disorders, and MMP-3 has been identified as a molecule elevated during the 
inflammatory response related to CNS disease and trauma (Agrawal et al., 2008; Candelario-Jalil 
et al., 2009).  Cell culture studies examining LPS injection in neuronal astrocytes and microglia 
demonstrate a large increase in MMP-3 (Kim et al., 2007; Kim et al., 2008), supporting the 
reciprocal activation between glial cells and cytokines or matrix molecules.  Specifically, 
microglia-secreted TNF-α and IL-1β may act on microglia themselves to induce MMP secretion 
and activation within the ECM (Cross and Woodroofe, 1999; Gottschall and Yu, 1995; Crocker 
et al., 2006).  Further, activated MMP-3 is also capable of triggering microglial production of 
inflammatory cytokines such as TNF-α, IL-6, and IL-1β production (Kim et al., 2005; Kim et al., 
2007; Kim and Hwang, 2011), highlighting the complex nature of the molecular interaction 
between glial cells and MMPs during the acute immune response following CNS injury.  
Subsequent downstream effects of this response may be detrimental as demonstrated in multiple 
experimental models of Parkinson disease (PD) which show an increase of MMP-3 contributing 
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to neuronal damage in the substantia nigra (Sung et al., 2005; Kim et al., 2007; Choi et al., 2008; 
McClain et al., 2009).  Similar effects were seen in human pathology and experimental animal 
models of AD (Gottschall and Deb, 1996; Yoshiyama et al., 2000).  In addition to chronic 
inflammatory disease, MMP-3 is significantly elevated following traumatic injury in models of 
ischemia (Rosenberg et al., 2001; Sole et al., 2004), brain contusion (Li et al., 2009), and 
synaptic deafferentation (Kim et al., 2005).  While these various models all exhibit different 
methods of trauma, and report increased MMP-3 following injury, they do not address whether 
the MMP role is deleterious or beneficial.  Previous studies in our lab indicate the importance of 
temporal expression of MMPs as MMP-3 mRNA and protein were elevated acutely after 
adaptive UEC, supporting its role in synaptic recovery after TBI (Falo et al., 2006).  Increased 
MMP-3 expression during degenerative phase of synaptogenesis was present in both adaptive 
and maladaptive models however MMP-3 elevation persists over time with maladaptive synaptic 
plasticity, consistent with diminished removal of degenerating pre-synaptic terminals, damaged 
synapses, and the failure of both structural and functional synapse reformation (Falo et al., 2006).  
Interestingly, acute postinjury MMP inhibition (MMPi) also attenuates MMP-3 production, and 
reduces synaptic recovery (Reeves et al., 2003).  This result indicates that MMP-3 can serve a 
beneficial role during reactive synaptogenesis, depending upon its time of activation.  Together, 
these studies point to important MMP-3 interaction with ECM proteins during the acute 
inflammatory response after injury, and further experiments may elicit the mechanisms behind 
how this MMP activation mediates synaptic reorganization. 
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Gelatinases (Matrix Metalloproteinase-2, -9) and Synaptogenesis 
The gelatinases consist of MMP-2 (73 kD) and MMP-9 (92 kD), a subfamily of type IV 
collagenases studied extensively in multiple physiological processes including bone growth, 
blastocyst implantation, inflammatory disease, cancer, and cardiovascular disorders (Van den 
Steen et al., 2002; Stamenkovic, 2003; Klein and Bischoff, 2011).  Similar to the stromelysins, 
their structure is also fairly simple, consisting of a hemopexin domain and fibronectin repeats 
upstream of the catalytic site (Handsley et al., 2005).  Given that gelatinase activity is elevated 
during the development of pathological disorders, MMP-2 and MMP-9 are good candidates for 
modulation of the early phases of synaptic reorganization following TBI.  High levels of 
gelatinase mRNA have been documented in the CNS during neuronal development, particularly 
within the first postnatal week in various cell types such as pericytes and endothelial cells 
(Ayoub et al., 2005; Planas et al., 2001; Szklarczyk et al., 2002), however, the major sites 
showing upregulation are astrocytes for MMP-2 and myelinated tracts for MMP-9 (Planas et al., 
2001; Szklarczyk et al., 2002).  Evidence in the developing CNS indicates that both MMP-2 and 
MMP-9 direct the migration of neural crest cells (NCCs), neural stem cells (NSCs), neurons, and 
astrocytes.  Interestingly, MMP inhibitor studies showed impaired NCC and NSC migration in 
avian embryos and embryonic rat cortex respectively, implicating the importance of gelatinase 
function in proper direction of neural precursor cells (Duong and Erickson, 2004; Ingraham et 
al., 2011).  Similarly, MMP-9 deficient mice and in vitro culture assays showed altered granule 
cell migration (Vaillant et al., 2003; Ayoub et al., 2005), while evidence correlating MMP-2 
positive pericytes with vessel sprouting suggests a role in angiogenesis (Girolamo et al., 2004; 
Virgintino et al., 2007).  Finally, MMP-2 and -9 are highly expressed in dendrites, and a number 
of their substrates are structural cytoskeletal components, growth factors (nerve growth factor, 
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NGF), CAMs (ICAM-5), or axonal guidance receptors (EphB2), implicating a functional role for 
these collagenases in dendritic (Tian et al., 2007; Gonthier et al., 2009; Saygili et al., 2011) and 
axonal outgrowth (Lin et al., 2008).  Taken together, these studies, along with evidence of MMP-
2 Schwann cell localization and MMP-9 expression in ECM near oligodendrocytes precursors 
(Uhm et al., 1998; Oh et al., 1999; Ulrich et al., 2005), highlight gelatinase activity in normal 
CNS development, specifically directing vascularization, cellular migration, myelination, and 
axonal outgrowth within the ECM. 
In addition to influencing CNS development, gelatinase modulation of neurogenesis and 
synaptic outgrowth has been described during physiological processes and following 
pathological events.  MMP-9, but not MMP-2, appears to play a role in adult plasticity during 
LTP by regulating extracellular proteolysis and neurotransmitter receptor trafficking and 
activation (Bozdagi et al., 2007; Michaluk et al., 2009).  Further, MMP-9 mRNA is transported 
and activated following LTP (Sbai et al., 2008; Dziembowska and Wlodarczyk, 2012), and 
behavioral analysis of MMP-9 KO mice display altered hippocampal-dependent behavioral and 
cognitive function (Nagy et al., 2006; Meighan et al., 2006).  Interestingly, the changes in 
dendritic spine morphology characteristic of LTP are mediated by integrin-directed modulation 
of actin filaments (Nagy et al., 2006; Kramar et al., 2006; Kim et al., 2009) which is regulated by 
MMP-9 proteolytic exposure of integrin ligands such as the Arg-Gly-Asp (RGD) sequence found 
in numerous ECM proteins (Ethell and Ethell, 2007; Ruoslahti, 1996a).  As mediators of LTP 
synaptic plasticity in the adult brain, the gelatinases also have potential to modulate synaptic 
regeneration in the injured CNS (Shubayev and Myers, 2000; Szklarczyk et al., 2002; Hughes et 
al., 2002; Platt et al., 2003). 
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Several studies have documented increased MMP expression following CNS injury in 
humans (Clark et al., 1997) and experimental animal models of stroke and ischemia (Rosenberg 
et al., 1998; Gasche et al., 1999; Heo et al., 1999).  Typically, MMPs have been thought of as a 
deleterious molecule when upregulated after injury due to their promotion of widespread 
proteolysis and breakdown of the local ECM and tight junctions between cells (Rosenberg, 1995; 
Rosenberg et al., 1998; Wang et al., 2000; Gursoy-Ozdemir et al., 2004; Michaluk and 
Kaczmarek, 2007).  Also supporting this theory of MMP-9 function are animal studies utilizing 
gelatinase KO mice, where loss of MMP-2 did not reduced injury effects (Asahi et al., 2001b), 
but MMP-9 KO mice were protected from the pathology of ischemia (Asahi et al., 2000) and 
TBI (Wang et al., 2000).  Protection from CNS injury has been linked to BBB integrity, where 
MMP-9 KO mice exhibit decreased white matter infarct volume and reduced myelin basic 
protein (MBP) fragment proteolysis after injury (Asahi et al., 2001b).  This effect may be related 
to the fact that gelatinases contain a fibronectin-like domain which binds collagens and elastins, 
making these basement membrane proteins easy targets for MMP-9 modulation of BBB integrity 
(Conant and Gottschall, 2005; Gidday et al., 2005).  While the gelatinases can clearly alter BBB 
integrity after trauma, their role in synaptic plasticity is not well understood.  Nevertheless, a few 
studies have linked gelatinases to modulation of growth factors (Rosell and Lo, 2008) and 
inflammatory cytokines through microglial production after trauma (Gottschall and Yu, 1995; 
Giraudon et al., 1997). 
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THE HIPPOCAMPUS: STRUCTURE AND VALUE AS A MODEL OF SYNAPTIC 
PLASTICITY AFTER TRAUMATIC BRAIN INJURY 
Structure and Function of the Hippocampus 
The hippocampus is a seahorse shaped structure located in the temporal lobe of humans, 
a brain region critical to memory formation.  The hippocampus and its associated cortical regions 
together comprise the hippocampal formation, which can be further divided into six anatomically 
distinct areas: the subiculum, the hippocampus proper, containing four cornu ammonis sectors 
(CA1 -4), the DG, along with presubiculum, parasubiculum, and entorhinal cortex (EC).  The 
CA fields are comprised of pyramidal neurons whose cell bodies lie within the pyramidal cell 
layer, while the basal dendrites reside in the stratum oriens and the apical dendrites extend 
through the stratum radiatum and stratum lacunosum.  The DG can be divided into three layers: 
the hilus, granule cell layer (GCL) which contains the cell bodies of granule neurons, and the 
molecular layer (ML), containing the dendrites of the granule cells (Amaral and Witter, 1995) 
(Fig. 1.2).  The hippocampal functional circuitry consists of synaptic connections involving both 
internal and external pathways.  Externally, information is shared reciprocally between a number 
of structures including the EC, other components of the limbic system, the association cortices, 
and septum, all regions which facilitate the processing of memory and emotion.  Internally, the 
principal hippocampal circuitry is processed along a trisynaptic pathway, and transmitted 
unidirectionally through a series of synaptic connections which receive their primary input from 
the external EC (Amaral et al., 2007).  The secondary axonal input from the medial septal 
nucleus contains acetylcholinesterase, identifying these as cholinergic projections, which travel 
dorsally along the fimbria, fornix, supracallosal stria, and ventrally within and around the 
amygdala, projecting to the inner 1/3 of the molecular layer (IML) of the DG.  The major 
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Figure 1.2  Laminar Structures of the Hippocampus.  Various labeling techniques 
visualize the arrangement of different laminae in the mouse hippocampus.  Within the dentate 
gyrus (DG), the granule cell layer (GCL) is labeled in pink, with neuronal cell bodies labeled 
in DAPI (blue).  The dendrites of these neurons extend to the inner molecular layer (IML, 
yellow) and outer molecular layer (OML, red), where they synapse with afferent projections 
from the entorhinal cortex (EC).  The pyramidal layers of CA1 and CA3 are shown in blue.  
(Forster et al., 2006) 
 39 
 
 
 
 
 
 
 40 
afferent pathway into the hippocampus is known as the perforant path (PP), originating from 
layers II and III of the EC, innervating the outer 2/3 of the ML (OML) of the DG.  More 
specifically, axons from the lateral EC innervate the outer most third of the ML and the medial 
axons project to the middle third, collectively deemed the first fiber tract in the hippocampal 
trisynaptic loop (Hjorth-Simonsen, 1972; Steward et al., 1973). 
The tri-synaptic loop (Fig. 1.3) is comprised of three pathways which are the major 
axonal projections and synaptic connections conducting information flow within the 
hippocampus.  As described above, the perforant path is the primary input into the hippocampus 
and also constitutes the first synapse within the trisynaptic loop.  The second portion of the 
hippocampal circuit conducts information from the DG to the pyramidal cells of CA3 through 
mossy fibers, which make the second synapse of the loop.  Finally, CA3 pyramidal neurons 
complete the tri-synaptic circuit when their axons converge as Schaffer collaterals onto synaptic 
junctions onto the CA1 pyramidal dendrites.  Ultimately, information is then free to flow out of 
the hippocampus from CA1, making connections with structures such as those in the limbic 
circuit.  This information circuit within the hippocampus is important due to its role in memory 
formation and contribution to the limbic system, a circuit which encompasses multiple structures 
related to memory and emotion.  Historically, the hippocampus has been instrumental in 
documenting the capacity to elicit LTP in cortical neurons, a property which continues to serve 
as a cellular model for learning and memory (McClelland et al., 1995; Battaglia et al., 2011).  
LTP has been applied experimentally within the hippocampus to demonstrate that repetitive 
stimulation of excitatory input leads to an increase in synaptic activity within the DG,  
suggesting that these neurons can be sensitized or ‘remember’ the previous input and become 
more responsive (Hall, 1998).  The earliest studies of the hippocampus date back to the 1950’s  
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Figure 1.3  Schematic of the Trisynaptic Circuit within the Hippocampus.  The major 
input into the hippocampus arises from the EC via the perforant pathway (PP) into the DG 
where it makes its primary set of synapses.  Information is then transmitted from the DG 
through the mossy fibers (MF) to CA3 where a second set of synapses occur.  Finally, activity 
is transferred from CA3 through the Schaffer collaterals (SC), synapsing on CA1 dendrites, 
after which information is free to flow out of the hippocampus (Moser, 2011). 
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when the structure was first identified as critical to the development in seizures and epilepsy.  
Original observations of H.M., a patient whom underwent bilateral hippocampal resections to 
treat intractable seizures, include descriptions of profound anterograde amnesia, pointing to the 
hippocampus as a key structure in explicit memory formation (Scoville and Milner, 1957).   
Similarly, TBI that disrupts hippocampal connectivity produces altered cognitive function 
in both humans (Nicholson, 2000; Dikmen et al., 2009; Benedictus et al., 2010; Creed et al., 
2011; McKee et al., 2009) and experimental animal models (Griesbach et al., 2009; Phillips et 
al., 1994).  It is interesting that the hippocampal circuits involved in memory formation are the 
same pathways implicated in seizure pathology, as there is a considerable amount of synaptic 
reorganization during seizure activity (de Lanerolle et al., 2003; O'Dell et al., 2012).  Patients 
who suffer from seizures exhibit aberrant electrical activity, often within the temporal lobe, 
followed by hippocampal neuronal loss as well as aberrant sprouting, astrogliosis, and 
microgliosis which have been replicated in kainic acid animal models (Zhang and Zhu, 2011).  
These synaptic and immune-related changes within the hippocampus following seizure activity 
are of particular importance to studies of neuroplasticity after brain injury as TBI also affects the 
hippocampus and can induce epilepsy in humans (Ferguson et al., 2010) and experimental 
animal models (Kharatishvili et al., 2006).  
 
Hippocampal Plasticity: Neurogenesis and Synaptogenesis 
The hippocampus is a site with extensive neuroplastic potential.  The two principal 
mechanisms which generate this plasticity are neurogenesis and synaptogenesis, each of which 
are activated after CNS insult, and significantly contribute to the extent of achievable recovery.  
The hippocampus has a special role in neuronal regeneration as it is one of the limited sites 
 44 
where neurogenesis occurs in the adult brain (Gould, 2007).  The subgranular zone (SGZ) of the 
DG is capable of generating neuronal precursors, a process which is enhanced by CNS insults 
such as ischemia (Liu et al., 1998; Jin et al., 2001), neurotoxic lesions (Weinstein et al., 1996; 
Gould and Tanapat, 1997), as well as both focal (Kernie et al., 2001; Dash et al., 2001), and 
diffuse TBI (Bye et al., 2011).  These proliferating cells are capable of differentiating into either 
neurons or glia, as well as migrating to injured locations (Magavi et al., 2000), and contributing 
to cognitive recovery (Sun et al., 2005; Sun et al., 2007).  The beneficial role of TBI-induced 
neurogenesis within the hippocampus is further supported by studies that administered vascular 
endothelial growth factor (VEGF) after TBI, which produced an increase in neuronal 
differentiation, decreased lesion volume, and improved neurological function (Thau-Zuchman et 
al., 2010).  Downstream synaptic reorganization is also supported by this neurogenesis, as new 
neurons generated within the SGZ migrate to the GCL, where they extend their processes to 
integrate into the circuits of the DG molecular layer and CA regions of the hippocampus proper 
(Dash et al., 2001; Emery et al., 2005). 
In addition to regenerative connections from newly derived neurons, intact, surviving 
axonal projections also make a significant contribution to the rewiring of hippocampal circuitry 
after CNS injury.  These events occur in the deafferented hippocampus within the same time-
dependent phases of reactive synaptogenesis described in detail above.  Injury-induced 
synaptogenesis is a well-documented feature of the hippocampus, as evidenced by previous 
studies which demonstrate synaptic sprouting and synapse replacement in the DG and CA 
following TBI (Steward et al., 1988b; Scheff et al., 2005).  Also as described in detail above, this 
reactive synaptogenesis is a process which our laboratory has shown to be mediated, in part, by 
MMP interaction with ECM proteoglycans and CAMs (Falo et al., 2006; Falo et al., 2008; Harris 
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et al., 2011; Warren et al., 2012).  Moreover, other researchers have found that the acute 
postinjury phase of this process is heavily reliant on the inflammatory response to induce early 
phagocytic clearance, a necessary prerequisite for structural and functional recovery after TBI 
(Morganti-Kossmann et al., 2002).  Recent evidence also indicates that the acute TBI-induced 
inflammation generated with reactive synaptogenesis and neurogenesis may be linked, given that 
robust microglial cell response was correlated with neurogenesis in the hippocampus following 
fluid percussion injury (Sun et al., 2005) or impact acceleration (IA) insult (Bye et al., 2011).  
The further evaluation of specific molecules which direct these time-dependent stages of repair 
in the hippocampus may lead to potential therapeutic treatments for reducing cognitive deficits 
seen after TBI.  One promising molecule is osteopontin (OPN), a protein secreted into the ECM, 
capable of functioning as both a cytokine and a modulator of axonal outgrowth following CNS 
injury (Hashimoto et al., 2003; Plantman, 2012).  Given OPN’s multiple functions, and its direct 
link to the inflammatory response, we believe that it is an excellent candidate to investigate as a 
model of the relationship between the acute immune response and effective hippocampal 
synaptic reorganization following TBI. 
 
OSTEOPONTIN 
Discovery, Structure, and Role in Inflammation 
      OPN is a pleiotropic molecule found in all body fluids which has the ability to act as both 
a cytokine and tissue repair molecule when released into the ECM (Denhardt and Noda, 1998; 
Mazzali et al., 2002).  Although independently discovered in a number of systems and functional 
roles, OPN was originally described in bone matrix as secreted phosphoprotein-1 (SPP1), 
produced by both osteoblasts and osteoclasts during bone remodeling, mediating resorption and 
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mineralization (Senger et al., 1979; Tezuka et al., 1992).  It is also known as bone sialoprotein-1 
(BSP-1), as a member of Small Integrin-Binding Ligand N-linked Glycoproteins (SIBLING) 
family (Fisher et al., 1983), and as early t-lymphocyte activation-1 (Eta-1), a name derived from 
its function as a cytokine-inducer of macrophage infiltration (Patarca et al., 1989).  Structurally, 
the molecular mass of OPN amino acid sequence is estimated to be around 32 kD, however, 
more precise matrix-assisted laser desorption/ionization-time of flight mass spectrometry 
(MALDI-TOF) studies have predicted a molecular weight ranging from 34.5-37.6 kD, depending 
on the tissue-specific OPN analyzed (Keykhosravani et al., 2005; Christensen et al., 2007).  
Despite an estimated molecular weight of about 30 kD, the high level of negatively charged 
amino acids and the heavy posttranslational glycosylation and phosphorylation of OPN introduce 
structural variability such that OPN migrates between 45- 75 kD in SDS-PAGE (Kazanecki et 
al., 2007b).  Further, posttranslational modifications are hypothesized to modulate OPN activity, 
supporting its wide range of function, from cytokine to tissue repair molecule in multiple organ 
systems (Denhardt and Guo, 1993; Kazanecki et al., 2007b; Wang and Denhardt, 2008).  Also 
critical to OPN’s versatile functions are the highly conserved arginine-glycine-aspartate domain 
(RGD), SVVYGLR, and ELVTDFPTLDLPAT sequences (Fig. 1.4 A).  
      The RGD (or GRGDS) sequence is commonly found in ECM proteins, and acts as a 
ligand recognized by multiple integrin receptors (Ruoslahti, 1996b; Denhardt et al., 2001), 
allowing OPN to attach to various cell types (Ruoslahti and Pierschbacher, 1987; Denhardt et al., 
1995).  Specifically, OPN has been shown to bind directly to several integrins including αv(β1, 
β3, or β5) and (α4, α5, α8, or α9)β1 (Yokosaki et al., 2005; Liaw et al., 1995a; Bayless et al., 1998; 
Bayless and Davis, 2001; Scatena et al., 2007; O'Regan and Berman, 2000; Schack et al., 2009; 
Barry et al., 2000a; Barry et al., 2000b; Hu et al., 1995), facilitating cellular signaling of 
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Figure 1.4  Structural Features of Osteopontin.  Colored sequences indicate cell adhesive 
domains (RGD: red; SVVYGLR: blue) and corresponding integrins which bind these ligands 
(A).  Human OPN sequence below indicates select MMP and thrombin proteolytic sites (B).  
(Scatena et al., 2007) 
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osteoclasts, epithelial cells, and smooth muscle cells (Denhardt et al., 1995).  To permit these 
cellular interactions, OPN tertiary structure often requires proteolytic processing to more directly 
expose the available binding sequences.  Two principal mechanisms have been identified in the 
generation of these functional fragments: thrombin and MMP proteolysis.  Thrombin cleavage of 
OPN is documented in the vascular system.  Lysis immediately following the SVVYGLR 
sequence unfolds the OPN protein backbone, exposing the SVVYGLR integrin binding site (Fig. 
1.4 B) (Senger et al., 1994; Smith and Giachelli, 1998; Bayless et al., 1998; Scatena et al., 2007; 
Yokosaki et al., 1999; Barry et al., 2000a; Barry et al., 2000b; Green et al., 2001) to permit the 
modulation of  outgrowth and regeneration in the ECM (Mukherjee et al., 1995; Lefcort et al., 
1992; Hynes, 1992; Venstrom and Reichardt, 1993; Martin et al., 2004; Midwood et al., 2004). 
In addition to thrombin cleavage, OPN is subject to MMP processing where MMPs -2, -3, -7, -9, 
-12, (Agnihotri et al., 2001; Hou et al., 2004; Dean and Overall, 2007; Goncalves DaSilva et al., 
2010) generate functional fragments and permit exposure of integrin binding sites important in 
cell adhesion (Agnihotri et al., 2001; Goncalves DaSilva et al., 2010; Scatena et al., 2007; 
Takafuji et al., 2007; Dean and Overall, 2007).  Of the known integrin receptors, OPN more 
selectively interacts with, αvβ3, a binding motif known to bind molecules such as vitronectin, 
directing cell migration, a critical aspect of the inflammatory immune response during tissue 
repair (Preissner and Jenne, 1991; Ria et al., 2002; Yue et al., 1994; Liaw et al., 1995b; Serini 
and Gabbiana, 1996). 
 The ability of OPN to function in the early inflammatory response has been well-
described in repair after cardiac injury, nephritic injury, and general wound healing (Liaw et al., 
1998).  After traumatic events such as myocardial infarction or nephritis, elevated OPN 
transcript and protein was localized to smooth muscle cells and macrophages (Giachelli et al., 
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1993; Murry et al., 1994).  This acute OPN expression was linked to cell migration to the injury 
site, as well as formation of the neointima, supporting an important role in the recovery process 
after trauma (Giachelli et al., 1994; Giachelli et al., 1995).  As indicated above, to effect recovery 
and repair during the immune response, the RGD and SVVYGLR N-terminal sequences within 
OPN interact with αβ integrins to promote cell adhesion and migration of inflammatory and 
angiogenic molecules to the site of injury (Liaw et al., 1995b; Hu et al., 1995; Smith et al., 1996; 
Smith and Giachelli, 1998; Denhardt et al., 2001).  Given the importance of inflammation in all 
healing mechanisms (Leibovich and Ross, 1975; Portera et al., 1997), and evidence of OPN as a 
matrix protein involved in wound healing, this versatile molecule requires further investigation 
as to its inflammatory role following traumatic CNS injury.  
Inflammation is one of the first cellular mechanisms to respond to after CNS injury, and 
is a response which has also been implicated in the development of chronic neurodegenerative 
disease.  Given the importance of the acute immune response in recovery, OPN signaling 
cascades are likely to be involved in the synaptic regeneration process following TBI.  The first 
descriptions of OPN immunological activity documented Eta-1 gene upregulation within 
lymphocytes in response to a rickettsia tsusugamushi, a bacterial infection which elicits a T-cell 
immune response (Patarca et al., 1989).  Subsequent studies identified this Eta-1 gene as OPN, 
and linked its acute elevation to T-lymphocyte activation and macrophage recruitment, 
confirming the importance of OPN in the acute T-cell mediated immune response (Singh et al., 
1990).  OPN’s ability stimulate phagocytosis in response to intracellular staph invasion (Schack 
et al., 2009), and its high expression in Th1 cells during T-cell differentiation further support its 
role in type-1 immune eradication of intracellular pathogens and delayed hypersensitivity 
reactions (Nagai et al., 2001).  Additional studies in type-1 immune responses to conditions such 
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as granulomas indicate that OPN exacerbates inflammation by increasing pro-inflammatory 
cytokine IL-12 and decreasing anti-inflammatory cytokines such as IL-10 (Ashkar et al., 2000) .  
Interestingly, these effects are thought to be mediated by integrin signaling via CD44 receptor 
binding, a glycoprotein important in the immune response.   
 
Inflammatory Role in the Central Nervous System 
The discovery of OPN as an early activator of T-lymphocytes and evidence of OPN 
participation in Th1-mediated pathology has led to the exploration of its role in the inflammatory 
response underlying CNS Th1-mediated diseases such as MS, a progressive neurodegenerative 
disease characterized by myelin degeneration (Chabas et al., 2001; Vogt et al., 2003).  MS is an 
autoimmune inflammatory disease of the CNS which affects both the brain and the spinal cord.  
As a progressive disorder, chronic inflammation exacerbates demyelination, and impedes the 
restorative remyelination process.  This progressive inflammation and subsequent demyelination 
manifests in white matter plaques and axonal damage (Trapp et al., 1998; Pitt et al., 2000), 
ultimately neurologically disabling the individual.  Interestingly, while MS is a chronic disorder, 
there is variation in the time course of its progression, and many patients will present with 
intermittent bouts of neurological dysfunction, characterized as a relapsing-remitting form of the 
disease (Compston and Coles, 2008).  Given the importance of the inflammatory response in 
myelination and axonal injury, OPN role has been studied in both human MS patients and 
experimental animal models of MS.  Clinical investigation indicated detectable OPN levels in 
both the serum and cerebral spinal fluid (CSF) of MS patients.  Interestingly, the highest OPN 
levels were found in the CSF of patients with active MS lesions (Vogt et al., 2003), and these 
elevated levels of OPN correlated with the severity of neurological impairment (Chowdhury et 
 52 
al., 2008).  Together, clinical evidence of OPN presence during periods of active lesions and 
motor dysfunction suggests that this cytokine may play a role in the inflammatory response 
associated with MS demyelination.  The precise OPN role, however, is unclear at this time since 
demyelination and remyelination occur within close temporal proximity.  This uncertainty 
highlights the need for additional studies to determine whether OPN prolongs inflammation 
underlying myelin degradation and axonal damage, or if it is functioning as a repair molecule 
during remyelination to promote axonal recovery.   
To better understand OPN role in MS, investigation of the molecular mechanisms 
surrounding this process have been studied in the experimental autoimmune encephalomyelitis 
(EAE) model of MS.  Although there are several mechanisms which can be used to induce EAE, 
the most common model utilizes subcutaneous injection of a myelin-based protein to trigger a 
CNS inflammatory response which mimics the MS pathology seen in patients (Van Epps, 2005).  
EAE animals expressed OPN in microglia during both relapsing and remitting phases of this 
pathology, and expression was concentrated within close proximity to MS-like lesions.  
Interestingly, increased OPN expression is also correlated with worsening neurological 
symptoms in MS patients (Chabas et al., 2001).  Together, these studies suggest OPN 
participations in the chronic inflammation underlying clinical MS.  Similarly, EAE models also 
mimic the interleukin pathology seen in granulomatous formations (Ashkar et al., 2000).  
Specifically, OPN acts as pro-inflammatory cytokine, increasing the secretion of other pro-
inflammatory cytokines such as interferon gamma (IFN-γ) and IL-12, and down-regulating 
secretion of anti-inflammatory cytokines such as IL-10 (Chabas et al., 2001; Weber et al., 2002).  
Based on investigations in MS patients and EAE models, OPN’s role in CNS type-1 immune 
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response appears to involve with the acute mediation of chronic inflammatory signaling which 
leads to axonal and neuronal damage. 
 
Role in Neurodegenerative Disease 
 In addition to chronic autoimmune disease, OPN appears to play a role in the 
pathogenesis of chronic neurodegenerative diseases such as Parkinson disease (PD) and 
Alzheimer disease (AD).  Characterized by neurological dysfunction, and generally affecting 
those over 60 years old, PD and AD are the leading neurodegenerative diseases in the world.  
While AD typically manifests as a neurocognitive disease characterized by dementia and deficits 
in memory, language, and behavior, the debilitating effects of PD present as motor dysfunction 
such as resting tremor, bradykinesia, and rigidity (Torrao et al., 2012).  One common theory 
places chronic inflammation as the likely mechanism producing the neurodegeneration which 
underlies cognitive and motor deficits seen in victims of each disease (Block and Hong, 2005).  
For example, the characteristic loss of dopaminergic neurons in the substantia nigra (SN) and 
alpha-synuclein aggregation in Lewy bodies (Torrao et al., 2012) is potentially caused by chronic 
neuroinflammation which translates into impaired motor activity (Jankovic, 2008).   
Evaluation of normal animal and human brains shows that OPN is in present within many 
structures, most prominently expressed in the brain stem, sensory neurons, and deep nuclei of the 
cerebellum (Shin et al., 1999; Ichikawa et al., 2000).  Complimentary studies by Iczkiewicz and 
colleagues detected OPN protein expression within the intact rat hippocampus and cortex, with 
the highest levels observed in the basal ganglia and SN, locations vulnerable to the pathology 
underlying the development of Huntington’s disease and PD, respectively (Iczkiewicz et al., 
2004).  Finally, evaluation of normal primate and human brain indicate a similar presence of 
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OPN within nigral neurons, but not glial cells, in the SN (Iczkiewicz et al., 2006).  This latter 
finding is of particular interest since OPN has been colocalized to glial cells during active 
synaptogenic development of the rat brain (Choi et al., 2004), and in experimental models of 
CNS disease (Van Epps, 2005).  These findings further support the hypothesis that OPN function 
is linked to both immune response and synaptic plasticity within the CNS.  
Similar to clinical MS studies, OPN in PD patients was increased in hallmark lesions 
(Lewy bodies), serum, and CSF compared to control subjects, where OPN serum protein levels 
correlated with an increase in symptomatic dementia (Maetzler et al., 2007).  This clinical 
evidence coincides with elevated OPN mRNA and protein expression in inflammatory models of 
PD utilizing direct LPS injection into the SN of rats (Iczkiewicz et al., 2005).  LPS injection 
produces an inflammatory response resulting in the death of dopaminergic neurons, a prototype 
of PD pathology.  Interestingly, both OPN mRNA and protein responded acutely, peaking at 48 
and 72 hours respectively.  Further, this rise in OPN production was correlated with an increase 
in OPN positive reactive microglia.  Astroglial reactivity also increased, however, this response 
was much later (120 hours postinjury), and staining for GFAP was not colocalized with LPS-
induced OPN.  Given this acute selective rise in microglial OPN coinciding with LPS-induced 
dopaminergic cell death, it is reasonable to predict that OPN may function as a modulator of the 
SN immune response, likely contributing to the loss of tyrosine-hydroxylase positive neurons in 
PD (Iczkiewicz et al., 2005).  Contrary to these results are studies utilizing subcutaneous 
injections of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) neurotoxin to induce 
dopaminergic death in a non-human primate model of PD, where reduced OPN expression was 
observed within the SN (Iczkiewicz et al., 2007).  In this same study the evaluation of 
postmortem human brain tissue showed decreased OPN levels in remaining dopaminergic 
 55 
neurons.  The fact that OPN is reduced within populations of surviving neurons suggests that it, 
in some way, influences the extent of neuroprotection, however, OPN may also be involved in 
recruiting reactive glial cells to the site of injury and the recurrent cycle of cell degeneration.  For 
example, additional studies by Iczkiewicz and colleagues addressed the inflammatory response 
during neuronal injury through the comparison of 6-hydroxydopamine (6-OHDA) toxin and 
mechanical lesions of the SN (Iczkiewicz et al., 2007).  In both models, OPN was colocalized 
with activated microglial cells but not dopaminergic, or GFAP positive cells, and dopaminergic 
cell death was correlated with increased OPN expression and ED1 positive macrophages.  
Together, these data suggest that OPN plays a role in both pro-inflammatory and anti-apoptotic 
mechanisms, highlighting the complex nature of OPN’s influence on both neuronal recovery and 
repair.  Further, OPN contribution to the recovery process may depend on the injury mechanism 
which generates the immune response, as seen in experimental animal models of 
neurodegeneration.  Nevertheless, it is undetermined whether OPN is beneficial or detrimental in 
the context of synaptic regeneration in these models, a question which must rely on further 
studies investigating the molecular neuropathology underlying the CNS disease. 
 While both chronic inflammatory diseases and inflammatory diseases of the 
extrapyramidal system in PD each indicate a role for OPN in the evolution of neuropathology, 
OPN has not been extensively studied in the development of AD.  AD is the leading cause of 
dementia in the world, with an increased incidence in those over 65 years old.  Histopathological 
hallmarks include the accumulation of extracellular amyloid-beta (Aβ) plaques and 
neurofibrillary tau, which are thought to induce progressive neuronal loss underlying the 
hippocampal dysfunction and cognitive deficits seen in AD patients (Torrao et al., 2012).  Early 
stages of AD are marked by inflammation and microglial activation, and most recently studies 
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have linked cognitive performance of AD patients with increased OPN CSF levels (von 
Bernhardi, 2007; Comi et al., 2010).  Anatomical studies have also documented an increase in 
OPN expression within the pyramidal neurons of the hippocampus, cells which make up a major 
pathway for memory formation (Wung et al., 2007).  Interestingly, this staining was found to 
correlate with Aβ deposition and age, suggesting that OPN may play an important role in AD 
disease development or remodeling during neurodegeneration.  Given recent evidence linking 
mild head injury with delayed cognitive impairment, these studies also suggest OPN response 
may be critical to the development of chronic degenerative pathology sometimes accompanying 
TBI, such as CTE.  CTE is characterized by cortical atrophy and enlarged ventricles caused by 
repeated blows to the head, such as those suffered by athletes or the military, and like that of AD, 
patients suffer cognitive deficits which are associated with hyperphosphorylated tau, chronic 
microglial reactivity, and inflammatory conditions (Blaylock and Maroon, 2011; Saulle and 
Greenwald, 2012).  When these observations are considered together, it is clear that elevated 
OPN correlates with inflammatory-associated neuropathogenesis in MS, PD, and AD, and likely 
contributes to the CNS cellular response underlying these debilitating neurological diseases. 
 
Role Following Central Nervous System Injury 
In addition to the chronic inflammatory response of neurodegeneration, OPN function has 
been evaluated during the acute immune response in focal models of stroke or ischemia.  Initial 
studies utilizing permanent middle cerebral artery occlusion (MCAO) in spontaneously 
hypertensive rats reported OPN mRNA elevation within the periinfarct region within 2 hours 
postinjury.  Further, OPN protein was expressed in periinfarct microglia 24 hours after injury, 
cells which migrated to the center of the infarct by 48 hours.  These results demonstrate an acute 
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trauma-induced OPN response, and migration of OPN containing glia toward the site of injury, 
similar to the chronic inflammatory OPN response in neurodegenerative disease (Ellison et al., 
1998).  Global ischemia using a transient 4-vessel occlusion model in rats revealed similar 
results, specifically documenting increased OPN mRNA in the hippocampal pyramidal layers 
and striatum within 24 hours following occlusion.  As seen with the cellular OPN response in 
focal stroke, global ischemia also induced OPN positive reactive microglia restricted to the sites 
of neuronal damage within hippocampal CA1 and CA3 at 3 -7d postinjury (Lee et al., 1999).  
These studies suggest microglia as principal secretors of OPN during the acute inflammatory 
response, but interestingly did not detect OPN mRNA within reactive astrocytes present around 
15d postinjury.  To further understand the potential link between OPN and cognitive damage 
following stroke or ischemia, mechanisms such as BBB impairment identified in the 
pathogenesis of vascular dementia were also examined.  Interestingly, BBB disruption alone 
induced elevated levels of OPN mRNA, verified by qRT-PCR (Iwanaga et al., 2008), suggesting 
cognitive deficits following stroke may be linked to OPN and vessel disruption.  Together, 
evidence that OPN is elevated after stroke or ischemia within microglia supports the idea that 
OPN, active in the immune response, promotes vascular and neuronal recovery. 
Given the similar cellular OPN response to stroke and ischemic, putative mechanisms 
behind its interaction with reactive glial cells was investigated.  While previous studies indicated 
OPN does not appear to be produced by reactive astroglia, their interaction with OPN is 
supported by colocalization of the cytokine and αvβ3 on the surface of glial fibrillary acidic 
protein (GFAP) positive astrocytes at 15d following MCAO (Ellison et al., 1998).  The 
upregulation and colocalization of αvβ3 within reactive astrocytes is also supported by 
independent studies in non-human primates subject to focal cerebral ischemia (Okada et al., 
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1996), and transient forebrain ischemia in the rodent four vessel occlusion and reperfusion model 
(Kang et al., 2008).  Further, OPN and αvβ3 upregulation was observed within the periinfarct 
region and newly synthesized glial scar, suggesting OPN may modulate axonal or vascular repair 
at that site (Ellison et al., 1998; Ellison et al., 1999).  More specifically, prior studies linking αvβ3 
upregulation with angiogenesis suggest OPN/ αvβ3 interaction via the SVVYGLR sequence 
modulates the synthesis or repair of blood vessels following stroke and ischemia (Brooks et al., 
1994; Okada et al., 1996; Reynolds et al., 2002; Serini et al., 2006).  In addition to modulating 
angiogenesis, OPN/αvβ3  interaction likely permits OPN to function as an astrokine and induce 
chemotaxis of reactive astrocytes to the site of stroke injury (Ellison et al., 1998; Ellison et al., 
1999), an effect similar to that of smooth muscle cell mobility after cardiovascular insult (Liaw 
et al., 1995a; Liaw et al., 1995b).  Such OPN/integrin interaction in response to TBI remains to 
be investigated, but it appears quite likely to occur since OPN binds to many different integrin 
receptor subtypes in the injure region.  For example, recent studies have linked OPN to the 
promotion of phagocytosis via the αxβ2 integrin receptor during bacterial infection (Schack et al., 
2009), as well as the alteration of cell migration (Lund et al., 2013).  The fact that microglia 
express αvβ3 and αvβ5 integrin receptors, and can influence angiogenesis during traumatic 
inflammation (Milner, 2009), points to their potential for OPN interaction to mediate 
inflammatory cell signaling  such as leukocyte extravasation during the acute immune response 
following TBI (Jones, 1996; Archelos et al., 1999).  
In addition to integrin receptor binding, OPN is also capable of interacting with cell 
surface CD44 receptors.  CD44 was first investigated as a receptor expressed on activated 
microglia and reactive astrocytes as a modulator of inflammation (Vogel et al., 1992; Foster et 
al., 1998; Pure and Cuff, 2001).  The hyaluronic receptor CD44 is a cell adhesion a receptor 
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linked to macrophage recruitment and facilitation of the acute immune reaction (Weber et al., 
1996).  Cellular studies indicate that OPN directs chemotaxis and macrophage migration 
utilizing the CD44 receptor via β1 integrin (Katagiri et al., 1999; Weber et al., 2002; Zhu et al., 
2004; Marcondes et al., 2008).  Specifically, OPN is known to bind CD44 splice variants, such 
as CD44v3-6, a form highly expressed on the surface of microglia (Smith et al., 1999; Kang et 
al., 2008).  Although OPN binding to these splice variants has been demonstrated, the exact 
sequence which forms a ligand for either CD44 or its splice variants has yet to be discovered 
(Weber et al., 1996; Weber et al., 2002; Takafuji et al., 2007).  Interestingly, studies document 
trauma-induced increase in CD44 and OPN in models of ischemia (Kang et al., 2008).  
Following ischemic insult, CD44 is colocalized with OPN in microglia at 1 day post-reperfusion, 
peaking in expression at 3 days, and then remission by the 7
th
 day.  This early 3d postinjury peak 
in OPN occurred in the CA1 pyramidal layer, as well as the dentate hilar region of the 
hippocampus (Kang et al., 2008).  Most recently, studies in LPS models of PD document both an 
increase in OPN and upregulation of CD44 within neurons and glia, which is interpreted as 
providing a neuroprotective role (Ailane et al., 2013). 
 While CD44 and integrin receptors link OPN to microglial activation and the acute 
inflammation associated with tissue degeneration after CNS injury, this same OPN/receptor 
interaction could play a more positive role in promoting repair during the later stages of synaptic 
recovery.  For example, repair of CNS vascular insult is a complex process, involving a two 
phases of OPN response in the injured area.  As previously mentioned, stroke induces an initial 
OPN mRNA response linked to the activation and migration of microglia within 24 hours of 
injury.  By contrast, the second phase of OPN expression occurs in reactive astrocytes at the 
penumbra 5d postinjury, cells which ultimately migrate to the injury core by 15d (Ellison et al., 
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1998).  These observations suggest that the same microglia which interact with OPN to control 
acute inflammation can also secrete OPN as an astrokine, promoting chemotactic recruitment of 
reactive astrocytes to the site of injury (Choi et al., 2007).  This idea is supported by the fact that 
OPN is acutely colocalized with CD44 and microglia, followed by a second colocalization with 
αvβ3 and astrocytes (Ellison et. al., 1998; Wang et al., 2001; Kang et al., 2008).  Similar biphasic 
response after MCAO followed by reperfusions (MCAO/R) (Okada et al., 1996), or transient 4-
vessel forebrain ischemia, shows αvβ3 expression within GFAP positive cells 3-15 postinjury 
(Kang et al., 2008).  This time frame overlaps with the window of synaptic recovery after TBI, 
further suggesting that OPN could direct alternative cellular responses in order to modulate 
different phases of synaptogenesis following traumatic insult. 
 
Interaction with Extracellular Matrix Proteins and Role in Synaptic Plasticity 
During synaptic reorganization, a number of molecules interact to condition the ECM for 
effective synaptic recovery.  While OPN has been linked to neuroplasticity, its expression and 
potential function models of synaptic deafferentation have yet to be examined.  OPN is 
promising as a mediator of effective synaptic reorganization because: 1) the cells principally 
involved in molding ECM during synaptic recovery can express OPN, 2) it binds to cell surface 
receptors utilized by these cells, and 3) it is processed into active functional forms by MMPs in 
the ECM.  Interestingly, recent studies have documented OPN/MMP interaction in models of 
MS or subarachnoid hemorrhage.  For example, in EAE model of MS, MMP-12 cleavage of 
OPN attenuated inflammatory damage (Goncalves DaSilva et al., 2010), while recombinant OPN 
(r-OPN) reduced BBB compromise through inhibition of MMP-9 activation (Suzuki et al., 
2010b).  In addition, OPN interacts with secreted growth factors like fibroblast growth factor to 
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increase neural progenitor proliferation in cell culture assays (Kalluri and Dempsey, 2012).  
These observations support OPN interaction with ECM molecules critical to the success of 
reactive synaptogenesis following TBI. 
While the role of OPN in the inflammatory process and its mediation of degeneration are 
well-documented, there are few studies examining its role during synaptic reorganization.  
Rodent studies do describe an increase in OPN expression during Wallerian degeneration of the 
sciatic nerve (Jander et al., 2002), but surprisingly, the elevated OPN levels were expressed in 
Schwann cells, not infiltrating macrophages.  This study is in contrast to another which found 
macrophage OPN expression following optic nerve crush, suggesting that  OPN role may be 
dependent on CNS or PNS-specific environmental cues such as MMP activity (Kury et al., 
2005).  OPN expression in Schwann cells has been further investigated in the cuprizone model of 
demyelination.  Cuprizone is a copper chelator toxic to oligodendrocytes, which causes 
demyelination within the corpus callosum when administered orally (Blakemore, 1972; Ludwin, 
1978; Matsushima and Morell, 2001).  Due to the spontaneous remyelination upon removal, this 
model provides a way to study both demyelination and remyelination properties (Arnett et al., 
2001; Mason et al., 2001; McMahon et al., 2001).  Interestingly, cuprizone treatment induced 
OPN in microglia and astrocytes surrounding axons undergoing demyelination-remyelination 
cycles (Selvaraju et al., 2004).  In the same study, administration of r-OPN to primary cultures of 
oligodendrocyte precursors resulted in proliferation and MBP synthesis, suggesting that OPN 
promotes myelination and axonal repair.  Similar OPN response was seen with damaged axons in 
models of SCI, where clip compression of the spinal cord increases acute OPN mRNA 
expression within white matter microglia as early as 24 hours postinjury (Hashimoto et al., 2003; 
Moon et al., 2004).  Moreover, OPN levels are increased in the degenerating neurons and axons 
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of the hippocampus during status epilepticus (Borges et al., 2008), as well as within a subset of 
microglia following kainic acid administration (Kim et al., 2002).  In aggregate, these models 
show that at least three primary components of TBI pathophysiology, microglial activation, 
direct axotomy, and excitotoxic insult, all induce OPN expression during the postinjury period of 
synaptic reorganization. 
 Other studies examining OPN after the CNS injury also point to its role in both 
degeneration and regeneration.  During the course of trauma-induced remodeling in the CNS, 
OPN may stimulate neurogenesis as part of effective recovery.  In models of forebrain ischemia, 
striatal OPN upregulation between 3-30 days after reperfusion induces migration of regenerative 
neuroblasts from the subventricular zone (SVZ) (Yan et al., 2009).  Interestingly, blockade of the 
β1 integrin receptor halted this progenitor migration, suggesting that OPN/integrin binding plays 
a role in this early stage of neurogenic recovery (Meller et al., 2005).  OPN’s neuroprotective 
effect is also supported by studies administering r-OPN, where administration following 
subarachnoid hemorrhage (SAH) protects the integrity of the BBB and microvasculature, 
minimizing extravasation (Suzuki et al., 2010b).  Similar to neuroregeneration studies in 
forebrain ischemia, blockade of the RGD sequence abolished these protective effects, again 
indicating that OPN/integrin receptor interaction is critical to neuroprotection.  Thus, multiple 
models of CNS disease and trauma point to a wide range of postinjury functions for OPN, most 
notably microglial recruitment to the site of injury, and the activation of astrocytes to promote 
regeneration.  
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Response after Traumatic Brain Injury 
           While OPN role during tissue repair has been studied in the context of inflammation and   
CNS disease, few studies have examined OPN role after TBI.  Due to the heterogeneous nature 
of TBI, OPN has been investigated in the broad context of varied neuronal, axonal, and vascular 
pathologies.  Recent studies include examination of OPN in focal cortical injury models (von 
Gertten et al., 2005; Shin et al., 2005; Israelsson et al., 2006; Plantman, 2012), as well as related 
to specific components of TBI pathology such as hippocampal damage (Morita et al., 2008),  
ischemia (Ellison et al., 1998; Wang et al., 1998; Meller et al., 2005), and axonal injury (Jander 
et al., 2002; Kury et al., 2005; Hashimoto et al., 2003; Moon et al., 2004; Hashimoto et al., 
2005).  To date, no studies have examined the details of OPN and its related inflammatory 
response during synaptic reorganization after TBI.  Only three animal models of TBI have been 
used to investigate OPN response: controlled cortical impact (CCI) which induces cortical 
contusion, cavitation, and axonal damage (Lighthall et al., 1989), cold probe cryolesion which 
generates a severe focal cortical lesion with BBB disruption (Sun et al., 2000), and brain stab 
wound creating physical tissue ablation and significant glial scar formation (Mathewson and 
Berry, 1985).  OPN transcript was reported to increase within the rat cerebral cortex following 
CCI (von Gertten et al., 2005), and is supported by evidence of transcript increase after severe 
TBI (Israelsson et al., 2006) and mild blast injury (Cernak et al., 2011).  Similar to previously 
discussed studies in stroke and ischemia, this OPN elevation was detected during the acute 
degenerative and onset of subsequent regenerative phases (1-7d postinjury), and was 
concomitant with CD44 elevation for both cold probe cryolesion, CCI, and brain stab wound 
models (von Gertten et al., 2005; Shin et al., 2005; Plantman, 2012).  Further, evidence that this 
OPN response may be reversed by FK506 immunosuppression (Morita et al., 2008) suggests that 
 64 
the acute trauma-induced OPN expression is related to inflammation.  Interestingly, cold probe 
cryolesion induction of OPN was similar to that after stroke, where the cytokine was colocalized 
within microglia early after injury (4-7d), and later at 7-14d within reactive astrocytes (Wang et 
al., 1998; Shin et al., 2005).  More recent studies have focused on OPN role in recovery, showing 
elevated neuronal, but not astrocytic, OPN expression after brain stab wound, which suggests a 
role for OPN in the process of neurite sprouting after injury (Plantman, 2012). 
In summary, evidence of OPN response in inflammatory CNS disease, models of 
vascular injury, and recent studies showing OPN elevation after TBI all would support the 
hypothesis that OPN plays an important role during reactive synaptogenesis.  While these studies 
map the inflammatory role of OPN in response to independent CNS insults, none address the 
capacity for the OPN to influence synaptic recovery following brain injury.  The studies of this 
dissertation will test the hypothesis that OPN mediates the efficacy of synaptic reorganization 
induced by TBI, and its involvement can serve to predict adaptive or maladaptive outcome.  
 
EXPLORATION OF OSTEOPONTIN ROLE IN SYNAPTOGENESIS AFTER 
TRAUMATIC BRAIN INJURY 
Traumatic Brain Injury Models of Adaptive and Maladaptive Plasticity 
To investigate the cellular and molecular mechanisms underlying the long term cognitive 
deficits produced by human TBI, a number of different animal models have been developed, 
each permitting a specific aspect of the complex TBI pathophysiology to be studied in a 
controlled fashion.  As described above, the CCI and the cold probe cryolesion models induce a 
focal lesion, concentrated at the cortical surface of the brain.  Others, such as blast, impact 
acceleration, and fluid percussion versions produce a more diffuse injury, permitting the direct 
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study of concussive insult often present in human TBI.  While each of these models is useful in 
studying the molecular pathways mediating human head injury, they generate diffuse 
deafferentation and do not permit clear evaluation of targeted synaptic insult and subsequent 
reinnervation processes.  A more precise injury paradigm used to study this targeted synaptic 
regeneration is the unilateral entorhinal cortex lesion (UEC), a well-established model of reactive 
synaptogenesis within the hippocampus (Steward et al., 1988b).  As described above, the EC 
comprises the major input into the hippocampus and, when lesioned, 80-90% of the afferent 
fibers which synapse in the ML of the rodent DG are ablated, inducing synaptic deafferentation.  
Following UEC, successful adaptive synaptic reorganization occurs in three well-defined stages 
(Steward and Vinsant, 1983).  For the first 4 days after lesion, there is an acute removal of 
degenerating terminals as well as dendritic retraction and spine remorphing.  At 6-7d postinjury, 
removal of these afferent terminals permits reemergence of new postsynaptic spines along 
dendrite, reextending into the denervated zone, accompanied by collateral sprouting of new 
presynaptic terminals (Cotman et al., 1977; Steward, 1989).  By 15d, the rate of this ML synaptic 
reorganization plateaus, and the phase of synapse stabilization and maturation begins.  During 
this adaptive process, glial cells, ECM proteins, and MMPs all interact to generate functional 
reconnection as demonstrated by immunohistochemistry (IHC) staining (Lynch et al., 1972), 
ultrastructural analysis (Matthews et al., 1976a; Matthews et al., 1976b), electrophysiological 
recordings (Reeves and Steward, 1986) , and hippocampal-dependent behavioral analysis 
(Steward, 1976; Loesche and Steward, 1977; Reeves and Smith, 1987).  This time-dependent 
remodeling of the deafferented DG provides an appropriate template to study how adaptive 
reactive synaptogenesis responds when challenged by the additional neuroexcitation insult of 
TBI.  Our laboratory has developed a model which directly challenges the adaptive remodeling 
 66 
of entorhinal deafferentation with the excessive neuroexcitation of fluid percussion TBI, the 
TBI+BEC paradigm (Phillips et al., 1994).  This combination generates a reproducible model of 
maladaptive synaptic plasticity with many of the persistent deficits seen with human TBI.  
Importantly, it can be directly contrasted with the UEC adaptive plasticity model to identify 
differences in molecular and cellular response underlying persistent impairment seen after 
human TBI.  In this dissertation, the role of OPN during reactive synaptogenesis will be 
examined in both the rat UEC and TBI+BEC models.  With this comparative approach, we can 
determine if OPN response differs under conditions of adaptive versus maladaptive plasticity, 
and if so, identify an additional target for turning maladaptive reorganization into adaptive 
recovery after TBI.  
 
Osteopontin Knockout Mice 
To further assess the OPN function in the context of CNS disease and injury, many 
groups have utilized OPN KO mice.  The OPN KO mouse was first generated in 1998 as a germ 
line SPP1 mutation where 4 of the 7 SPP1 exons were replaced by a neomycin cassette, 
rendering a null protein in mixed 129S6 Black Swiss mice (Liaw et al., 1998).  Currently, these 
mice are available from Jackson Laboratory as homozygotes on a C57BL/6 background, and are 
considered viable and fertile with no gross or behavioral abnormalities (The Jackson 
Laboratory).  Due to their normal development and growth, they have been used in numerous 
studies to assess OPN function in general wound healing (Liaw et al., 1998), kidney repair 
(Giachelli et al., 1994), and after myocardial infarction (Murry et al., 1994).  A number of studies 
have utilized OPN KO mice to assess OPN response in CNS disease and injury, indicating that 
OPN may have both beneficial and detrimental roles.  These findings again support its diverse 
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functions, which are considered to depend upon environmental conditions and the form of OPN 
present.  In models of inflammatory CNS disease, OPN appeared to be a detrimental, as OPN 
KO mice exhibited decreased EAE severity, and immunity to disease progression which would 
normally lead to death (Chabas et al., 2001).  Further, pharmacological treatment of these OPN 
KO EAE models with exogenous OPN exacerbated disease presentation, supporting the negative 
effects of OPN within chronic CNS inflammation (Hur et al., 2007).  In exploring the hypothesis 
that OPN KO mice exhibit decreased inflammatory function in models of PD, Maetzler and 
colleagues described reduced microglial activation, and altered astrocytic response compared to 
WT mice (Maetzler et al., 2007).  Following MPTP administration, longer astrocytic processes 
and increased neuronal survival in the absence of OPN further suggests this cytokine plays a 
detrimental role in neurodegenerative disease, much like that of the inflammatory conditions of 
MS (Maetzler et al., 2007).  Contrary to these inflammatory neurodegenerative disease models, 
stroke, hypoxic-ischemic injury (HI), and SCI models generated in the same OPN KO mice 
showed reduced injury, suggesting a neuroprotective role for OPN.  Specifically, OPN deficient 
mice exhibited increased thalamic neurodegeneration and NO release compared to WT controls 
(Schroeter et al., 2006), and in vivo studies utilizing clip compression show OPN KO mice had 
increased  locomotor deficits over WT due to greater neuronal loss and less white matter sparing 
(Hashimoto et al., 2007).  Similarly, neonatal OPN KO mice subjected to HI developed increased 
gray and white matter sensorimotor dysfunction, and decreased cell proliferation and 
oligodendrocyte generation (van Velthoven et al., 2011). 
As in the EAE studies described above, replacing OPN reversed many of the OPN KO 
effects.  For example, OPN KO cultures from mice subject to SCI had decreased levels of MBP, 
and administration of r-OPN stimulated MBP synthesis (Hashimoto et al., 2005).  Other 
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recombinant studies utilizing MCAO or SAH models also support OPN functioning as a 
beneficial molecule after injury.  They show that postinjury administration of r-OPN reduced 
weight loss, neurological impairment, infarct size, brain edema, and BBB disruption (Meller et 
al., 2005; Suzuki et al., 2010a; Suzuki et al., 2010b).  Finally, studies in the cuprizone 
demyelination model suggest OPN is supportive of remyelination and MBP synthesis by 
showing that administration of r-OPN increased MBP expression, while OPN KO mice had 
decreased myelin-forming capacity and fewer mature oligodendrocytes (Selvaraju et al., 2004).  
Together, these results suggest that the OPN KO model can be used to dissect details of OPN’s 
neuroprotective role, such as examining its potential for altering the immune response to reduce 
neurodegeneration, or for promoting white matter regeneration, myelination, and angiogenesis. 
 
SUMMARY AND EXPERIMENTAL HYPOTHESES 
This Introduction has outlined the complexity of TBI and its pathophysiology, 
components which contribute to the growing economic and societal burden of managing human 
brain injury.  As this epidemic continues, many individuals are at risk and require novel therapies 
to treat the consequences of TBI.  TBI is a heterogeneous insult, involving perturbations in a 
number of cellular and molecular pathways.  Given the myriad of long term effects resulting 
from these perturbations, this present set of studies will explore how one of the first postinjury 
changes, acute immune response, determines the quality of synaptic recovery underlying long 
term outcome.  These studies will also test an acute immune mediator for its potential to serve as 
a therapeutic alternative in patients suffering from TBI.  
The inflammatory response is one of the first cell processes to be engaged after CNS 
injury, and the significance of its contribution following head trauma has been the subject of 
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considerable debate.  In addition to the severe edema, the immune response directs cell migration 
and clearance injured neurons and axons.  While initially supportive, chronic inflammation may 
be detrimental, leading to prolonged and extensive neurodegeneration and synaptic disruption.  
Understanding the molecular players which permit effective synaptic reorganization is critical 
for future therapies.  Within the ECM there are several immune regulators of this reorganization, 
including reactive glia and their secreted cytokines and MMPs.  The studies of this dissertation 
will address the role of OPN, a cytokine already linked to tissue repair in multiple organ systems.  
A novel function for OPN will be examined, exploring its role as a cytokine and modulator of 
synaptic reorganization caused by axonal injury.  It is hypothesized that OPN is elevated during 
the acute postinjury immune response, mediating cellular reactions which direct deafferentation-
induced degeneration and promote the onset of successful synaptic reformation.  A corollary to 
this hypothesis posits that contrasting models of adaptive and maladaptive plasticity will reveal 
differences in OPN-directed response to synaptic deafferentation, identifying novel inflammatory 
pathways which discriminate effective synaptic reorganization.  To test this hypothesis, we will 
first map the spatial and temporal profile of OPN in the rat following UEC and TBI+BEC using 
Western blot (WB) analysis, IHC, and qRT-PCR.  Further analysis of the acute immune response 
will examine OPN lytic fragments to explore potential cell signaling mechanisms with OPN 
receptors and determine the extent of MMP/OPN proteolytic interaction.  This OPN response 
will be manipulated by immune suppression with the antibiotic minocycline, after which we will 
examine how immune activation affects OPN response, and probe for effects on a marker of 
presynaptic structure during acute postinjury intervals. 
In a second set of studies, we will utilize more specific OPN manipulation with OPN KO 
mice to more accurately establish OPN role during synaptogenesis and address its interaction 
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with MMPs.  We hypothesize that absence of OPN will alter the acute immune response leading 
to impaired cellular interaction during the acute postinjury period, which will result in poor 
synaptic reorganization and cognitive dysfunction.  To test this hypothesis, we will again use 
WB and IHC analysis to characterize the temporal and spatial profile of OPN during the acute 
degenerative phase in OPN KO subjected to UEC, contrasting their response with that of paired 
WT C57BL/6 mice.  Molecules important in synaptic remodeling, including those contributing to 
cytoskeletal structure, synaptic junction stabilization, and presynaptic terminal formation will be 
compared between strains.  In addition, the effect of OPN KO on postinjury behavioral function 
will be evaluated using a cognitive test of hippocampal-dependent learning.  Finally, gelatin 
zymography and WB analysis will assess the potential for MMP and its regulator lipocalin-2 to 
mediate upstream OPN response.  Together, these studies will provide insight into how acute 
OPN expression affects plasticity during the degenerative and regenerative phases of synaptic 
reorganization.  They will determine if OPN can influence effective neurological recovery 
following deafferentation, highlighting the importance of the acute immune response in effective 
synaptic reorganization following traumatic CNS injury.
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CHAPTER 2 
 
OSTEOPONTIN RESPONSE FOLLOWING TRAUMATIC BRAIN INJURY
 72 
 
ABSTRACT 
Osteopontin (OPN) is a pleiotropic molecule which can act as both a cytokine and axonal 
growth modulator during the acute immune response.  OPN has been documented to increase 
after CNS injury, however, its response during trauma-induced synaptic reorganization is not 
known.  This study sought to determine whether OPN can serve as a functional link between the 
acute immune response and adaptive synaptic recovery following traumatic brain injury (TBI).  
We contrasted OPN in two TBI models, adaptive synaptogenesis induced by unilateral entorhinal 
cortex lesion (UEC), and maladaptive plasticity produced by combined central fluid percussion 
injury and bilateral entorhinal cortex lesions 24 hours later (TBI+BEC).  Our results showed an 
acute (1-2d postinjury) elevation in both OPN protein and transcript within the hippocampus and 
its deafferented molecular layer (ML), the site of synaptic reorganization in these models.  This 
acute OPN protein elevation was seen under conditions of both adaptive and maladaptive 
plasticity.  Interestingly, proteolytic fragments of OPN with exposed integrin binding domains 
were also generated in the ML over the first week postinjury.  In the deafferented zone, OPN was 
primarily localized to glial cell types, including reactive astroglia and active microglia containing 
OPN transcript.  Notably, these OPN positive cells were directed to the border between the 
injured and intact ML in the adaptive UEC model.  This was in contrast to the maladaptive 
TBI+BEC insult, where OPN label was reduced in reactive microglia, and active glial cells failed 
to migrate to the boundary zone of ongoing synaptic reorganization.  As a marker of 
deafferentation-induced dendritic morphing, ML microtubule associated protein 1B (MAP1B) 
was reduced during acute degeneration, and reemerged with axonal sprouting.  However, we 
observed few instances of the potential binding between MAP1B and OPN, suggesting a limited 
role for OPN in cytoskeletal reorganization after injury.  Finally, blunting the immune response 
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with minocycline reduced OPN response to UEC, attenuating presynaptic terminal removal and 
producing altered glial cell distribution closely resembling the pattern of the maladaptive injury.  
In addition, this attenuated immune response reduced injury-induced matrix metalloproteinase 
(MMP) activity and MMP-generated OPN integrin binding fragments.  These results suggest a 
positive role for OPN in the early immune response, one which facilities the conditioning of the 
extracellular matrix to permit effective synaptic reorganization following TBI. 
 
INTRODUCTION 
Traumatic brain injury (TBI) is a serious health concern nearly 2 million individuals 
suffer each year (Faul et al., 2010).  This is further compounded by the TBI-induced long term 
motor and cognitive deficits more than 5.3 million Americans endure, imposing a substantial 
economic burden estimated at $60 billion annually due to rehabilitation costs and loss of 
productivity (Langlois et al., 2006; Rutland-Brown et al., 2006; Finkelstein et al., 2006).  Of 
these deficits, impaired cognition is of particular importance as this has profound effects on the 
patient’s ability to return as a functional member of society.  One structure particularly 
vulnerable to TBI insult is the hippocampus, a brain region important in memory formation and 
essential to proper cognitive function.  Following the initial traumatic insult, the hippocampus 
becomes damaged through a number of pathophysiological mechanisms, resulting in diffuse 
axonal damage, neuronal death, and deafferentation.  During the recovery and repair of injured 
synapses, one of the first processes to respond to traumatic central nervous system (CNS) injury 
is the inflammatory immune response.  While the immune response has previously been regarded 
as a deleterious mechanism following TBI, more recent evidence indicates the acute immune 
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response is essential to effective synaptic reorganization, directing cytokines and reactive glia to 
the injured area (Ziv et al., 2006; Derecki et al., 2010). 
 In an attempt to develop new therapeutics in the treatment of TBI, many injury paradigms 
have been designed to mimic the pathophysiologic events leading to CNS dysfunction in human 
TBI.  Following traumatic insult, the CNS undergoes a series of well-defined stages of reactive 
synaptogenesis: degeneration of injured synaptic terminals (1-5d), regeneration of postsynaptic 
spines and collateral axonal sprouting to form new synapses (6-15d postinjury), and the 
maturation of stabilized synapses (15d+ postinjury) (Steward et al., 1988b).  One model that 
demonstrates these time-dependent stages of synaptic reorganization is the unilateral entorhinal 
cortex lesion (UEC), which results in predictable remodeling of injured synapses.  Following 
electrolytic lesion of the EC, 80-90% of the fibers that synapse in the outer molecular (OML) of 
the dentate gyrus (DG) are ablated.  While this model is appropriate to study effective reactive 
synaptogenesis, it fails to recapitulate the impaired recovery seen in TBI patients.  The TBI+BEC 
model however, pairs a mild-moderate midline fluid percussion injury with bilateral entorhinal 
cortex lesions (BEC) 24 hours later, inducing diffuse neuroexcitation and deafferentation that 
leads to persistent structural, functional, and behavioral deficits which mimic the CNS 
impairment in human TBI (Phillips et al., 1994; Phillips and Reeves, 2001).  By contrasting these 
models of adaptive and maladaptive plasticity, we can determine differences in the expression 
profile of proteins, potentially identifying candidates which may underlie unsuccessful injury-
induced synaptogenesis. 
 As previously mentioned, the first development in response CNS injury is immune-
mediated, a process which occurs during the degenerative phase, and likely sets the stage for 
synaptic reorganization.  Previous studies have identified matrix metalloproteinases (MMPs) and 
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their substrates as important molecules in effective synaptic reorganization after trauma (Falo et 
al., 2008; Harris et al., 2011; Warren et al., 2012).  MMPs are a diverse set of molecules known 
to function in the immune response through reciprocal interaction with active microglia and 
proinflammatory cytokines (Kim et al., 2005; Kim et al., 2007; Kim and Hwang, 2011).  One 
cytokine which is a substrate of MMPs (Agnihotri et al., 2001), and capable of acting as a 
modulator of synaptic outgrowth (Kury et al., 2005; Plantman, 2012), is osteopontin (OPN).  
This highly negative and posttranslationally modified glycoprotein contains several binding sites 
which function in integrin receptor signaling when secreted in the extracellular matrix (ECM) 
(Kazanecki et al., 2007b; Hu et al., 1995; Ellison et al., 1998) (see Fig. 1.4).  Previous studies 
have demonstrated acute OPN response in the tissue repair in a number of organ systems 
including bone (Denhardt and Guo, 1993), heart (Giachelli et al., 1993), kidney (Lopez et al., 
1993), and CNS (Wang et al., 1998).  Most recently, OPN has been implicated in inflammatory 
neurodegeneration (Iczkiewicz et al., 2006; Wung et al., 2007; Maetzler et al., 2007), and 
identified as a molecule significantly upregulated following stroke/forebrain ischemia (Wang et 
al., 1998; Lee et al., 1999), SCI (Hashimoto et al., 2003; Moon et al., 2004), and TBI (von 
Gertten et al., 2005; Shin et al., 2005).  Additional studies utilizing OPN knockout (KO) mice 
suggest OPN may be a neuroprotective molecule, functioning during the acute immune response 
which overlaps with the window of postinjury degeneration, implicating OPN as a potential 
modulator of effective trauma-induced synaptic reorganization. 
In this study, we examined reactive synaptogenesis in rats during the subacute postinjury 
intervals following TBI to determine if immune-stimulated OPN plays a role in establishing the 
early phases of synaptic recovery.  In preliminary microarray screening experiments, we found 
significant increase in OPN transcript within the hippocampus at 7d after both UEC (14-fold) 
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and combined TBI+BEC insult (41-fold) (see Appendix A), prompting mapping of its protein 
expression between during the first week postinjury.  We initially profiled the expression of OPN 
using Western blot (WB) to examine hippocampal extracts from 1, 2, and 7d survivors, 
contrasting protein levels generated by adaptive UEC and maladaptive TBI+BEC plasticity.  
Additional blots were probed with an antibody which specifically recognizes MMP-cleaved OPN 
fragments (Fig. 2.1).  We used parallel immunohistochemistry (IHC) to determine cellular OPN 
colocalization in reactive glia and its association with potential cytoskeletal binding partner 
microtubule associated protein (MAP1B) within the injured dentate gyrus.  In addition 
quantitative real time-polymerase chain reaction (qRT-PCR) was employed to assess changes in 
OPN transcript at postinjury intervals when the cytokine protein level was highest.  Finally, we 
applied minocycline in the UEC model to test whether blunting immune-driven OPN expression 
would alter patterns of synaptic recovery, employing synapsin 1 and IBA1 IHC to map 
differences in synapse and microglia redistribution within the deafferented region.  We 
hypothesized OPN would increase significantly after TBI, likely acting as a cytokine to effect 
debris clearance during the degenerative phase, and anticipated specific OPN MMP-cleaved 
fragments would exhibit unique temporal profiles, consistent with the multifunctional capacity of 
OPN.  Further, we posited OPN colocalization within reactive glial cells, where it facilitates 
chemotaxis and the acute immune response, driving the degeneration of damaged presynaptic 
terminals after injury, responses we found to be impaired by minocycline immunosuppression.  
Our results suggest that OPN is an early response molecule, elevated in expression during the 
acute degenerative phase of reactive synaptogenesis, a protein which localized within activated 
glia of the deafferented zone, showing distinct differences in expression and tissue distribution 
when plasticity is maladaptive.  Moreover, the increase of integrin-binding OPN fragments in the 
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Figure  2.1  MMP/OPN Proteolysis Schematic.  OPN proteolysis occurs through multiple 
MMPs.  This example of chondrocyte OPN proteolysis by MMP-3 and MMP-7 shows the 
generation of 40 kD and 32 kD fragments after a single cleavage.  The 40 kD fragment 
contains the RGD and SVVYGLR integrin receptor-binding regions while the 32 kD 
fragment is subsequent to further proteolytic processing. 
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deafferented zone provides a cell signaling mechanism for this glial migration.  These studies are 
the first to document OPN expression in the acute inflammatory phase of reactive synaptogenesis 
induced by TBI.  Further, we provide evidence that immune-mediated attenuation of OPN 
expression alters the subsequent pattern of adaptive synaptic reorganization.  
 
METHODS 
Experimental Animals 
The procedures in this study met national guidelines for the care and use of laboratory 
animals, and all experimental protocols were approved by the VCU Institutional Animal Care 
and Use Committee.  Male Sprague Dawley rats (300-350 g; Harlan Laboratories) were used in 
these experiments, housed in pairs under a temperature (22°C) and humidity controlled 
environment with food and water ad libitum, and subjected to a 12 hour dark-light cycle.  Rats 
were randomly assigned to one of three groups: UEC (n=78), TBI+BEC (n=32), or Sham-injured 
(n=32) and evaluated at 1, 2, 4, or 7d postinjury by either WB, IHC, qRT-PCR or gelatin 
zymography.  For the minocycline study, rats were randomly assigned to UEC saline-treated or 
UEC minocycline-treated groups, and evaluated at 1 or 2d postinjury by either WB or IHC (n=8 
per group, total n=32).  For all analyses, contralateral hemisphere served as a control for UEC 
lesioned animals while Sham-injured served as controls for TBI+BEC animals. 
 
Rat Unilateral Entorhinal Cortex Lesion 
The rat UEC protocol is a modification of that described by Loesche and Steward (1977).  
Rats were anesthetized with 4% isoflurane in carrier gas of 70% N2O, 30% O2 for 4 minutes, 
heads shaved, then maintained on 2% isoflurane in carrier gas of 70% N2O, 30% O2 delivered 
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via nose cone for the duration of the surgery.  Body temperature was maintained at 37°C via 
heating pad (Harvard Apparatus, Holliston, MA), and animal heart rate (beats per minute, bpm), 
arterial oxygen saturation (%), breath rate (breaths per minute, brpm), pulse distention (μm), and 
breath distention (μm) were monitored via pulse oximeter (MouseOx; Starr Life Sciences, 
Oakmont, PA).  While under anesthesia, rats were secured in a stereotaxic device, and a midline 
incision exposed the cranium to permit a 2 mm wide craniectomy to visualize the intact dura 
mater above the right EC.  Electrolytic lesions were delivered via Teflon®-coated wire 
transmitting 1.5 mA for 40 seconds to eight stereotaxic coordinates: 10° lateral to perpendicular; 
1.5 mm rostral to the transverse sinus; 3 and 4 mm lateral to the midline at 6, 4, and 2 mm 
ventral to the brain surface; and 5 mm lateral at 4 and 2 mm ventral to the brain surface (Fig. 
2.2).  After lesion completion, the electrode was removed, and the incision sutured closed and 
treated with topical anesthetic and antibiotic.  Animals were then housed singly in a heated 
holding cage during the acute recovery phase and monitored for discomfort or distress before 
being returned to their home cage.   
 
Surgical Preparation for Rat Central Fluid Percussion Injury 
In preparation for central fluid percussion injury, animals underwent surgical preparation 
24 hours prior to injury.  Rats were anaesthetized, secured in a stereotaxic apparatus, and vitals 
monitored as described above for UEC.  Under anesthesia, rats received a circular 4.8 mm 
craniectomy along the sagittal suture midway between bregma and lambda, exposing the intact 
dura mater.  Two      inch long steel screws were implanted into the skull at a bias 1 cm rostral 
and caudal to the midline, and the craniectomy fitted with a modified Luer Lock hub (2.6 mm 
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Figure 2.2  Rat Unilateral Entorhinal Cortex Lesion Stereotaxic Locations.  1.5 mA 
electrolytic lesions of 40 seconds each were delivered to eight stereotaxic sites as shown.  
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internal diameter) fixed with cyanoacrylate adhesive.  To provide additional hub stability during 
fluid percussion injury, dental acrylic (Coltene/Whaledent, Inc., Cuyahoga Falls, OH) was 
applied to solidify the Luer Lock hub and screws into a single complex.  The incision wound was 
then sutured closed over the complex and animals were then monitored for post-surgical stress as 
described above before returning to their home cage.  
 
Central Fluid Percussion Injury 
The fluid percussion injury device consists of a weighted pendulum, 0.9% saline-filled 
Plexiglas cylinder, and is fitted with a metal extra-cranial pressure transducer (Entram Devices, 
Inc., model EPN-0300-100A).  Fluid percussion injury is induced by releasing the metal 
pendulum from a pre-determined height that coincides with the desired injury severity, striking 
the rubber piston on one side of the acrylic cylinder to produce a pressure wave and injecting a 
small volume of saline onto the dura of the animal attached to the metal transducer via the Luer 
Lock fitting (Dixon et al., 1987) (Fig. 2.3 B).  Twenty-four hours  after craniectomy and hub 
implantation, animals were anaesthetized 4% isoflurane in carrier gas of 70% N2O, 30% O2 for 4 
minutes, and a scalp incision was made to expose the hub complex.  Animals were then attached 
to the fluid percussion device by filling the hub with sterile 0.9% saline to ensure a seal free of 
air bubbles.  Animals then received a moderate midline fluid percussion injury (2.0+0.1 
atmospheres) via saline injection into the closed cranial cavity.  The pressure pulse measured by 
the transducer was displayed on an oscilloscope (Tektronix 1000 S, Beaverton, OR) and the peak 
of the pressure curve was recorded.  Prior to waking, the hub was removed and incision sutured 
closed and treated with topical triple antibiotic and lidocaine.  To confirm injury severity, 
reflexes (ear, tail, corneal blink) and righting times were recorded prior to acute recovery.  Sham 
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Figure 2.3  TBI+BEC Injury Locations and Fluid Percussion Injury Device.  Schematic 
of craniectomy locations (A) for central fluid percussion (yellow circle) and bilateral 
entorhinal cortex lesions (red ovals) and fluid percussion injury device (B). 
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injured animals underwent the same surgical preparation and hub removal procedures with the 
exception of the actual central fluid percussion injury. 
 
Combined Central Fluid Percussion Injury and Bilateral Entorhinal Cortex Lesions 
For the TBI+BEC paradigm, rats were first subject to central fluid percussion injury 
surgical preparation and moderate injury as described above, then at 24 hours post-TBI, 
subjected to bilateral entorhinal cortex lesions (BEC) utilizing the method described for UEC 
above with the addition of a second, left entorhinal lesion (Phillips et al., 1994) (Figure 2.3 A).  
Animals were then monitored for distress and discomfort during recovery as previously 
described. 
 
Administration of Minocycline 
The general immune response was blunted using the tricyclic antibiotic minocycline.  
Selected rats received two acute intraperitoneal minocycline doses (Sigma-Aldrich, Co., St. 
Louis, MO) of 45 mg/kg at 30 minutes and 6 hours postinjury, a paradigm previously shown to 
induce immunosuppression (Homsi et al., 2009).  Control animals underwent the same procedure 
but received a saline vehicle instead of minocycline. 
 
Morphological and Molecular Assessments  
Protein Extraction and Analysis 
Selected rats were anaesthetized with 4% isoflurane in carrier gas of 70% N2O, 30% O2 
for 4 minutes, then sacrificed at 1, 2, 4, or 7d postinjury via decapitation  (n=4 each whole 
hippocampus and enriched molecular layer (ML) dissection for UEC, TBI+BEC, Sham; total n= 
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96).  For minocycline studies, rats were sacrificed at 1 or 2d postinjury and hippocampi dissected 
(n=4 each saline and minocycline treated; total n=16).  Whole hippocampi or ML samples were 
dissected, homogenized on ice in 125 µl of T-PER (Thermo Scientific, Rockford, IL), and  
centrifuged at 8,000 x g for 5 min at 4°C.  Supernatant was aliquotted and stored at -80°C for 
protein quantification, WB, or gelatin zymography analysis.  Protein concentration was 
determined using Thermo Scientific Pierce Protein Assay Reagent (Rockford, IL) and FLUOstar 
Optima plate reader (BMG Labtech, Inc., Durham, NC).   
 
Western Blot Analysis 
WB analysis was carried out utilizing Bio-Rad products (Hercules, CA).  Thirty µg of 
protein were prepared for WB with XT sample buffer and XT reducing buffer then denatured at 
95°C for 5 minutes.  Samples were electrophoresed on 4-12% Bis-Tris Criterion XT gels (200 V 
x 45 min) then protein transferred to polyvinylidene fluoride (PVDF) membranes (100 V x 60 
min).  Following transfer, post-blot gels were stained with 0.1% coomassie brilliant blue in 
destain #1 (40% methanol (MeOH), 10% glacial acetic acid (HOAc) x 30 minutes), then 
destained at room temperature (#1 x 30 minutes; #2: 7% MeOH , 10% HOAc x 30 minutes) to 
confirm even transfer of protein.  To prevent non-specific protein binding, membranes were first 
washed in nanopure H2O (2 x 5 minutes) and TBS (tris-buffered saline; 1 x 5 minutes), then 
blocked in 5% milk Tris-Buffered Saline with 0.05% Tween 20 (mTBST).  Blots were then 
separated at the 25 kDa marker and the appropriate pieces incubated overnight at 4°C in mTBST 
with either anti-OPN (0.25 μg/ml, R&D Systems, Minneapolis, MN; 1:300, Rockland 
Immunochemicals Inc., Gilbertsville, PA) or anti-cyclophilin A (1:2,500, Millipore, Billerica, 
MA) as a loading control.  Blots were washed with mTBST (5 x 5 minutes) then incubated in 
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appropriate secondary in mTBST (1:10,000 goat anti-mouse; 1:20,000 bovine anti-rabbit, Santa 
Cruz Biotechnology Inc., Dallas, TX) at room temperature for 1 hour.  Finally, blots were 
washed in TBST (5 x 5 minutes) and incubated with Super Signal Dura West chemiluminescent 
substrate (Thermo Scientific, Rockford, IL) for signal detection.  WB images were captured with 
Syngene G:Box and positive band signal subjected to densitometric analysis (relative optical 
density, ROD) with Gene Tools software (Syngene, Frederick, MD).  Protein data are expressed 
as either fold change over controls or percent change relative to paired control cases. 
 
Gelatin Zymography Analysis 
Twenty µg of protein from 2d whole hippocampal extracts as described above were 
prepared with 2x Tris-glycine SDS sample buffer then separated by gelatin electrophoresis at 
4°C on Novex® 10% zymogram gels (Life Technologies, Grand Island, NY).  Gels were then 
renatured in Novex® Zymogram Renaturing Buffer (LC2670, Life Technologies, Grand Island, 
NY) at room temperature before development in Novex® Zymogram Developing Buffer 
(LC2671) over 6 days at 37°C.  Gelatin lysis was visualized with coomassie brilliant blue and 
purified enzyme run as positive control.  Zymogram signal was captured as an inverted image 
with Syngene G:BOX, and densitometry analyzed as ROD with Gene Tools software (Syngene, 
Frederick, MD).  Enzyme activity data are expressed as percent change relative to paired control 
cases. 
 
Immunohistochemical Analysis 
At 1, 2, 4, or 7d (n=4 each UEC, TBI+BEC, Sham; total n= 48) animals were selected for 
fluorescent IHC analysis.  Rats were anaesthetized and sacrificed with a lethal dose of sodium 
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pentobarbital (90 mg/kg, i.p.).  Rat brains were then preserved using transcardiac perfusion with 
0.9% saline (500 ml) followed by aldehyde fixative (500 ml 4% paraformaldehyde (PFA) in 0.1 
M NaHPO4, pH=7.4).  Perfused brains were then extracted and placed in fixative for an 
additional 24 hours before transfer to 0.03% NaN3 in 1.0 M phosphate buffered saline (PBS).  
For IHC staining, brains were blocked at the dentate gyrus and 40 µm coronal sections were 
sliced using the VT1000S microtome (Leica, Buffalo Grove, IL).  Slices were then pre-treated in 
0.5% peroxidase (30 minutes) and washed in PBS (3 x 10 minutes).  To prevent non-specific 
binding, sections were blocked in Blotto (5% Cold Water Fish Skin Gelatin, Aurion, 
Netherlands, 5% Triton in 1.0 M PBS) for 30 minutes prior to overnight primary antibody 
incubation in Blotto (anti-OPN MPIIIB10, 1:300, Iowa Hybridoma, Iowa City, IA; anti-IBA1, 
1:300, Wako Chemicals, Richmond, VA; anti-glial fibrillary acidic protein (GFAP),1:300, Dako, 
Carpinteria, CA; anti-synapsin 1 a/b (N-19, sc-7379), 1:250, Santa Cruz Biotechnology, Inc., 
Dallas, TX; anti-MAP-1B (H-130, sc-25729), 1:200 Santa Cruz Biotechnology, Inc., Dallas, 
TX).  The next day, tissue sections were washed with PBS, blocked in Blotto at room 
temperature (30 minutes), then incubated in Blotto with the desired secondary fluorescent 
antibody (Alexa Fluor® 488 or 594, 1:1,000, Life Technologies, Grand Island, NY) for 1 hour at 
room temperature.  Free floating sections were then washed in PBS (3 x 5 minutes), equilibrated 
in phosphate buffer, and mounted on Superfrost Plus slides (Fisher Scientific, Pittsburgh, PA) 
with Vectashield (Vector Laboratories, Burlingame, CA).  IHC signal was visualized using the 
TCS-SP2 AOBS (Leica, Buffalo Grove, IL) or LSM 700 (Carl Zeiss, Thornwood, NY) confocal 
microscope. 
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Quantitative Reverse Transcriptase-Polymerase Chain Reaction 
At 1 or 2d after UEC, selected rats were anesthetized, decapitated, and whole hippocampi 
(n=10) or ML enriched fractions dissected (n=10).  Total RNA was extracted from either whole 
hippocampal or ML enriched dissections with TRIzol® (Life Technologies, Grand Island, NY) 
were processed for OPN gene assessment utilizing Qc analysis and qRT-PCR with TaqMan® 
Assay Reagents (Life Technologies, Grand Island, NY).  Probes and primer sets for detection of 
OPN (Rn00582114m1) were obtained from Inventoried Assays (Life Technologies, Grand 
Island, NY).  Probes were labeled at the 5’ end with 6-carboxyfluorescein and with a dark 
quencher at the 3’ end.  Efficiency was determined with 10-fold serial dilutions of template and 
cyclophilin A was used as an endogenous control (Pre-developed TaqMan® Assay Reagents; 
Life Technologies, Grand Island, NY).  Experiments were performed in the ABI Prism 7500 
Sequence Detection System using the TaqMan® One-Step PCR Master Mix Reagents Kit (Life 
Technologies, Grand Island, NY).  All samples were tested in triplicate under cycling conditions 
(48°C/30 minutes, 95°C/10 minutes; 40 cycles 95°C/15 seconds, and 60°C/1 minute).  Fold 
change in OPN mRNA expression was calculated by the 2-ΔΔCt method (Dumur et al., 2009). 
 
In Situ Hybridization  
Sense and antisense probes were generated against full length OPN (SPP1, MRN1768-
202780755) and synaptobrevin (Vamp1, MRN1768-202782932) which was used as a positive 
control (Thermo Scientific, Rockford, IL).  Riboprobes were synthesized using digoxigenin 
(DIG)-tagged dNTPs (Roche, Mannheim, Germany) and the MAXIscript® in Vitro 
Transcription Kit (Life Technologies, Grand Island, NY) and hydrolyzed to ~500nt as previously 
described (Su et al., 2010).  Selected 40 µm coronal sections from 1, 2, and 7d animals in the 
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previous IHC studies were mounted free floating in PB on Superfrost Plus slides (Fisher 
Scientific, Pittsburgh, PA) as described above, then prepared and hybridized at 65°C as 
previously described (Yamagata et al., 2002).  Bound riboprobes were detected by horseradish 
peroxidase (POD)-conjugated anti-DIG and fluorescent Cy3 staining with Tyramide Signal 
Amplification (TSA) systems (PerkinElmer, Shelton, CT).  For fluorescent ISH colabeling with 
IHC, standard IHC was performed following the TSA step above.  ISH/IHC signal was 
visualized using the TCS-SP2 AOBS (Leica, Buffalo Grove, IL) confocal microscope. 
 
Statistical Analyses 
Changes in protein or RNA levels, due to injury or minocycline treatment, were 
evaluated using the General Linear Model (GLM) programs in SPSS v.11 (International 
Business Machines Corp., Armonk, NY).  The time course of changes in OPN protein and 
transcript after UEC injury were assessed using a mixed model analysis of variance (ANOVA) 
with hemisphere (contralateral vs. ipsilateral to injury) as a within-subjects variable, and day 
postinjury as a between-subjects measure.  The significance of changes at specific postinjury 
days was evaluated as a priori planned comparisons using simple-main effects based on marginal 
means, and implemented using multivariate ANOVA (MANOVA) routines in SPSS.  In 
experiments which compared animals receiving a TBI+BEC injury to sham-injured animals, 
protein and RNA changes were analyzed using a completely randomized ANOVA design, with 
Duncan post-hoc tests used for pairwise comparisons.  Results are reported as mean +/- SEM.  
An alpha level of 0.05 was used in all analyses. 
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RESULTS 
Osteopontin Expression Is Time Dependent During UEC Reactive Synaptogenesis 
We first examined the postinjury time course of OPN protein expression during UEC 
adaptive synaptogenesis, focusing on acute survival intervals which sample the period of initial 
immune response (1d) and onset of presynaptic terminal degeneration (2d).  These time points 
were contrasted with a later pre-regenerative interval (4d) and a time point matching the onset of 
presynaptic terminal sprouting (7d).  Using whole hippocampal extracts, we first performed 
routine WB analysis with polyclonal goat OPN antibody (R&D Systems) which identified full 
length OPN (66 kD) as the principal signal.  In the control samples, OPN signal was near 
background, supporting low constitutive OPN expression as reported in prior studies of brain 
tissue (Choi et al., 2004; Iczkiewicz et al., 2004).  Results showed a time-dependent increase in 
full length 66 kD OPN protein (Fig. 2.4 A), initiated by 1d (29.42 ± 1.38 fold, p<0.05), peaking 
at 2d (51.58 ± 2.57 fold, p<0.05), and reduced by 4d (3.38 ± 0.53 fold).  At the 7d onset of 
sprouting, OPN protein was no longer significantly elevated over paired controls (2.94 ± 0.15 
fold).  In a parallel experiment, we utilized a polyclonal rabbit OPN antibody (Rockland), which, 
in our samples, recognized MMP-cleaved OPN fragments of 45 and 32 kD.  Here we probed 
enriched extracts of the deafferented ML, revealing a significant acute elevation in a 45 kD 
fragment at 1d (166.21 ± 24.05%, p<0.05) and an increase at 2 and 7d postinjury that did not 
reach significance (109.96 ± 9.69; 126.29 ± 15.27%).  In addition, 32 kD OPN was elevated at 
1d postinjury (128.75 ± 12.37%), significantly reduced at 2d (86.90 ± 3.79%, p<0.05), then 
significantly elevated at 7d (117.30 ± 5.63%, p<0.05) (Fig. 2.4 B).  As a structural correlate, 
hippocampal tissue sections were subjected to OPN fluorescent IHC at 1, 2, and 7d postinjury 
(Fig. 2.5).  In the control hemisphere, we found OPN signal within granule cell bodies of the 
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Figure 2.4  Hippocampal or Dentate Molecular Layer OPN Protein Expression 
Following Adaptive UEC.  WB analysis of full length 66 kD OPN protein in whole 
hippocampal extracts (A).  UEC induced an acute robust increase in OPN protein, peaking at 
2d postinjury compared to contralateral controls.  OPN response then showed a significant 
reduction at 4d and a return to baseline by 7d.  Using antibody raised against peptide 
sequences exposed by MMP proteolysis (B), two principal OPN fragments (45, 32 kD) were 
identified in extracts of enriched dentate ML.  The 45 kD fragment, containing integrin 
receptor binding RGD sequence, was significantly increased compared to controls 1d 
postinjury, but not at 2 or 7d.  By contrast, the 32 kD C terminal fragment did not change in 
level at 1d, but was modestly reduced at 2d, with a shift to elevation over controls at 7d 
following UEC.  Results are displayed as fold change over control (A) or percent of control 
(B), with representative blot images and cyclophilin A loading controls shown below.  
*p<0.05, relative to paired control cases; §p<0.05; §§§p<0.001. 
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Figure 2.5  IHC of OPN in the Dentate Gyrus.  Confocal OPN staining in the granule cell 
layer was observed in all cases, and remained qualitatively unchanged at 1, 2, and 7d 
postinjury (A-F).  Following UEC, OPN increased in the ML between 1 and 2d postinjury 
returning to baseline by 7d.  The 2d OPN signal was pronounced in cell bodies within the 
deafferented zone (arrows).  Scale bar = 75 µm. 
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dentate gyrus, with a diffuse, low level label over the dentate ML.  At 1d following UEC, we 
observed no visible differences in OPN staining between injured and control hippocampi (Fig. 
2.5 A-B), however at 2d there was a prominent increase over the deafferented ML, including 
both fine punctate label and cellular localization consistent with reactive glia (Fig. 2.5 C-D).  By 
7d postinjury, no qualitative differences were observed between lesioned and control hippocampi 
(Fig 2.5 E-F).  OPN signal within granule cell body layers did not change at any postinjury 
interval.  This acute increase in full length OPN 1-2d after UEC is in agreement with reported 
elevation for other models of traumatic CNS insult (Ellison et al., 1998; Hashimoto et al., 2003; 
Shin et al., 2005), each reporting onset of OPN elevation within 24 hours after injury.  The 
present results suggest that OPN is part of the acute immune response after deafferentation, and 
support a potential role for the protein in reactive synaptogenesis.  Focal elevation of OPN 
fragments over regions of synaptic plasticity is consistent with the fact that MMP-3, a matrix 
enzyme which cleaves OPN to expose integrin binding epitopes, shows similar spatial and 
temporal increase after UEC (Falo et al., 2006). 
 
Osteopontin Is Expressed in Reactive Glial Populations During Synaptogenesis  
To determine the identity of OPN labeled cells within the deafferented molecular layer, 
we performed double label colocalization OPN immunofluorescence experiments using 
antibodies specific for microglia (IBA1) and astrocytes (GFAP).  We found that at 1-2d after 
UEC, increased OPN staining in the deafferented zone was associated with both reactive 
microglia (Fig. 2.6 B, C) and astroglia (Fig. 2.6 E, F), compared to low level OPN signal in 
paired controls (Fig 2.6 A, D).  ML OPN increased between 1 and 2d postinjury, where 
microglia exhibited greater labeling.  A subset of reactive microglia migrated to positions  
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Figure 2.6  IHC of OPN and Glial Cells in the Dentate Gyrus Following UEC.  Confocal 
OPN (green) staining increased over the ML after UEC (B, C, E, F) compared to contralateral 
control hemispheres (A, D).  Injury-induced staining was colocalized with activated microglia 
(red; B, C) and reactive astrocytes (red; E, F), each of which showed cellular alignment at the 
inner molecular layer (IML) border with the deafferented zone (arrows).  Scale bar = 50 µm. 
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along the boundary between the outer deafferented dendritic region and the inner non-
deafferented ML, marking the interface between intact and damaged synapses.  Such alignment 
was not striking for OPN positive astrocytes.  These results suggest that acute OPN increase 
during deafferentation-induced synaptogenesis is principally glial in nature, and that the potential 
immune-initiated role of OPN may be mediated through reactive microglia.  Similarly, OPN 
localization within reactive glia was reported for models of CNS cortical injury (Shin et al., 
2005; von Gertten et al., 2005; Plantman, 2012), and following both stroke and ischemia (Ellison 
et al., 1998; Choi et al., 2007).  Prior UEC studies show that activated microglia position 
themselves along dendritic boundaries, potentially interacting with matrix proteins like agrin to 
direct synaptic reconstruction (Falo et al., 2008), and that reactive astroglia express MMP-3, 
providing a glial pathway for generating OPN integrin signals (Falo et al., 2006). 
 
Osteopontin Does Not Colocalize with Cytoskeletal Proteins 
 In a second experiment, we explored the relationship between OPN and the cytoskeletal 
protein MAP1B during UEC reactive synaptogenesis.  Recent reports suggest that intracellular 
OPN may stabilize cell cytoskeleton through a direct binding with MAP1B (Long et al., 2012).  
We reasoned that the structural reshaping of dentate postsynaptic dendrites induced by 
synaptogenesis may involve changes in neuronal OPN/MAP1B distribution.  Again, using 
double label immunofluorescence, we probed the dentate ML for OPN and MAP1B at 2 and 7d 
after UEC.  As expected, we observed a high concentration of MAP1B in primary granule cell 
dendrites, and along branched dendritic processes of control ML (Fig. 2.7 A), consistent with 
microtubule cytoarchitecture.  A progressive aggregation of signal along proximal dendrites and 
within granule cell bodies was seen at 2d, then a reemergence of signal into the neuropil at 7d 
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Figure 2.7  IHC of MAP1B in the Dentate Gyrus.  Confocal MAP1B staining in the injured 
ML decreased at 2d after lesion (B) relative to control (A), correlated with the retraction of 
injured dendrites during the degenerative phase.  A reemergence of MAP1B staining was 
observed with the onset of synaptic regeneration at 7d postinjury (C).  Confocal overlay of 
MAP1B (red, D) and OPN (green, E) revealed minimal colocalization (arrows) during both 
phases of synaptic reorganization (illustrated for 2d in F, with cells enlarged in insets).  Scale 
bar = 30 µm; inset 80X. 
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after UEC (Fig. 2.7 B, C), consistent with synapse degeneration and dendritic retraction, 
followed by extension of dendrites at the onset of synapse regeneration, a process well-defined in 
the UEC model (Steward, 1976; Steward et al., 1988b).  Surprisingly, there was little evidence of 
OPN/MAP1B colocalization in granule cell dendrites, however, isolated cells within the 
deafferented ML did show cytoplasmic colocalization of the two proteins (arrows, Fig. 2.7 F).  
These results suggest that dendritic interaction between OPN and MAP1B is not a major 
component of the granule cell reorganization with UEC deafferentation.  Cellular OPN/MAP1B 
colocalization in the ML is consistent with cytoskeletal associated OPN within reactive glia in 
the deafferented zone.  
 
Elevated Osteopontin Transcript in Sites of Synaptogenesis Is Localized to Microglia 
Given that OPN protein showed significant elevation during the acute postinjury phase of 
reactive synaptogenesis, and that this elevation was largely cellular in the ML, we applied qRT-
PCR and in situ hybridization (ISH) methods to assay whether OPN transcription was involved.  
As noted above, preliminary microarray screening showed an increase in hippocampal OPN 
mRNA by 14-fold with UEC, and 41-fold after TBI+BEC, while the deafferented ML showed 
21-fold and 6-fold elevations, respectively (see Appendix A).  To examine OPN transcript 
expression, we performed qRT-PCR on RNA extracts from either whole hippocampi or enriched 
in ML dissections at 1 and 2d after UEC lesion.  Results showed multifold elevation of OPN 
mRNA in both whole hippocampus and enriched dentate ML relative to paired control extracts 
(Fig. 2.8 A).  Significant injury-induced elevation of hippocampal OPN transcript was seen at 
each time point (74.96 ± 23.33 fold for 1d; 79.25 ± 31.08 fold for 2d; p<0.05).  ML extracts 
showed higher mean fold changes in OPN transcript than controls (126.55 ± 55.72 fold for 1d; 
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Figure 2.8  OPN Transcript Expression and Microglial Localization Following UEC.  
OPN mRNA was measured by qRT-PCR using RNA extracts prepared from whole 
hippocampus and enriched ML samples (A).  Significant fold elevation in hippocampal OPN 
transcript relative to paired contralateral controls was observed at both 1 and 2d following 
UEC.  ML samples showed greater variance in OPN transcript, but did trend toward higher 
levels than in the whole hippocampus.  Interestingly, 2d enriched ML had the highest fold 
increase and was significantly elevated over paired controls.  Using DIG-tagged riboprobes 
for OPN, antisense probe binding and confocal fluorescent detection (green) showed 
transcript localization within reactive cells of the deafferented dentate ML, identified as 
activated microglia (red) after post hybridization labeling with IBA1 antibody (B).  The same 
protocol conducted with GFAP antibody staining showed no colocalization of OPN transcript 
in reactive astrocytes (C).  Hybridization signal was validated by the absence of fluorescent 
signal when control sense strand was applied (D).  Results are displayed as fold change over 
control.  *p<0.05, relative to paired control cases.  Scale bar = 10 µm. 
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150.10 ± 44.16 fold for 2d, p<0.05), however, only the 2d differences reached statistical 
significance.  When 2d postinjury UEC cases were subjected to ISH with digoxigenin (DIG)-
tagged riboprobes for OPN transcript (Su et al., 2010), antisense strand binding was localized 
within reactive microglia of the deafferented zone, identified by post-hybridization staining for 
IBA1 (Fig. 2.8 B).  Parallel hybridized sections were probed with anti-GFAP antibody and no 
mRNA signal was observed in reactive astrocytes of the ML (Fig. 2.8 C).  Sense control binding 
was negative, confirming the specificity of the signal (Fig. 2.8 D).  These results suggest that 
reactive microglia are a principal source of OPN during the acute phases of reactive 
synaptogenesis. 
 
Maladaptive Plasticity Alters Distribution, but Not Elevation of Osteopontin 
 In prior studies we have contrasted UEC adaptive synaptogenesis with the maladaptive 
synaptic plasticity of combined TBI+BEC insult to explore how the response of molecules 
controlling synaptic repair differ under maladaptive conditions (Phillips et al., 1994; Falo et al., 
2006; Falo et al., 2008; Warren et al., 2012).  As for UEC, we profiled the expression of full 
length 66 kD OPN protein in TBI+BEC hippocampal extracts.  Interestingly, we found that the 
time-dependent OPN elevation was similar to the UEC (Fig. 2.9).  OPN was elevated by 1d 
(17.25 ± 3.96 fold, p<0.01), peaking at 2d (59.40 ± 11.12 fold, p<0.001), and significantly 
attenuated (p<0.001) by 4d (27.32 ± 6.72 fold).  As with UEC, 7d OPN protein was no longer 
different from paired controls (15.30 ± 3.85 fold).  These findings suggest that acute OPN 
expression during reactive synaptogenesis is associated with a broad, 1-4d immune response, 
which is similar in both models.  This pattern is in contrast to the clear differences in expression  
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Figure 2.9  Hippocampal OPN Protein Expression Following Maladaptive TBI+BEC.  
WB analysis of full length 66 kD OPN protein in whole hippocampal extracts.  TBI+BEC 
induced an acute robust increase in OPN protein, peaking at 2d postinjury compared to sham-
injured controls.  OPN response then showed a significant reduction at 4d and a return to 
baseline by 7d similar to that of UEC animals.  Results are displayed as fold change over 
control with representative blot images and cyclophilin A loading controls shown below.  
**p<0.01, ***p<0.001, relative to paired control cases; §§§p<0.001. 
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between adaptive and maladaptive plasticity observed for MMPs (Falo et al., 2006; Warren et al., 
2012), and their matrix substrates (Falo et al., 2008; Warren et al., 2012).  As for UEC, we 
applied double label OPN immunofluorescence staining in maladaptive TBI+BEC, using IBA1 
and GFAP antibodies to identify OPN labeled microglia and astrocytes within the deafferented 
zone.  Consistent with UEC, we observed an increase in reactive microglia and astrocytes over 
the deafferented zone at 1 and 2d after injury relative to sham controls (Fig. 2.10).  Interestingly, 
there was less OPN localized to microglia, and microglia were more randomly distributed within 
the 2d ML, showing poor alignment at the inner/outer dendritic layer boundary (Fig. 2.10 C).  
This reduced microglial alignment is consistent with the loss of agrin matrix boundary in the 
TBI+BEC model (Falo et al., 2008).  OPN positive astrocytes, however, were more evident at 2d 
after the maladaptive insult, extending their processes throughout the breadth of molecular layer 
dendrites (Fig. 2.10 F).  In contrast to UEC, astroglia were highly reactive and a principal OPN 
containing cell of the deafferented zone.  Together, these findings support a successful immune-
driven OPN response in the hippocampus under maladaptive conditions, but one which is 
marked by an altered cellular expression and tissue distribution.  
 
 
Immunosuppression Alters OPN Response and Reactive Synaptogenesis 
 Collectively, the present data support OPN role in the acute inflammatory response 
following deafferentation, likely through microglial activation to orchestrate the early stages of 
synaptic reorganization and reinnervation.  Since OPN is highly expressed under conditions of 
inflammation (Patarca et al., 1989; Hwang et al., 1994; Weber and Cantor, 1996; Chabas et al., 
2001), facilitating the migration of macrophages and microglia to sites of injury (Ellison et al., 
1998; Shin et al., 2011; Hashimoto et al., 2003), the manipulation of inflammation should affect 
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Figure 2.10  IHC of OPN and Glial Cells in the Dentate Gyrus Following TBI+BEC.  
Confocal OPN (green) staining increased over the ML after TBI+BEC (B, C, E, F) compared 
to sham controls (A, D).  As for UEC, OPN was colocalized within activated microglia 
(arrows; B, C) and reactive astrocytes (arrows; E, F) of the deafferented zone.  Scale bar = 50 
µm. 
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synaptogenesis, which recruits these processes during its initial phases.  To test this possibility, 
we used the tricyclic antibiotic minocycline (delivered acutely at 30 minutes and 6 hours post-
lesion) to attenuate inflammatory response, as well as reduce microglial activation (Yrjanheikki 
et al., 1998; Yrjanheikki et al., 1999).  We then examined the evolution of the early phases of 
UEC-induced synaptogenesis.  OPN protein expression was measured in hippocampal extracts 
by WB, which showed that injury-induced elevation of OPN (48.64 ± 2.24 fold, p<0.05) was 
significantly reduced by 53% (p<0.05) following minocycline administration (22.64 ± 1.92 fold, 
p<0.05) when compared with vehicle treated cases (Fig. 2.11).  When double OPN 
immunofluorescence was performed with IBA1 antibody (Fig. 2.12 A-D), we found that OPN 
positive reactive microglia were more randomly distributed after minocycline (Fig. 2.12 B, D).  
Notably, minocycline-induced alteration in OPN and glial response was correlated with altered 
presynaptic terminal loss during the early phases of reactive synaptogenesis (boxed area, Fig. 
2.12 F, H).  By 2d after UEC, vehicle treated animals show predicted loss of presynaptic marker 
synapsin 1 over the deafferented dentate ML (Fig. 2.12 F) (Lund and Lund, 1971; Greif and 
Trenchard, 1988), however, animals with minocycline reduction of OPN showed altered 
distribution of synapsin 1 positive presynaptic terminals over the deafferented ML (Fig. 2.12 H).  
Further, reduced OPN was also associated with altered synapsin 1 distribution at the inner/outer 
ML boundary (Fig. 2.12 F, H).  After minocycline, the presynaptic terminal marker is no longer 
distinct at this boundary, but rather shows a diffuse, irregular pattern, extending into the 
proximal deafferented neuropil.  This suggests that, even with partial immune inhibition of OPN, 
pre-synaptic terminal and microglial response to deafferentation is altered, attenuating critical 
changes during the initial degenerative phases of reactive synaptogenesis. 
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Figure 2.11  Minocycline Attenuates Hippocampal UEC-Induced OPN Response.  
Minocycline was administered at 30 minutes and 6 hours postinjury (45 mg/kg, i.p.), a dose 
previously demonstrated to attenuate inflammatory response, as well as reduce MMP-9 
activity.  At 2d postinjury, full length 66 kD OPN response was significantly reduced by over 
50% with acute administration of minocycline compared to saline-treated controls.  Results 
are displayed as fold change over control with representative blot images and cyclophilin A 
loading controls shown below.  *p<0.05 relative to control cases; §p<0.05. 
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Figure 2.12  Minocycline Alters Migration of OPN Positive Microglia and Pattern of 
Presynaptic Terminal Removal in Deafferented Molecular Layer Following UEC.  
Confocal imaging of minocycline-treated animals 2d after UEC lesion (A) showed OPN 
(green) colocalized within microglia (red), however, these glia appeared randomly distributed 
in the ML and did not position themselves along the distinct border between the IML and 
outer deafferented zone, as was observed for injured saline control cases (arrows, B).  During 
the 2d degenerative phase, removal of presynaptic terminals is marked by loss of synapsin 1 
staining (F), with a crisp boundary between the intact synapses of the IML and the 
deafferented zone was disrupted and diffuse, indicating a reduced presynaptic terminal 
clearance compared to injured saline treated controls (boxed area; F, H).  Together, these 
observations suggest that manipulation of OPN through minocycline immunosuppression 
disrupts microglial migration to establish tissue boundaries for removal of degenerating 
terminals in the early phases of reactive synaptogenesis.  Scale bar = 20 µm. 
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To assess the potential for generation of OPN functional fragments during the acute 
recovery period of degeneration, we also utilized gelatin zymography and WB analysis to 
evaluate MMP activity and the presence of OPN fragments.  Consistent with previous studies 
documenting increased MMP activity during the degenerative phase of debris clearance (Kim et 
al., 2005; Falo et al., 2006), both MMP-2 and MMP-9 activity was significantly elevated within 
the hippocampus of saline-treated animals at 2d following UEC (374.14 ± 34.05%; 370.43 ± 
35.45%; p<0.05) (Fig. 2.13 A).  Acute administration of minocycline did not alter MMP-2 
activity (351.82 ± 39.46%), but significantly reduced MMP-9 injury-induced activity by 41.18% 
(p<0.05) compared saline-treated controls at 2d (152.54 ± 28.11), a finding consistent with 
previous literature documenting minocycline inhibition of MMPs in other models of CNS trauma 
and stroke (Machado et al., 2006; Cayabyab et al., 2013).  Additional studies evaluating changes 
in MMP-generated OPN fragments revealed an injury-induced increase in the 45 kD fragment at 
2d after UEC in saline-treated animals (152.88 ± 28.27%, p<0.05), and reduction in the 32 kD 
fragment (90.29 ± 1.19%, p<0.05).  Similar to minocycline-reduction in MMP-9 activity, the 
injury-induced expression of the 45 kD form of OPN was significantly reduced by 62% (p<0.05) 
2d after UEC (57.68 ± 19.79) (Fig. 2.13 B).  Together, these results suggest OPN and MMP act 
in concert during the acute immune response to signal cellular removal of debris and 
degenerating terminals in the early stages of reactive synaptogenesis, potentially contributing to 
the preparation of the ECM for synaptic sprouting during the regenerative phase.  
 
DISCUSSION 
In this study, the temporal and spatial pattern of OPN response was examined in two 
models of synaptic deafferentation.  Following adaptive UEC or maladaptive TBI+BEC insult,  
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Figure 2.13 Minocycline Immunosuppression Attenuates Hippocampal MMP-9 Activity 
and OPN Proteolytic Fragment Generation Following UEC.  At 2d postinjury, gelatin 
zymography shows both MMP-2 and MMP-9 activity elevated in hippocampal extracts of the 
vehicle treated cases when compared with contralateral controls (A).  Minocycline treatment 
selectively reduced MMP-9 proteolytic activity (A), which was correlated with a significant 
decrease in the generation of OPN 45 kD integrin receptor-binding fragment (B).  By 
contrast, minocycline did not affect injury induced changes in either MMP-2 activity or 32 kD 
OPN fragment expression.  Results are expressed as percent of control, with representative 
gel or blot images and cyclophilin A loading control shown below.  *p<0.05 relative to paired 
contralateral controls; §p<0.001. 
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hippocampal OPN protein levels were quantified and localized to cellular subtypes within the 
injured dentate.  Traumatic injury induced a robust OPN increase compared to controls during 
the acute degenerative phase of reactive synaptogenesis.  This significant OPN elevation 
occurred during early terminal degeneration (1-2d postinjury) before returning baseline during 
axonal sprouting and synaptic regeneration (7d postinjury).  IHC staining for OPN showed 
granule cell staining which remained unchanged after injury as opposed to ML dendritic staining 
which increased following synaptic deafferentation.  Microtubule associated protein MAP1B 
was not colocalized with OPN during axonal sprouting at 7d postinjury, however, injury-induced 
OPN was colocalized within both activated microglia and reactive astrocytes of the injured 
dentate.  Interestingly, groups of activated microglia organized themselves along the dendrites at 
the border of deafferentation and contained OPN mRNA, indicating microglia act as synthesizers 
of OPN.  Studies contrasting adaptive UEC and maladaptive TBI+BEC showed that level of 
OPN expression was similar in the two conditions, however, IHC revealed differences in OPN 
and glial cell distribution.  Animals subjected to the combined injury paradigm showed altered 
glial distribution, which appeared in a random pattern within the injured ML, suggesting 
impaired migration of reactive glial cells toward the deafferented dendritic layer compared to the 
effective alignment during UEC synaptic reorganization.  The presence of reactive immune cells 
in the injured ML is consistent with previous findings of elevated local MMP activity, and the 
present findings indicating an increase in a MMP-cleaved 45 kD OPN fragment at the site of 
deafferentation.  Finally, attenuation of acute UEC immune response with minocycline 
dampened injury-induced OPN expression compared to controls, and altered reactive glial cell 
distribution generating a pattern similar to that of TBI+BEC.  To further evaluate the effect of an 
attenuated immune response during synaptic reorganization, we probed for synapsin 1 expression 
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as a marker of the presynaptic terminals affected by deafferentation.  During the acute 
inflammatory response, animals treated with minocycline exhibited persistent synapsin 1 staining 
in the injured dentate, suggesting impaired removal of injured presynaptic terminals. 
Together, these results suggest that OPN is highly elevated over the acute postinjury 
period and plays an important role during the degenerative phase of reactive synaptogenesis.  It 
has the potential to induce chemotaxis through its cytokine properties, and promote migration of 
reactive glia to select sites within the injured dentate, influencing phagocytosis of degenerative 
presynaptic terminals and the reshaping of postsynaptic spines in preparation for regrowth.  
Further, as the comparison of adaptive and maladaptive plasticity models shows, proper 
execution of terminal removal and spine morphing likely promotes correct ECM conditioning in 
preparation for the successful synapse regeneration. 
 
Robust Osteopontin Expression Is Time-Dependent During Reactive Synaptogenesis 
Our evaluation of OPN expression and distribution following hippocampal 
deafferentation clearly points to a time dependent relationship with the process of reactive 
synaptogenesis.  This was an effect observed for both the UEC and TBI+BEC cases.  Following 
deafferentation, full length hippocampal OPN protein increase was very robust, reaching as high 
as 80-fold over contralateral controls.  This significant OPN elevation occurred as early as 24 
hours postinjury, during the rapid, acute inflammatory response, before peaking within the 
degenerative phase at 2d postinjury.  Mapping of OPN mRNA levels in hippocampal and ML 
extracts showed that this rise was associated with transcriptional change in OPN gene 
expression.  Interestingly, other published studies also demonstrate a similarly robust change in 
OPN mRNA following traumatic insult (Morita et al., 2008; Iwanaga et al., 2008; van Velthoven 
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et al., 2011).  The fact that OPN increase subsided by 4d, and was no longer seen at 7d, when the 
recovery paradigm shifts to regeneration, points to a precise inflammation-related role for OPN 
during the acute degenerative phase of synaptic reorganization.  This pattern is consistent with 
prior studies of inflammatory response following TBI.  For example, previous reports document 
rapid postinjury increases in inflammatory cytokines such as TNF-α, IL-6, and IL-1β with human 
TBI (Helmy et al., 2011), as well as several experimental models of TBI, including impact 
acceleration (Shohami et al., 1994), fluid percussion injury (Vitarbo et al., 2004), controlled 
cortical impact (Kelso et al., 2011), and moderate blast-induced neurotrauma  (Dalle Lucca et al., 
2012).  By contrast, the study of specific OPN response in CNS insult is limited.  Nevertheless, 
the association of OPN signaling with immediate postinjury response is verified in several 
models.  Acute elevation similar to that of the 24 hour period in our study was reported for 
models of stroke (Wang et al., 1998), ischemia (Lee et al., 1999), and SCI (Hashimoto et al., 
2003; Moon et al., 2004).  More recently traumatic insult models of focal TBI with hemorrhage 
and contusion have been examined, pointing to a rapid OPN response.  These models include 
controlled cortical impact (von Gertten et al., 2005; Israelsson et al., 2006), cold probe 
cryolesion (Shin et al., 2005), and brain stab wound (Plantman, 2012).  Importantly, no studies 
describe the acute OPN response in models of targeted synaptic deafferentation, a pathological 
condition present in both diffuse and focal types of TBI.  Thus, the novel approach taken in the 
present study is valuable in that it shows an equally critical role for OPN during the specific 
stages of circuit reorganization following CNS insult.   
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Osteopontin Role During Acute Postinjury Response Is Mediated Through Neuroglia 
  The fact that OPN response was greatest during the acute degenerative phase of reactive 
synaptogenesis suggests that its principal role may be to act as a cell surface signal for reactive 
neuroglia, promoting removal of degenerating presynaptic terminals and supporting subsequent 
synapse regeneration.  Our IHC experiments mapping OPN distribution in the deafferented 
hippocampus showed that the molecule was present in both granule neurons and neuroglia.  
Importantly, deafferentation failed to notably alter the high level OPN found in neuronal cell 
bodies, but clearly increased OPN labeling over the deafferented ML, supporting a targeted glial 
interaction at the site of plasticity.  Several of our findings corroborate this interaction.  First, 
OPN was colocalized within reactive microglia and astrocytes of the deafferented zone during 
the 2d acute degenerative phase for UEC and TBI+BEC, returning to control levels by 7d 
postinjury.  This reflects a similar time course as was seen with OPN expression in tissue 
extracts.  In addition, reactive microglia, but not astroglia, express OPN mRNA at 2d after UEC, 
suggesting the microglia act as the principal source for subsequent signaling steps.  Interestingly, 
OPN mRNA was similarly associated with reactive microglia at 24 hours after stroke induction, 
but did appear within reactive astroglia as late as 15d after the insult (Ellison et al., 1998).  This 
result suggests that if we were to probe for OPN transcript at later time points near 15d, we may 
discover a second, astroglial localization of OPN mRNA and protein elevation.  Unpublished 
IHC studies in our laboratory do indeed show evidence of elevated astroglial OPN and its 
targeted localization to the cell bodies of astrocytes at 15d after UEC (Appendix E).  Future 
studies will more thoroughly address the possibility that these patterns represent the proposed 
microglial/astroglial signaling pathway.  Finally, there is a significant acute elevation of the OPN 
cleavage fragment containing exposed integrin receptor binding sites within the deafferented 
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ML, providing a mechanism for local cell signaling to recruit phagocytic cells.  These IHC 
observations raise questions as to how OPN might influence the glial response.  At least three 
possibilities are suggested by our results:  intracellular control of neuronal and glial 
cytoarchitecture to facilitate cell shape changes critical to plasticity, extracellular direction of 
glial migration and control of acute phagocytosis, and extracellular signaling between reactive 
glial types to coordinate the shift between degenerative and regenerative phases.  
Given that recent studies demonstrate a cytosolic form of OPN which can bind to 
microtubule associated proteins MAP1A and MAP1B (Long et al., 2012), we reasoned that, if 
OPN played a role in cytoskeletal stabilization-destabilization during synaptogenesis, changes in 
the IHC distribution of OPN and MAP1B might map together.  While we found the predicted 
pattern of reduced, then reemerging MAP1B dendritic staining between 2-7d postinjury, OPN 
colocalization with MAP1B was minimal at either postinjury time point, suggesting its role in 
postsynaptic dendritic retraction and spine reformation is limited.  Thus, the principal role for the 
large elevation of OPN during acute postinjury intervals does not appear to involve the 
cytoarchitectural reorganization component of synaptic regeneration. 
A second, more likely scenario for OPN action would be its mediation of neuroglial 
recruitment within the zone of deafferentation.  The first phase of synaptic reorganization is the 
removal of degenerating severed terminals, a process known to occur by glial phagocytosis 
(Steward, 1989).  Clearly, activated microglia can serve this role.  However, previous studies 
also support the dual role of active microglia and reactive astrocytes to carry out the removal of 
degenerating terminals (Pellerin and Magistretti, 2004; Belanger and Magistretti, 2009).  
Absence of this process can lead to a persistent degenerative state, preventing proper axonal 
sprouting and subsequent neuronal and functional recovery from TBI (Sofroniew, 2005; Laird et 
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al., 2008; Belanger and Magistretti, 2009).  In the adaptive UEC model, these reactive microglia 
also align themselves along the affected dendrites at the boundary between intact and 
deafferented zones.  This pattern is consistent with the deposition of ECM proteins like agrin 
along this boundary to serve as border forming molecules delineating zones of repair (Falo et al., 
2008).  Local OPN signaling can also be chemotactic, possibly through its extracellular lysis and 
release of an integrin receptor binding fragment, which can then target activated microglia, 
driving their movement to the intact/degenerating boundary.  Notably, we found both reduced 
glial OPN expression, and a disruption of this microglial boundary alignment with the 
maladaptive TBI+BEC insult.  This suggests that reduced OPN expression and chemotactic 
stimulus in the ML under maladaptive conditions may contribute to impaired debris clearance 
and attenuated recovery.  
A third mechanism of action for OPN could be its role as a microglia-secreted astrokine, 
activating pathways which alter the form, distribution, and synthetic processes of astrocytes 
(Ellison et al., 1999).  During reactive synaptogenesis, endogenous astrocytes shape the ECM 
and local synaptic environment, including the regulation of growth factor signaling to guide 
emerging axonal sprouts and postsynaptic spines.  Thus, these cells have a prominent role in 
facilitating the regenerative phase of synaptogenesis.  We found OPN to be preferentially 
produced in the reactive microglia early after UEC, with only modest levels present in reactive 
astrocytes at the acute degenerative stage.  Upon microglial secretion and lysis, OPN signaling 
fragments could diffuse short distances and bind to neighboring astrocytes at critical time 
intervals between degeneration-regeneration cycles, inducing their migration and gene 
expression.  Evidence from the stroke literature describes a similar pattern of early microglial 
OPN secretion as a chemotactic astrokine, causing astrocytes to move from the penumbra to an 
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OPN-rich infarct core region over time (Ellison et al., 1998; Ellison et al., 1999).  This profile is 
further supported in models of SCI (Hashimoto et al., 2003) and ischemia (Choi et al., 2007) 
which show acute OPN colocalization within microglia 1-3d postinjury, and delayed astrocytic 
colocalization between 7-15d postinjury.  Given that astrocytes are known to secrete growth 
factors and nutrients important in the facilitation of effective axonal outgrowth (Matthews et al., 
1979; John et al., 2003; Pellerin and Magistretti, 2004), our results suggest appropriate OPN 
response may be necessary to promote effective synaptic recovery following trauma-induced 
deafferentation as well.  Indeed, MMPs are enzymes produced and secreted into the ECM by 
astrocytes after UEC, clearly capable of cleaving pro-growth factors into their active forms (Lee 
et al., 2001; Cunningham et al., 2005; Lu et al., 2008), flipping the local switch to axonal 
outgrowth and synapse regeneration (Matthews et al., 1979; John et al., 2003; Pellerin and 
Magistretti, 2004).  Taken together, our investigation of OPN cellular distribution following 
hippocampal deafferentation suggests that the cytokine plays a major role in microglial signaling 
to promote the execution of early degenerative changes in the deafferented CNS.  The results 
also support the activation of a subsequent microglia-astroglia OPN signaling pathway when 
regeneration is initiated, similar to the astrokine cell signaling prototype described in stroke and 
SCI.   
 
Osteopontin Fragments and Integrin Receptor Signaling During Reactive Synaptogenesis 
The possibility of OPN playing a role in multiple phases of synaptic reorganization led us 
to examine its proposed cell signaling potential in more detail.  As suggested by its biphasic 
expression in stroke models, OPN is a versatile molecule, capable of acting as both an acute 
inflammatory cytokine, and an astrokine modulator of axonal regeneration, functions which may 
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be mediated by proteolytic cleavage exposing peptide sequences which bind to cell surface 
receptors (Senger et al., 1994; Giachelli et al., 1995; Smith et al., 1996; Yokosaki et al., 1999; 
Bayless and Davis, 2001).  Two of the principle cell surface receptors for OPN are the αvβ3 
integrin receptor, or vitronectin (Yue et al., 1994; Yokosaki et al., 2005), and the haemopoetic 
cell surface receptor CD44 (Weber et al., 1996; Kang et al., 2008).  Cleavage by thrombin and 
MMPs generates OPN fragments with fully exposed integrin receptor-binding sites (Agnihotri et 
al., 2001).  Each of these lytic pathways can be linked to TBI related plasticity.  Hemorrhagic 
lesion activated thrombin cleaves OPN, which, for example, induces endothelial cell αvβ3 
expression, promoting their migration to injured tissue (Ellison et al., 1998).  In addition, a recent 
report of CNS stab wound, which also induces local MMP elevation, suggests a link between 
OPN and CD44-mediated neurite outgrowth (Plantman, 2012).  Based on this data, we posited 
that OPN fragment generation is critical to its role during deafferentation induced synaptic 
reorganization.  This view was appealing because integrin receptor upregulation has been 
documented during LTP (Milner and Campbell, 2002; Nikonenko et al., 2003), a functional 
correlate of reemerging synaptic structure.  We also hypothesized that OPN-cleaved fragments 
modulate dendritic reorganization and cell migration during synaptic plasticity caused by TBI, an 
idea supported by the published integrin role following axotomy of the facial motor nucleus 
(Kloss et al., 1999).  Our results showing correlated MMP activity and OPN expression within 
the injured dentate suggested that MMPs cleave the cytokine to permit greater cellular 
interaction, a process similar to the activation of growth factors through MMP lysis 
(Cunningham et al., 2005; Lee et al., 2001; Lu et al., 2008).   
When UEC ML tissue extracts were probed for OPN fragments, the results only partially 
addressed these hypotheses.  They showed that UEC increased the generation of two cleavage 
 128 
 
products known to carry exposed αvβ3 and CD44 binding sites, however, the two fragments were 
elevated at different time intervals postinjury.  A 45 kD, RGD/SVVYGLR containing OPN 
fragment was increased over controls during the degenerative phase (1-2d postinjury), while a 32 
kD OPN fragment containing the highly conserved C-terminus showed a reduction in the 
degenerative phase, but a subsequent elevation when regenerative sprouting begins (7d 
postinjury).  We interpret this difference as indicating a greater role for the 45 kD integrin 
receptor binding fragment during acute inflammation, participating in the early microglial 
activation to clear damaged presynaptic terminals following UEC deafferentation.  By contrast, 
the 32 kD OPN which contains the C-terminus known to undergo significant posttranslational 
modification (Kazanecki et al., 2007a; Kazanecki et al., 2007b) and bind αvβ3 (Christensen et al., 
2012), an integrin receptor important in cell migration (Brooks et al., 1994), is elevated at 7d at 
the onset of sprouting and synaptogenesis.  This suggests the 32 kD form may direct the 
chemotaxis of astrocytes and their active growth factor secretion to promote successful 
reformation of synaptic junctions.  While unexplored in this study, this chemotaxis could also 
affect local collateral axon sprouting which regenerates presynaptic terminals.  Further, it is 
possible that the 2d reduced levels of the 32 kD OPN fragment may reflect a damping down of 
the regenerative OPN signal as the degenerative phase completes presynaptic terminal clearance.  
At present, the specific role(s) of these OPN lytic fragments during reactive synaptogenesis are 
speculative and will require additional studies which manipulate their specific expression to 
confirm their role in the process. 
Given the potential for specific OPN fragments to modulate different cellular aspects of 
the synaptogenic process, mapping the receptors which bind OPN ligand sequences exposed by 
thrombin or MMP cleavage may help reveal fragment function.  While our study did not address 
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the expression of these receptors, prior in vitro studies do show that when the αvβ3 integrin 
receptor is exposed to OPN under conditions of thrombin cleavage, endothelial cell migration is 
increased and angiogenesis promoted (Senger et al., 1996).  Further, in models of stroke and 
ischemia, there is an upregulation of OPN and αvβ3 within astrocytes at the penumbra border of 
the glial scar, implicating a role for this pair in synaptic recovery following injury (Ellison et al., 
1998).  Interestingly, αvβ3 is also expressed on the surface of microglia (Milner, 2009), and 
recent ischemia studies colocalized αvβ3 and OPN within activated microglia, suggesting a role 
for OPN/integrin interaction facilitating the production of cytokines during acute immune 
response (Kang et al., 2008).  Another receptor which interacts with OPN is CD44 (Weber et al., 
1996), a molecule important in producing immune chemotaxis, microglial activation, and 
immune regulation (Pure and Cuff, 2001).  Original reports of CD44 primarily focused on the 
receptor’s role in this chemotaxis, however, later studies show the receptor upregulated in 
response to CNS trauma, including stroke (Wang et al., 2001) and cortical stab wound (Stylli et 
al., 2000).  Further, TBI models using cold probe cryolesion demonstrated upregulation and 
colocalization of injury-induced OPN and CD44 within reactive microglia and astrocytes (Shin 
et al., 2005).  An interesting recent study of brain stab wound goes further to link OPN with 
CD44-mediated neurite outgrowth (Plantman, 2012).  While the present study did not probe for 
CD44 changes after UEC or TBI+BEC, our laboratory has found unpublished evidence that these 
receptors exist on reactive astrocytes within the deafferented ML, the same cells which we do 
show contain OPN (Appendix E).  Taken together, the present findings, and published evidence 
of αvβ3 integrin and CD44 receptor colocalization with OPN positive glia, support a role for OPN 
in the migration of reactive neuroglia and modulation of axonal outgrowth during trauma-
induced synaptic reorganization.  
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Acute Immunosuppression Attenuates Osteopontin Response and MMP-9 Activity 
To further assess the relationship between the acute inflammatory response and OPN 
following deafferentation, we attenuated the immune response using the tricyclic antibiotic 
minocycline, then examined OPN expression, looking for changes in cellular response with 
synaptogenesis.  As a tetracycline derivative, minocycline is widely used to treat bacterial 
infection and may provide neuroprotection in CNS injury and disease (Elewa et al., 2006).  
Following TBI, minocycline attenuates apoptosis (Matsukawa et al., 2009; Zhu et al., 2002), as 
well as free radical formation (Golub et al., 1991), and microglial activation (Yrjanheikki et al., 
1998; Yrjanheikki et al., 1999; Guasti et al., 2009; McAllister and Miller, 2010; Kobayashi et al., 
2013).  The drug also inhibits MMPs elevated with multiple sclerosis (MS), stroke, and cerebral 
hemorrhage (Brundula et al., 2002; Power et al., 2003; Machado et al., 2006; Cayabyab et al., 
2013).  Since many of minocycline’s pathological targets are common to brain injury, we chose 
to evaluate its effect on synaptic plasticity using the adaptive UEC deafferentation model.  Our 
results showed that acute dosing of minocycline does significantly attenuate postinjury OPN 
elevation, providing a good tool for in vivo manipulation of the cytokine.  Using IHC methods, 
we were able to demonstrate that when OPN was reduced acutely, the documented elevation of 
OPN signal in reactive microglia was also reduced and, importantly, microglial migration to the 
intact/deafferented molecular boundary was disrupted.  As microglia secrete OPN, it is likely 
that minocycline reduced their state of activation and, as a consequence, less OPN was produced 
and cellular mobility attenuated.  This finding is consistent with previous studies in the impact 
acceleration model of TBI where gene microarray or cytokine array analyses demonstrate 
minocycline reduction in cytokines IL-1β, IL-6, MCP-1, and MIP-2 (Sanchez Mejia et al., 2001; 
Bye et al., 2007; Crack et al., 2009). 
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At this time, it is not entirely clear whether minocycline-like immunosuppression and its 
attenuation of molecules like OPN would be disruptive or beneficial in the context of 
synaptogenesis.  Previous minocycline studies in CNS injury models show mixed results.  For 
concussive TBI, Sanchez Mejia and colleagues originally reported that minocycline reduced 
lesion size and improved motor recovery (Sanchez Mejia et al., 2001), a finding also supported 
by improved hind limb function after SCI (Wells et al., 2003), and reduced neurobehavioral 
deficits after blast injury (Kovesdi et al., 2012).  In addition, animals subjected impact 
acceleration insult plus postinjury minocycline had improved neuro-cognitive recovery, 
including transient neuroprotection (Bye et al., 2007), improved locomotor function (Homsi et 
al., 2009; Homsi et al., 2010), reduced anxiety states, and attenuated memory impairment (Siopi 
et al., 2012).  Despite these potential benefits of minocycline therapy for TBI, a number of 
studies in CNS disease and injury report that minocycline may worsen related neuropathology 
(Diguet et al., 2004).  Of most concern are clinical trial results showing that minocycline 
treatment actually exacerbated Parkinsonian symptoms (Ravina et al., 2003).  The drug was also 
found to be ineffective in models of Huntington disease (Smith et al., 2003), MPTP models of 
Parkinson disease (Yang et al., 2003), and acute controlled cortical impact TBI (Kelso et al., 
2011).  Further, minocycline can worsen hypoxic-ischemic brain injury (Tsuji et al., 2004), and 
inhibit peripheral nerve regeneration following sciatic nerve resection (Keilhoff et al., 2007).  
These negative effects of minocycline are consistent with our results showing that the removal of 
degenerated presynaptic terminals is delayed in the UEC model after acute minocycline dosing 
that reduces OPN production.  This delay is marked by the attenuated reduction of presynaptic 
terminal marker synapsin-1 over the denervated zone.  Taken together with the disorganized 
microglial response under conditions of minocycline OPN reduction, these results mimic the 
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profile of disrupted degeneration seen with the maladaptive plasticity of the TBI+BEC model.  It 
can be concluded that, during the acute postinjury intervals, inflammatory response is beneficial, 
including the elevation of OPN expression, which appears to influence microglial activation and 
facilitate the early stages of synaptogenic recovery.  This observation points to further caution in 
the use of minocycline or other compounds with broad immune attenuation as TBI therapy.  
Alternative methods to affect immune response following TBI might be investigated, such as 
those manipulating the processing of individual cytokines to more specifically target time-
dependent mechanisms underlying effective synaptic reorganization following trauma. 
Lytic processing of OPN in the ECM of the deafferented zone may serve as a means to 
more finely tune cytokine-mediated aspects of reactive synaptogenesis.  Prior studies in our 
laboratory have shown that the incomplete breakdown of damaged axon terminals generates a 
maladaptive degenerative state, marked by aberrant MMP activity.  Here we extended our study 
to include assessment of gelatinase activity, profiling MMP-2 and 9 lysis and concurrent OPN 
fragment generation.  Our results point to MMP-9 as a principal source of the αvβ3 integrin 
binding 45 kD OPN fragment, which is consistent with published studies showing MMP-9 role 
in generation of functional OPN peptides (Takafuji et al., 2007).  We found that minocycline 
reduction of OPN expression was spatially and temporally correlated with the attenuation of 
MMP-9 activity and OPN 45 kD fragment production.  These results are in agreement with 
reported minocycline inhibition of MMPs (Brundula et al., 2002; Power et al., 2003), particularly 
the gelatinases following stroke or cerebral hemorrhage (Cayabyab et al., 2013; Machado et al., 
2006).  Similar to the proteolytic fragment studies mentioned above, these results support a role 
for 45 kD OPN during the 2d acute inflammatory period.  Interestingly, minocycline did not alter 
the production of the 32 kD OPN fragment at 2d postinjury, a result consistent with our earlier 
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finding that injury-induced elevation of this peptide appears to play a more prominent role during 
regeneration at 7d or later, potentially interacting with integrin receptors and astrocytes to 
facilitate synaptic outgrowth.  It is also tempting to speculate that full length OPN is not wholly 
responsible for its documented neuroprotective effects, but may require lytic processing by 
MMPs or other proteases to be truly functionally effective.  Cleavage of OPN may permit the 45 
kD form to signal additional immune response, while the 32 kD fragment might contribute to 
effective synaptic growth during the regenerative window.  While attenuation of inflammatory 
response impairs MMP activity, OPN response, and presynaptic terminal clearance during the 
degenerative phase, arguing against acute immunosuppression during reactive synaptogenesis, 
minocycline remains a drug capable of acting on many different cellular pathways.  As 
previously noted, these functions can produce both positive and negative effects, as minocycline 
negatively affects microglial function, but attenuates gelatinase induced hemorrhage in models of 
pial vessel disruption (Cayabyab et al., 2013).  While we cannot confirm the cellular 
mechanism(s) underlying OPN, MMPs, and synaptic plasticity, our results show the three are 
interactive, and support the need for additional studies that more specifically manipulate OPN 
and its response after CNS trauma.  One way to more directly assess OPN role in trauma-induced 
synaptogenesis is to probe the same outcome measures in OPN KO mice subjected to UEC 
deafferentation.  We have generated a colony of this KO strain, and tested the effect of OPN KO 
on both structural and functional parameters of synaptogenesis as detailed in Chapter 3. 
 
SUMMARY 
Here we have shown that OPN responds with a robust increase in expression during the 
acute phase of terminal degeneration induced by traumatic deafferentation.  The temporal injury 
response of full length OPN is similar after adaptive UEC and maladaptive TBI+BEC insult, 
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however, the attenuated distribution of OPN, active microglia, and reactive astrocytes at the 
border of intact and deafferented dendrites in the maladaptive model suggests that glial OPN is 
critical for successful cellular migration, as well as debris phagocytosis during the acute 
inflammatory response.  Elevated OPN mRNA in whole hippocampal extracts is greatest in 
deafferented ML, and transcript localized to activated ML microglia, further supporting cell 
directed OPN mediation of the acute immune response.  Similar to studies in stroke, OPN may 
act as a cytokine early after injury, and later serve as an astrokine, recruiting and interacting with 
astrocytes through integrin receptors to promote pre and postsynaptic outgrowth during the 
regenerative phase.  These different OPN functions may be achieved through proteolytic 
processing of the cytokine, as evidenced by time dependent differences in the levels of the 45 kD 
and 32 kD fragments of OPN.  Further, acute minocycline administration attenuated OPN 
response, a finding correlated with altered glial distribution similar to the random pattern in the 
maladaptive model.  In addition, inhibition of the immune response impaired the removal of 
degenerating terminals, MMP activity, and production of the functional 45 kD OPN fragment.  
Taken together, these results suggest a mechanism of OPN, MMP, and reactive glial interaction 
during the acute postinjury immune response, directing effective neuroglial migration to the site 
of injury, and optimizing the removal of damaged terminals in preparation for effective synaptic 
reorganization.  Further investigation of OPN role in trauma-induced synaptic plasticity will 
more clearly determine the extent to which this proposed mechanism contributes to beneficial 
and detrimental outcome.  
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CHAPTER 3 
 
OSTEOPONTIN KNOCKOUT MICE AND SYNAPTOGENESIS
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ABSTRACT 
OPN is a pleiotropic molecule capable of acting as a cytokine in the acute immune 
response to trauma, as well as a modulator of synaptic outgrowth.  Given the results from studies 
in Chapter 2 showing a robust OPN elevation following trauma-induced deafferentation, and its 
localization within reactive glial cells at the site of reactive synaptogenesis, the studies of 
Chapter 3 employed OPN KO mice to determine if loss of OPN will alter this regenerative 
process.  Our strategy was to determine if removing OPN alters molecular expression of proteins 
which mark three structural components critical to synaptic repair.  To do this, we used MAP1B 
to track OPN interaction with the cytoskeleton, a critical organelle system for axon terminal 
growth and reshaping postsynaptic spine morphology, N-cadherin, an adhesion protein whose 
expression may be controlled by OPN and acts to stabilize nascent pre and postsynaptic 
elements, and lastly, synapsin 1, a molecule found in the membrane of transmitter-containing 
synaptic vesicles whose expression marks the integrity of presynaptic terminals.  Both OPN KO 
and WT cohorts were subjected to UEC, and protein extracts obtained from whole hippocampus 
and enriched ML at 2d postinjury, the period when OPN expression was highest in the rat model.  
We probed for expression of MAP1B, N-cadherin, and synapsin 1 in these extracts, looking for 
strain differences which might reflect effects of OPN loss.  Hippocampal tissue distribution of 
each protein was determined in paired cohorts with IHC methods.  
 In order to determine status of cognitive outcome after UEC in OPN KO, we also 
utilized the novel object recognition (NOR) task, comparing behavior to WT animals with UEC 
deafferentation.  A final set of experiments tested whether lipocalin (LCN2)-mediated MMP 
proteolysis induced by UEC is altered in the absence of OPN.  Overall, we observed reductions 
in the principal forms of each protein at 2d after UEC, a result predicted for the degenerative 
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phase of reactive synaptogenesis.  MAP1B and N-cadherin were each reduced compared to 
controls in both hippocampal and ML extracts, however, no strain differences were observed.  
By contrast, synapsin 1 in OPN KO mice showed differences in response to UEC deafferentation 
compared with WT mice.  One of its primary forms had significantly less reduction under 
conditions of OPN KO, a result which is consistent with the impaired removal of synapsin 1-
marked degenerating terminals observed after rat UEC in Chapter 2.  These synapsin 1 
differences were correlated with altered microglial migration within the ML during the acute 
degeneration phase.  Interestingly, the acute synapsin 1 changes in OPN KO mice were also 
associated with deficits in cognitive function as determined by poor performance in the NOR 
task, specifically during the subsequent 4-21d period of synapse regeneration.  Evaluation of 
MMPs known to cleave OPN and produce integrin binding fragments showed injury-induced 
elevation of MMP-9 activity in WT mice, an effect significantly attenuated with OPN KO.  
Expression of hippocampal MMP-9-bound LCN2 was also elevated in WT 2d after UEC, but 
significantly reduced when OPN was absent.  Notably, this KO reduction in MMP-9-bound 
LCN2 was not observed in the enriched ML samples, indicating that MMP-9 role in local 
dendritic OPN processing may be regulated by different mechanisms.   
These results suggest that OPN interacts with MMP-9 during the degenerative phase of 
reactive synaptogenesis, potentially generating integrin receptor mediated activation and 
migration of local microglia within the denervated DG.  This OPN-associated microglial 
response appears to target presynaptic terminal clearance, preparing the extracellular 
environment for the collateral axonal sprouting and synaptogenesis critical to the evolution of 
hippocampal functional recovery after traumatic insult. 
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INTRODUCTION 
Living with the chronic effects of TBI is a growing concern for both civilian and military 
populations worldwide.  One critical outcome for the nearly 2 million individuals who fall victim 
to TBI each year are long term motor and cognitive deficits (Faul et al., 2010).  These deficits 
not only reduce quality of life, but incur substantial cost for extensive rehabilitation adding 
further burden to the victims and their families (Langlois et al., 2006; Rutland-Brown et al., 
2006; Finkelstein et al., 2006).  Current treatment of TBI patients focuses on ameliorating the 
existing symptoms, a process often requiring months to years, with slow or little improvement.  
Unfortunately, most clinical trials of potential TBI therapies have focused on neuroprotection 
rather than enhancing recovery of surviving cells and circuitry.  While none of these trials has 
identified a successful way to reverse traumatic injury and behavioral deficits, several 
interventions targeting acute inflammatory response show promise for enhancing the recovery 
process (Doppenberg et al., 1997; Chen et al., 2007; Pan et al., 2007).  For example, ongoing 
TBI clinical trials with progesterone treatment suggest that the hormone may reduce 
neuroinflammation as part of its therapeutic value, potentially affecting the initial phases of 
synaptic reorganization (National Institute of Neurological Disorders and Stroke).  Thus, it is 
reasonable to further evaluate how the immune system affects the development of TBI sequelae 
which may influence the progress of effective recovery.  
During the repair of injured synapses, one of the first cellular responses is local 
inflammation.  While this inflammation was initially regarded as an entirely deleterious 
following TBI, recent evidence indicates the proper evolution of the acute immune response is 
essential to effective synaptic reorganization, directing cytokines, and reactive glia to the injured 
area (Scherbel et al., 1999; Sullivan et al., 1999; Feuerstein and Wang, 2001; John et al., 2003).  
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For example, IL-1, a proinflammatory molecule important for the initiation of the cellular 
immune cascade and glial mobilization, was one of the first cytokines shown to be elevated after 
TBI (Rothwell, 1999; Ziebell and Morganti-Kossmann, 2010).  Similarly, TNF-α, another 
proinflammatory molecule, is produced by reactive microglia in response to TBI (Shohami et al., 
1994; Ziebell and Morganti-Kossmann, 2010).  In order to determine if these proinflammatory 
cytokines act in a positive or negative role with respect to TBI neuroplasticity, researchers used 
both receptor inhibition and gene KO models to probe for cytokine effects on structural 
pathology and cognitive outcome.  Interestingly, TNF KO mice had impaired neurological 
recovery, as well as exacerbated cortical and BBB damage (Scherbel et al., 1999; Sullivan et al., 
1999), implicating a protective role for at least one cytokine following CNS trauma.  While 
rather limited, several additional studies in SCI, neurodegenerative disease, stroke, and focal TBI 
also suggest that OPN may direct cellular immune response, facilitating recovery after CNS 
trauma.  Our results in Chapter 2 suggest that the cytokine OPN may also act as a mediator of 
synaptic plasticity induced by brain injury, making it a promising therapeutic target for 
influencing recovery after TBI.  Here we describe studies which manipulate OPN expression 
using the OPN KO mouse model, probing for effects on UEC-induced synaptic organization and 
recovery of cognitive behavior.   
  In these studies we first contrasted WT and OPN KO response to UEC at the 2d 
postinjury interval, the period when OPN response was the highest in the rat model (see Chapter 
2 Results).  The effect of OPN loss on synaptic structural components altered during the early 
phases of reactive synaptogenesis was assessed using molecular markers for these structures: 
MAP1B to track cytoskeletal reorganization, N-cadherin to monitor adhesive stability of synaptic 
junctions, and synapsin 1 to mark presynaptic terminals undergoing massive clearance.  MAP1B, 
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along with MAP2 and tau, regulates microtubule assembly responsible for the cytoskeletal 
structure of neurons and glia (Emery et al., 2003), and is part of the dynamic morphing of these 
cells during development (Yamanouchi, 2005; Riederer, 2007).  N-cadherin is a Ca
2+
-dependent 
cell adhesion molecule (CAM), often found at synapses, where it serves as a major structural 
protein comprising the adherens junction (Yap et al., 1997), thereby modulating synaptic 
plasticity in the adult brain  (Huntley et al., 2002).  Synapsins are abundant in presynaptic nerve 
terminals (Goelz et al., 1981; De Camilli et al., 1983a), serving a critical role in the binding of 
synaptic vesicles to cytoskeletal filaments during neurotransmitter release (Bahler et al., 1990; 
Sudhof, 1990; Greengard et al., 1993).  Importantly, synapsin 1 mediates formation of synaptic 
contacts (Lohmann et al., 1978; Melloni et al., 1994; Ferreira et al., 2000) and presynaptic 
terminals (Han et al., 1991), as well as influences neurite elongation (Melloni et al., 1994).   
Here, protein expression was used as the principal endpoint, which was measured with 
WB and IHC analysis.  For these blot experiments we also compared whole hippocampus and 
ML extracts in order to investigate whether OPN KO preferentially affects the deafferented 
dendritic zone during the acute postinjury interval.  Parallel cohorts of WT and OPN KO mice 
were subjected to UEC and the effect of OPN loss on cognitive function tested using the mouse 
novel object recognition (NOR) paradigm over 4-28d after injury.  While previous OPN KO 
studies in SCI (Hashimoto et al., 2007) and PD models (Maetzler et al., 2010) have documented 
OPN-dependent alterations in neuropathology or motor function, none have assessed cognitive 
function following traumatic insult.  For the this study, we chose the NOR task to evaluate 
cognitive function based on successful NOR assessment of hippocampal function in mice 
subjected to TBI (Baratz et al., 2011; Messier, 1997; Siopi et al., 2012).  To our knowledge, this 
is the first study to utilize NOR in the assessment of spatial memory performance following UEC 
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in WT and OPN KO mice.  Moreover, we demonstrate that UEC generates transient 
hippocampal-associated functional deficits which resolve over 28d postinjury, consistent with 
findings utilizing alternative hippocampal-dependent task such as Morris Water Maze (MWM), 
Alternation Maze, and Barnes Maze in rats (Steward et al., 1977) and mice (Hardman et al., 
1997).  To assess the association between our behavioral results and structural and biochemical 
changes, alterations in synaptic marker proteins in the degenerative phase were then compared 
with extent of functional recovery achieved during the subsequent regenerative phase for each 
mouse strain.  We also further explored possible mechanisms by which secreted OPN could 
influence structural and functional outcome during synaptogenesis by evaluating one of the 
known pathways involved in processing the full length OPN protein for ECM signaling.  This 
approach appeared feasible since we found significant elevation of OPN fragments with 
functionally active integrin receptor binding sites in the deafferented ML of the rat after UEC 
(Chapter 2).  We hypothesized that, at 2d postinjury, secreted full length OPN is targeted by 
activated MMP-9 in the brain ECM, generating OPN peptides with exposed RGD integrin 
binding sequences which target receptors on reactive microglia.  We further posited that this 
MMP-9 proteolysis of OPN is mediated through binding to the ECM siderophore lipocalin 2/ 
neutrophil gelatinase-associated lipocalin (LCN2/NGAL), which persistently activates MMP-9 
(Fig. 3.1).  The result of this intermolecular action is fully activated glial response in the acute 
degenerative phase, fostering efficient debris clearance and successful regenerative sprouting for 
functional recovery.  Here we probed for MMP-9 in WT and OPN KO mice with gelatin 
zymograms to determine if OPN KO affects this activity, and is correlated with altered WB 
expression of the MMP-9 bound form of LCN2.  Our results show that under OPN KO 
conditions, there was a significant reduction in presynaptic synapsin 1 lysis and synapsin 1 
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Figure 3.1  Lipocalin 2 Schematic Representation of Tertiary Structure and Proposed 
Binding Mechanisms.  LCN2 three-dimensional structure is comprised of β-strands 
surrounding an internal binding pocket with an open-end ligand-binding loop at the top, and 
folded receptor binding patch below (A-B).  LCN2 is capable of complexing with soluble 
molecules through non-covalent association, and covalent disulfide linkage such as that with 
MMP-9 (C).  Cell membrane receptor binding occurs through interaction with the receptor 
binding patch or the loop scaffold (D), and ligand-binding may occur with small ligands 
enclosed within the pocket or partly bound by the loop and pocket (E) (Flower, 1996). 
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presynaptic terminal removal, while ML reactive microglia were less ramified.  Interestingly, 
hippocampus and ML samples showed similar WT and OPN KO patterns of reduced expression 
for each synaptic marker protein, and the overall lack of significant difference between the two 
regions suggests that OPN role is equally important in the cellular and dendritic zones.  Parallel 
functional deficits in the subsequent regenerative phase were detected with NOR assessment.  
Interestingly, these observations were matched with reduced MMP-9 activity and LCN2 binding 
in OPN KO mice.  Together, these experiments support OPN role in the acute inflammatory 
response after UEC, showing that its absence significantly alters structural plasticity and 
functional outcome.  The results also suggest that one ECM-based mechanism for these acute 
deafferentation effects likely involves LCN2-mediated MMP-9 cleavage of OPN to generate 
peptide fragments which can activate local microglia through integrin receptor signaling. 
 
METHODS 
Experimental Animals 
The procedures in this study met national guidelines for the care and use of laboratory 
animals, and all experimental protocols were approved by the VCU Institutional Animal Care 
and Use Committee.  WT C57BL/6J mice or OPN KO mice (B6.129S6(Cg)-Spp1
tm1Blh
/J) (20-30 
g; 8-11 weeks old; The Jackson Laboratory, Bar Harbor, ME)  were used in these experiments,  
housed under a temperature (22°C) and humidity controlled environment with food and water ad 
libitum, and subjected to a 12 hour dark-light cycle.  For molecular assessments, WT or OPN KO 
mice were randomly selected, subjected to UEC, and evaluated at 2d postinjury via WB, IHC, or 
gelatin zymography (n=40 each strain; total n= 80).  For the behavioral analysis study, WT and 
OPN KO mice were randomly assigned to an uninjured or UEC group and evaluated via the 
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NOR task at 4, 7, 14, 21, and 28d postinjury before being sacrificed for either tissue extraction or 
IHC analysis (n=12 /group per strain; total n=48).  For molecular analyses, the contralateral 
hemisphere served as a control for UEC lesion effects, and WT versus OPN KO compared for 
experimental effect.  Uninjured animals served as controls for UEC lesioned animals in 
behavioral analyses. 
 
Mouse Unilateral Entorhinal Cortex Lesion 
The mouse UEC protocol is a modification of that described by Hardman and colleagues 
(1997).  Mice were anesthetized with 4% isoflurane in carrier gas of 70% N2O, 30% O2 for 4 
minutes, heads shaved, then maintained on 2.5% isoflurane in carrier gas of 70% N2O, 30% O2 
delivered via nose cone for the duration of the surgery.  Body temperature was maintained at 
37°C via heating pad (Harvard Apparatus, Holliston, MA), and animal heart rate (beats per 
minute, bpm), arterial oxygen saturation (%), breath rate (breaths per minute, brpm), pulse 
distention (μm), and breath distention (μm) were monitored via pulse oximeter (MouseOx; Starr 
Life Sciences, Oakmont, PA).  While under anesthesia, mice were secured in a stereotaxic device 
and a midline incision exposed the cranium to permit a 2 mm wide craniectomy exposing the 
intact dura mater above the right EC.  Electrolytic lesions were delivered via Teflon®-coated 
wire transmitting 2.0 mA for 15 seconds to three stereotaxic coordinates: 10° lateral to 
perpendicular; 0.5 mm rostral to the lamdoidal suture; 2 and 3 mm lateral to the midline at 3.5 
mm ventral to the brain surface; and 3.5 mm at 3.0 mm ventral to the brain surface.  After lesion 
completion, the electrode was removed, and the incision sutured closed and treated with topical 
anesthetic and antibiotic.  Animals were then housed singly in a heated holding cage during the 
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acute surgical recovery and monitored for discomfort or distress before being returned to their 
home cage. 
 
Molecular and Morphological Assessments 
Protein Extraction and Analysis 
Selected mice were anaesthetized with 4% isoflurane in carrier gas of 70% N2O, 30% O2 
for 4 minutes, then sacrificed at 2d postinjury via decapitation  (n=64 each strain; total n= 128).  
Whole hippocampi or ML enriched fractions were dissected, homogenized on ice in 100 µl of 
RIPA#2 (1X Pierce RIPA Buffer, 1% Triton™ X-100, 0.1% SDS and protease inhibitor (Thermo 
Scientific, Rockford, IL; Roche, Mannheim, Germany), and centrifuged at 8,000 x g for 5 
minutes at 4°C.  Supernatant was aliquotted and stored at -80°C for protein quantification, WB, 
or gelatin zymography analysis.  Protein concentration was determined using Thermo Scientific 
Pierce Protein Assay Reagent (Rockford, IL) and FLUOstar Optima plate reader (BMG Labtech, 
Inc., Durham, NC). 
 
Western Blot Analysis 
WB analysis was carried out utilizing Bio-Rad products (Hercules, CA).  Thirty µg of 
protein were prepared for WB with XT sample buffer and XT reducing buffer, and denatured at 
95°C for 5 minutes.  Samples were electrophoresed on 4-12% Bis-Tris Criterion XT gels (200 V 
x 45 minutes) then protein transferred to PVDF membranes (100 V x 60 minutes).  Following 
transfer, post-blot gels were stained 0.1% coomassie brilliant blue in destain #1 (40% MeOH, 
10% HOAc x 30 minutes), then destained at room temperature (#1 x 30 minutes; #2: 7% MeOH , 
10% HOAc x 30 minutes) to confirm even transfer of protein.  To prevent non-specific protein 
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binding, membranes were first washed in nanopure H2O (2 x 5 minutes) and TBS (1 x 5 
minutes), then blocked in mTBST.  Blots were next cut at the 25 kD marker and the appropriate 
pieces incubated overnight at 4°C in mTBST with either anti-OPN (0.25 μg/ml, R&D Systems, 
Minneapolis, MN; or 1:300, Rockland Immunochemicals Inc., Gilbertsville, PA) or anti-
cyclophilin A (1:2,500, Millipore, Billerica, MA), used as a loading control.  Blots were washed 
with mTBST (5 x 5 minutes) then incubated in appropriate secondary in mTBST (1:10,000 goat 
anti-mouse; 1:20,000 bovine anti-rabbit, Santa Cruz Biotechnology Inc., Dallas, TX) at room 
temperature for 1 hour.  Finally, membranes were washed in TBST (5 x 5 minutes) and 
incubated with Super Signal Dura West chemiluminescent substrate (Thermo Scientific, 
Rockford, IL) for signal detection.  WB images were captured with Syngene G:Box and positive 
band signal subjected to densitometric analysis (expressed as ROD) with Gene Tools software 
(Syngene, Frederick, MD).  Protein data are expressed as either fold change over controls or 
percent change relative to paired control cases. 
 
Gelatin Zymography Analysis 
Twenty µg of protein from 2d whole hippocampal extracts described above were 
prepared with 2x Tris-glycine SDS sample buffer and separated by gelatin electrophoresis at 4°C 
on Novex® 10% zymogram gels (Life Technologies, Grand Island, NY).  Gels were then 
renatured in Novex® Zymogram Renaturing Buffer (LC2670, Life Technologies, Grand Island, 
NY) at room temperature before development in Novex® Zymogram Developing Buffer 
(LC2671) over 6 days at 37°C.  Gelatin lysis was visualized with coomassie brilliant blue and 
purified enzyme run as positive control.  Zymogram signal was captured as an inverted image 
with Syngene G:BOX, and densitometry analyzed as ROD with Gene Tools software (Syngene, 
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Frederick, MD).  Enzyme activity data are expressed as percent change relative to paired control 
cases. 
 
Fluorescent Immunohistochemical Analysis 
At 2d postinjury (mouse n=5 each C57BL/6 and OPN KO, total n=50), animals were 
selected or fluorescent IHC analysis.  Mice were anaesthetized and sacrificed with a lethal dose 
of sodium pentobarbital (90 mg/kg, i.p.), followed by transcardiac perfusion with 0.9% saline 
(500 ml) and aldehyde fixative (500 ml 4% PFA in 0.1 M NaHPO4, pH=7.4).  Perfused brains 
were then removed and placed in fixative for an additional 24 hours before transfer to 0.03% 
NaN3 in 1.0 M PBS.  For IHC staining, brains were blocked at the dentate gyrus, and 40 µm 
coronal sections sliced using the VT1000S microtome (Leica, Buffalo Grove, IL).  Slices were 
then pre-treated in 0.5% peroxidase (30 minutes) and washed in PBS (3 x 10 minutes).  To 
prevent non-specific binding, sections were blocked in Blotto for 30 minutes (5% Cold Water 
Fish Skin Gelatin, Aurion, Netherlands, 5% Triton in 1.0 M PBS) and Triton X-100 in PBS prior 
to overnight primary antibody incubation in Blotto (anti-OPN MPIIIB10, 1:300, Iowa 
Hybridoma, Iowa City, IA; anti-IBA1, 1:300, Wako Chemicals, Richmond, VA; anti-GFAP, 
1:300, Dako, Carpinteria, CA; anti-synapsin 1 a/b (N-19, sc-7379), 1:250, Santa Cruz 
Biotechnology, Inc., Dallas, TX; anti-MAP-1B (H-130, sc-25729), 1:200 Santa Cruz 
Biotechnology, Inc., Dallas, TX; anti-N-cadherin (L-13, sc-31029), 1:100, Santa Cruz 
Biotechnology, Inc., Dallas, TX; anti-NGAL (M-145, sc-50351), Santa Cruz Biotechnology, 
Inc., Dallas, TX).  The next day, tissue sections were washed with PBS, blocked in Blotto at 
room temperature (30 minutes), then incubated in Blotto with the desired secondary fluorescent 
antibody (Alexa Fluor® 488 or 594, 1:1,000, Life Technologies, Grand Island, NY) for 1 hour at 
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room temperature.  Free floating sections were then washed in PBS (3 x 5 minutes), equilibrated 
in phosphate buffer, and mounted on Superfrost Plus slides (Fisher Scientific, Pittsburgh, PA) 
with Vectashield (Vector Laboratories, Burlingame, CA).  IHC signal was visualized using the 
TCS-SP2 AOBS (Leica, Buffalo Grove, IL) or LSM 700 (Carl Zeiss, Thornwood, NY) confocal 
microscope. 
 
Osteopontin Knockout Mouse Analysis 
Genotype Verification 
Confirmation of the transgenic OPN KO was assessed utilizing the PCR-verification 
method by The Jackson laboratory to test for presence of the neo
r
 cassette replacing exons 4-7 of 
the OPN gene which creates a null mutation, and renders it incapable of producing a OPN 
transcript in B6.129S6(Cg)-Spp1
tm1Blh
/J mice (Liaw et al., 1998).  Genomic DNA was isolated 
from 1 cm of tail, and genotyping confirmed utilizing the oIMR8444 primer ‘5GCC TGA AGA 
ACG AGA TCA GC3’ for OPN and the HotSHOT method as previously described (Truett et al., 
2000; Su et al., 2010). 
 
Protein Expression Ablation Verification 
To confirm the absence of OPN protein expression in the injured hippocampus, OPN KO 
and WT hippocampal extracts of mice subjected to UEC were analyzed via WB analysis as 
described above using polyclonal anti-OPN antibody raised in goat (0.25 μg/ml, R&D Systems, 
Minneapolis, MN). 
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Novel Object Recognition 
 Cognitive performance was assessed using a modified NOR test based on previous 
studies (Dixon et al., 1987; Ennaceur and Delacour, 1988; Messier, 1997; Han et al., 2011; 
Baratz et al., 2011; Siopi et al., 2012).  The NOR apparatus consists of a 42 x 42 x 30 cm
3 
open 
field arena under red light illumination (1 lux at mouse height) in a sound-isolated room as 
previously described (Fuller et al., 2012).  The NOR task consists of three phases: habituation, 
familiarization, and testing.  During habituation (3, 6, 13, 20, 27d postinjury), a single UEC 
(C57BL/6 n=12, OPN KO n=9; total n=21) or uninjured (C57BL/6 n=12, OPN KO n=12; total 
n=24)  mouse was acquainted with the black opaque plastic testing chamber for two 
nonconsecutive 5 min intervals.  Twenty four hours later, animals started the familiarization 
phase in the same chamber and were allowed to explore two identical objects: 50-mL conical 
plastic tubes affixed to the floor with Velcro® tape in symmetrical positions within the chamber.  
After a one hour delay, the animals entered the testing phase (4, 7, 14, 21, 28d postinjury) and 
returned to the testing chamber where one of the objects was replaced by a new object: a Lego® 
DUPLO® configuration of similar material and dimensions (height and width), but differing in 
shape from that of the conical tube (Fig. 3.2).  Time spent exploring each object during both the 
familiarization and testing phases was recorded for each minute with an overhead video camera, 
and later scored.  Object exploration was operationally defined as object touching, or orienting 
behaviors (sniffing, rearing, or head orientation) occurring within 2 cm of the object.  Sitting on 
top of or circling was not counted.  To prevent olfaction distraction or bias, the chamber and 
objects were thoroughly cleaned with 70% ethanol between trials.  Conversely, to prevent long 
term memory as confounder, a different novel object configuration was presented during each 
progressive trial.  Results of the testing phase are represented by recognition index (RI=time 
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Figure 3.2  Novel Object Recognition Cognitive Assessment Task Schematic.  Animals 
are placed in a plastic 42 x 42 x 30 cm
3
 box illuminated by 1 lux at animal height.  During the 
familiarization phase (A), animals are allowed to explore two identical 50 ml conical tubes 
(grey circles) in symmetric locations for 5 minutes.  After a 1 hour delay, animals are tested 
(B) for their recall of the familiar object by replacing one of the objects with a novel Lego® 
object (star) and recording the percentage of time spent exploring each object over a 5 minute 
period. 
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spent with novel object/(time spent with familiar object+time spent with novel object) x 100).  
An RI score of 50 represents a chance level of performance (no object preference) and RI 
significantly greater than 50 indicates an intact memory capacity for this task. 
 
Statistical Analyses 
Changes in protein levels or enzyme activity, induced by injury or associated with genetic 
strain, were evaluated using the GLM in SPSS v.11 (International Business Machines, Corp., 
Armonk, NY).  These alterations were assessed using a mixed model ANOVA with hemisphere 
(contralateral vs. ipsilateral to injury) as a within-subjects variable, and strain as a between-
subjects measure, and specific pairwise comparisons evaluated as simple main effects.  The 
effects of strain and UEC injury on NOR behavioral performance, was evaluated with a 
completely randomized ANOVA design followed by Duncan post-hoc tests.  Results are 
reported as mean +/- SEM.  An alpha level of 0.05 was used in all analyses. 
 
RESULTS 
Osteopontin Knockout Mouse Genotype Verification 
          We first examined the genotype of the homozygous OPN KO mice utilizing PCR-
verification, as described by The Jackson Laboratory, to confirm presence of the neo
r
 cassette 
replacing exons 4-7 of the OPN gene, creating a null mutation of the OPN gene, and rendering it 
incapable of producing a functional OPN protein in B6.129S6(Cg)-Spp1
tm1Blh
/J mice (Liaw et al., 
1998) (Fig. 3.3 A).  In addition, we confirmed ablated OPN response by WB analysis of whole 
hippocampal extracts using the polyclonal goat OPN antibody (R&D Systems) at 2d following 
UEC, the time point where we found maximal OPN response in rat experiments of Chapter 2 
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Figure 3.3  OPN KO Mouse Genotype Verification.  PCR confirmation of the neo
r
 cassette 
replacing exons 4-7 of OPN (A) and representative WB of full length 66 kD OPN protein in 
whole hippocampal extracts (B).  Similar to the response in rats, OPN increased robustly in 
WT C57BL/6 mice 2d after UEC, while OPN KO mice had only background signal detection, 
with no change between injured and contralateral control sides. 
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(see again Fig. 2.4).  Similar to the result found when rats were subjected to UEC, WT C57BL/6 
mice showed a robust OPN response within the hippocampus compared to contralateral controls 
(88.38 ± 0.67 fold, p<0.001) (Fig. 3.3 B).  This is in contrast to a null OPN response in the 
hippocampi of OPN KO mice, where only background signal was detected, and which did not 
differ from controls (0.81 ± 0.12 fold).  Together, these data confirm successful knockout of the 
OPN gene and lack of functional OPN protein response to trauma in our OPN KO mouse colony. 
 
Osteopontin Knockout Does Not Alter MAP1B Cytoskeletal Changes Following UEC 
In this experiment, similar to that of the rat, we explored the relationship between OPN 
and the cytoskeletal microtubule associated protein MAP1B during UEC reactive synaptogenesis 
in the mouse.  As previously indicated, recent reports suggest that intracellular OPN may act to 
stabilize the cell cytoskeleton by binding with MAP1B.  While MAP1B did not appear to interact 
significantly with OPN during the rat acute immune response, we investigated the potential for 
OPN to direct UEC-induced reshaping of the postsynaptic dendrites in mice, looking for 
differences from WT animals subjected to the same injury.  Here we utilized WB to probe both 
whole hippocampal extracts and ML enriched fractions for MAP1B expression (Fig. 3.4).  Goat 
polyclonal antibody for MAP1B detected three principal bands, at 220, 80, and 35 kD.  The 220 
kD signal represents full length MAP1B, while the 80 and 35 kD represent cleaved fragments, 
which may be generated by either calpain- or caspase-mediated cleavage, enzyme pathways 
known to be important in cytoskeletal reorganization after injury (Fifre et al., 2006).  Results 
showed an overall decrease in MAP1B protein expression within the hippocampus and 
deafferented dentate ML 2d following UEC, consistent with the removal of injured terminals 
during the degradation phase of reactive synaptogenesis.  Notably, no significant differences in 
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Figure 3.4  MAP1B Protein Expression Following UEC.  At 2d postinjury, WB analysis of 
MAP1B in whole hippocampal and enriched molecular layer (ML) extracts detected three 
major bands: a full length 220 kD signal, and two lytic fragments at 80 and 35 kD.  Overall, 
UEC deafferentation decreased MAP1B expression for both WT and OPN KO mice.  In 
whole hippocampus, MAP1B showed significant reduction in the 80 kD form for both strains, 
and in the 35 kD form for WT animals.  Within ML fractions, WT 220 and 80 kD forms were 
significantly reduced, while only the 80 kD fragment showed significant reduction in OPN 
KO animals.  There was no significant difference in MAP1B expression between strains after 
UEC.  Results are displayed as percent of control, with representative blot images and 
cyclophilin A loading controls shown below.  *p<0.05, **p<0.01 relative to paired control 
cases. 
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MAP1B forms were detected between the two mouse strains, or between the two regions 
sampled.  For WT mice, the 220 kD (76.9± 12.2%) and lysed forms were decreased in the 
hippocampus compared to control hemispheres, with both the 80 (51.6 ±3.1%, p<0.05) and 35 
kD (91.2 ± 2.9%, p<0.05) reductions reaching significance.  In extracts of the WT injured ML, 
there was a similar overall reduction in MAP1B expression after UEC for the 220, 80, and 35 kD 
forms, however, change in the 35 kD did not reach significance relative to paired controls (98.2 
± 3.6%).  Interestingly, the reduction in the 220 kD full length form was significant in this 
enriched fraction (55.8 ± 11.1%, p<0.05), and the 80 kD reduction (36.5 ± 8.6%, p<0.01) was to 
lower levels in the ML, but, as noted above, failed to show statistical difference by strain or 
region.  For OPN KO mice, hippocampal results showed changes similar to that of WT MAP1B 
protein.  MAP1B expression of the full length 220 (82.9 ±10.7%) and 80 kD (46.8 ± 7.1%, 
p<0.05) fragment were lower, however, only the 80 kD band showed significant reduction.  
Unlike WT, the hippocampal 35 kD trended toward increase at 2d (104.1 ± 8.0%), but this 
difference was clearly not significant.  For the OPN KO ML fractions, MAP1B appeared to go 
down in the 220 (77.1 ±19.1%) form and showed no change in the 35 kD (99.5 ±5.2) form, but 
reduction in the 80 kD fragment was more consistent, reaching statistical significance (59.7 
±10.6%, p<0.05).  Fluorescent IHC for MAP1B revealed slight decreases in staining at the IML 
after UEC relative to paired controls for both WT and OPN KO mice (Fig. 3.5).  While major 
qualitative differences were not observed between strains, overall MAP1B signal did appear 
stronger in the OPN KO mice. 
Together, our WB results indicate no significant differences in altered MAP1B 
expression between the hippocampus and ML, nor strain differences between WT and OPN KO 
mice.  This conclusion was supported by parallel IHC staining for MAP1B in each strain.  While 
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Figure 3.5  IHC of MAP1B in WT and OPN KO Mice Following UEC.  Confocal MAP1B 
staining in WT and OPN KO mice shows a slight decrease over the IML (B, D) compared to 
paired contralateral controls (A, C) after UEC.  Other than an overall higher signal in the 
OPN KO cases, no apparent differences in MAP1B signal occurred between WT and OPN 
KO mice.  Scale bar = 50 µm. 
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the predicted IHC postinjury redistribution of MAP1B seen in the rat did not occur in mice 
subjected to UEC, the significant reduction of 80 kD MAP1B within both regions and strains 
suggests this form of MAP1B plays a prominent role during deafferentation-induced cytoskeletal 
reorganization in the mouse model. 
 
Osteopontin Knockout Does Not Alter N-cadherin Mediated Synaptic Stabilization after UEC  
Here, we extended our evaluation of WT and OPN KO synaptic response to UEC by 
examining changes in N-cadherin expression.  N-cadherin is a transmembrane adhesion protein 
which exhibits homologous binding to stabilize the synaptic junction.  N-cadherin protein level 
was compared in WT and OPN KO mice using WB analysis of hippocampal and injured ML 
extracts (Fig. 3.6), as well as with IHC spatial localization during at the 2d degeneration phase 
(Fig. 3.7), again matching the interval of maximal OPN response for the rat studies in Chapter 2.  
Utilizing a goat polyclonal antibody for N-cadherin, we evaluated changes in two major bands: a 
full length 115 kD form, and a principal 35 kD cleaved fragment.  Results showed a general 
decrease compared to paired controls, again predicted for the destabilization of synapses during 
the acute degenerative period.  As for MAP1B, no regional or strain differences were significant.  
Nevertheless, relative to contralateral controls, WT mice exhibited lower expression of both the 
115 and 35 kD forms in the hippocampus (73.9 ± 2.1%, p<0.05; 73.2 ± 14.5%) and enriched ML 
fractions (76.7 ± 4.7%, p<0.05; 98.5 ± 19.7%), however only the reduction of the full length 
form reached significance.  For OPN KO mice, hippocampal 115 kD N-cadherin level trended 
toward reduction compared with controls (82.9 ±5.7%), but the 35 kD fragment showed higher 
variability and was actually maintained at control levels (105.2 ± 25.4%).  Neither of these shifts 
from control was statistically significant.  Interestingly, although hippocampal N-cadherin 
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Figure 3.6 N-cadherin Protein Expression Following UEC.  At 2d postinjury, WB analysis 
of N-cadherin in whole hippocampal and enriched ML extracts detected two major bands:  
full length 115 kD, and a cleaved 35 kD form.  As for MAP1B, UEC induced a decrease in N-
cadherin expression for both WT and OPN KO mice.  WT hippocampal extracts exhibited 
significant reduction only in the 115 kD form, while OPN KO samples had higher variance, 
with no significant change in either the 115 or 35 kD N-cadherin.  Within ML fractions, 115 
and 35 kD forms were reduced in OPN KO mice, but only the 115 kD form was decreased in 
WT animals.  There was no significant difference in N-cadherin expression between strains 
after UEC.  Results are expressed as percent of control, with representative blot images and 
cyclophilin A loading controls shown below.  *p<0.05 relative to paired control cases. 
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Figure 3.7  IHC of N-cadherin in WT and OPN KO Mice Following UEC.  Confocal N-
cadherin staining increased over the OML in after UEC (B, D) compared to contralateral 
control hemisphere (A, C).  This increase was observed in non-neuronal cells distributed 
throughout the zone.  Injury-induced cellular staining (arrows) in OPN KO mice (D) was 
more prominent than that of WT controls (B).  Scale bar = 50 µm. 
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change in OPN KO mice did not reach significance, reductions within the ML were significant 
for both the full length 115 kD form (83.6 ± 5.7%, p<0.05) and cleaved 35 kD fragment (69.2 ± 
4.8%, p<0.05).  While there were no overall region or strain differences for either WT or OPN 
KO mice, the shift in the 35 kD N-cadherin fragment from essentially no change in KO whole 
hippocampus to significant reduction in the ML supports more complete local N-cadherin 
proteolysis in the deafferented zone where synapse destabilization is underway.  Parallel IHC of 
N-cadherin within the DG (Fig. 3.7) revealed slight increase in non-neuronal ML signal for the 
injured WT mice relative the paired control tissue.  This N-cadherin response was even more 
robust within the outer ML of injured OPN KO mice.  Since N-cadherin is known to localize 
within reactive astrocytes of the ML, these results are consistent with glial proteolysis of full 
length N-cadherin suggested by our WB data.  
 
Osteopontin Knockout Alters Synapsin 1 and Effective Removal of Presynaptic Terminals 
As for MAP1B and N-cadherin, WB analysis and fluorescent IHC were utilized to map 
synapsin 1 expression in order to determine the potential for OPN to direct presynaptic terminal 
degradation during the acute degenerative phase of reactive synaptogenesis.  Utilizing a goat 
polyclonal antibody which recognizes the full length 80 kD form, as well as a cysteine protease-
cleaved 55 kD product of synapsin 1, we evaluated the response of this protein in the 
hippocampus and enriched ML extracts of WT and OPN KO mice subjected to UEC (Fig. 3.8).  
As a protein linked to synaptic vesicles, we utilized this antibody as a marker of presynaptic 
terminals and anticipated a reduction in synapsin 1 staining, indicating removal of injured 
terminals, similar to that in the rat studies of Chapter 2.  Results show a very similar pattern of 
synapsin 1 reduction in both full length and cleaved forms for WT and KO cases when compared 
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Figure 3.8  Synapsin 1 Protein Expression Following UEC.  At 2d postinjury, WB analysis 
of synapsin 1 in whole hippocampal and enriched ML extracts detected two major bands:  a 
80 kD full length form, and a 55 kD fragment, representing the principal cysteine-specific 
cleavage product.  Overall, both strains showed a similar pattern of synapsin 1 reduction after 
injury, each form being significantly lower than in paired control samples.  The 
deafferentation-induced reduction of the 55 kD form was attenuated in the OPN KO mice 
relative to WT animals, however, this difference reached significance only for the whole 
hippocampus.  Interestingly, the ML 55 kD synapsin 1 level was significantly lower than the 
corresponding hippocampal value for the OPN KO cases.  Results are expressed as percent of 
control, with representative blot images and cyclophilin A loading controls shown below.  
*p<0.05 relative to paired control cases; § p<0.05. 
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to control mice.  Further, in contrast to MAP1B and N-cadherin, significant differences in 
synapsin 1 protein expression were found for select bands between regions and mouse strains.  
For WT mice, the full length 80 kD and cleaved 55 kD protein were significantly reduced at 2d 
after UEC in both the hippocampus (66.6 ± 5.4%; 52.6 ± 4.7%; p<0.05) and ML enriched 
fractions (71.7 ± 6.6%; 55.6 ± 5.7%; p<0.05) compared to contralateral controls, with maximal 
reduction occurring in the hippocampal 55 kD form.  OPN KO mice showed a similar synapsin 1 
response to UEC with significant decreases in both the 80 kD and 55 kD forms within the 
hippocampus (73.6 ± 1.4%; 83.2 ± 3.6%; p<0.05) and injured ML extracts (57.8 ± 6.7%, 72.9 ± 
3.3%; p<0.05) relative to paired controls.  WT animals did not exhibit any differences in 
synapsin 1 reductions between the hippocampus and ML extracts, however, OPN KO reduction 
in 55 kD synapsin 1 was significantly lower in the injured ML versus hippocampus (p<0.05).  
Notably, the full length 80 kD synapsin 1 response did not differ between strains, however, 55 
kD synapsin 1 was significantly reduced in the hippocampus of WT mice compared to that of 
OPN KO mice (p<0.05).  This difference, like the previously described lower ML levels of N-
cadherin, is consistent with greater proteolysis in that zone of deafferentation.  The fact that 2d 
regional and strain differences are apparent in the 55 kD cleaved synapsin 1 also suggests 
potential interaction between OPN and synapsin 1 during presynaptic terminals breakdown.  
Impaired removal of synapsin 1 protein in the hippocampus OPN KO mice is also supported by 
parallel IHC staining.  As anticipated, and consistent with previous literature, synapsin 1 staining 
is absent in the injured dentate of WT mice compared to controls (Fig. 3.9 A-B), indicating the 
loss of entorhinal fibers which innervate the outer ML of the DG, and the successful ongoing 
removal of their injured terminals during the acute postinjury phase.  In contrast to WT mice, 
ML synapsin 1 staining is persistent within the injured ML of OPN KO mice (Fig. 3.9 C-D),  
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Figure 3.9  IHC of Synapsin 1 in WT and OPN KO Mice Following UEC.  Confocal IHC 
of synapsin 1 after UEC in WT mice exhibited reduced staining in the OML (boxed area, B) 
compared to control hemisphere (A), indicating the clearance of presynaptic terminals 
containing synapsin 1, similar to that seen in the rat UEC model.  Clearance of axonal 
terminals was attenuated in OPN KO mice (boxed area, D) suggesting impaired degeneration.  
Scale bar = 50 µm. 
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consistent with the incomplete removal of synapsin 1 in the rat UEC model when OPN 
expression is reduced by minocycline immunosuppression.  Together, these IHC results suggest 
that absence of OPN impairs the removal of degenerating presynaptic terminals from the 
deafferented ML following UEC.  This conclusion is supported by evidence of lower proteolysis 
of terminal marker protein synapsin 1 at 2d postinjury. 
 
Absence of Osteopontin Impairs Cognitive Function Following UEC 
          The NOR task was utilized to examine hippocampal-dependent long term memory 
function following UEC in mice (Fig. 3.10).  First, uninjured naïve WT and OPN KO mice were 
evaluated to confirm the absence of any nascent behavioral differences between strains.  
Uninjured WT animals successfully recalled the familiar object, spending significantly more 
exploration time with the novel object compared to chance alone (68.5 ± 1.59, p<0.001).  
Similarly, OPN KO mice spent significantly more time with the novel object (65.2 ± 4.10, 
p<0.01), results that did not differ from WT performance, indicating both strains performed 
similarly in the absence of injury.  Following UEC, mice were evaluated for 28d during the 
recovery window associated with sprouting (4d), synapse reformation (7d), and once a week (14, 
21, 28d) during the synapse maturation and stabilization phase until 28 d postinjury, the end of 
the testing period.  Similar to previous reports, we observed that a small percentage of mice did 
not explore either object, but engaged in unrelated behaviors (e.g., grooming or freezing) 
(Meunier et al., 2013).  Because no RI can be computed for such periods, mice which exhibited 
this behavioral pattern for greater than 50% of the recorded time (n=2 WT and n=5 OPN KO) 
were excluded from statistical analysis.  Accordingly, n=38 mice were assessed on the NOR task 
grouped as follows:  WT naïve n=12, KO naïve n=10, WT UEC n=10, KO UEC n=6.  WT  
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Figure 3.10  OPN KO Mice Exhibit Cognitive Deficits in the NOR Test.  NOR 
performance during UEC-induced synaptic reorganization (4-28d postinjury) was expressed 
as the RI metric (see Methods for formula details).  RI values for uninjured WT and OPN KO 
show that mice spent significantly more time exploring the novel object compared to the 
familiar object.  No differences were found between uninjured animals in the two strains.  At 
4d after UEC, WT RI values were significantly higher than that predicted by chance level 
behavior, while RI values for OPN KO mice were reduced by half.  Although KO 
performance remained above chance, the percentage of time spent with the novel object at 4d 
was significantly less than for the WT controls.  Between 7- 21d, RI values for OPN KO mice 
reflected significant cognitive deficits, no longer different from chance performance, while 
WT mice continued to successfully recall the familiar object.  At these later time points, the 
difference between strains was no longer significant.  Interestingly, by 28 days, RI values 
were similar between strains, with both WT and KO mice recognizing the familiar object and 
spending significantly more time with the novel object.  *p<0.05, **p<0.01, ***p<0.001, 
relative to performance at the 50% chance level; §p<0.05. 
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mice successfully recalled the familiar object after UEC, obtaining RI values significantly above 
chance throughout the entire testing period.  At 4d postinjury, during early collateral sprouting, 
WT performed similarly to naïve mice (68.5 ± 2.37, p<0.001), most likely due to functional 
compensation by the intact contralateral hippocampal circuitry.  This performance, however, 
declined throughout sprouting and maturation at 7d (65.3 ± 2.87, p<0.001), 14d (62.4 ± 2.84, 
p<0.01), and 21d postinjury (57.8 ± 2.88, p<0.05), potentially demonstrating some degree of 
familiarization with the task.  Interestingly, WT performance rebounded 28d after UEC, with RI 
values similar to that of uninjured mice (66.4 ± 1.89, p<0.001), consistent with long term 
strengthening of synaptic connections.  For the OPN KO group, animals managed to successfully 
recognize the familiar object 4d postinjury (57.1 ± 3.39, p<0.05), however, RI values were 
significantly lower than those of WT mice during this window prior to sprouting (p<0.05).  KO 
animals failed to reach criterion for the task at 7d (55.9 ± 7.00, p=0.07), 14d (59.1 ±6.13, 
p>0.05), and 21d (60.1 ± 4.24, p>0.05) postinjury, and their exploratory behavior was quite 
variable.  While this variability precluded statistical difference between WT and KO 
performance at these three time points, KO mice clearly showed cognitive deficits, while the WT 
mice continued to reach criterion performance.  Interestingly, OPN KO behavior trended toward 
improvement over the testing period, the mice spending more time with the novel object between 
14 and 28d postinjury.  It was also noted that over the entire testing period, WT and OPN KO 
showed distinct behavioral curves, with WT drifting toward a nadir at 21d, then returning to 
naïve performance by 28d, while the KO showed immediate postinjury reduction and persistent 
deficit until a rebound at 28d.  Indeed, both strains showed improved NOR at this four week 
interval, with RI values (WT 66.4 ± 1.89, p<0.001; KO 62.6 ± 4.56, p<0.01) nearing those of 
uninjured naïve animals.  Overall, WT mice subjected to trauma performed better than OPN KO 
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animals after UEC, although each group improved with time, suggesting that OPN loss did not 
prevent the eventual strengthening of new synaptic connections.  This result shows that the 
absence of OPN impairs the progress of synaptic regeneration and delays functional hippocampal 
recovery. 
 
Osteopontin Knockout and Microglial Response to Trauma 
 
Given the change in microglial migration following minocycline attenuation of the acute 
immune response of the injured rat in Chapter 2, we utilized IHC to stain for active microglia in 
WT and OPN KO mice and compare glial morphology (Fig. 3.11).  Similar to the rat model, 
microglia responded to UEC in WT mice by displaying a reactive morphology and migrating 
from the outer ML toward the border of intact/deafferented dendrites (arrows, Fig. 3.11 B).  
Microglia in OPN KO mice responded similarly to deafferentation in the injured ML, however, 
glial morphology differed, revealing a more persistent ramified state, with many extended 
processes permeating the granule cell layer (arrows, Fig. 3.11 D).  This pattern of microglial 
response is consistent with previous PD studies documenting abnormal reactive microglial 
morphology in response to degenerative insult (Maetzler et al., 2010). 
 
Osteopontin Knockout, MMP Activity, and Osteopontin Proteolytic Processing 
 
Studies in Chapter 2 indicated MMP processing may play a role exposing integrin 
receptor binding sites on OPN, subsequently permitting various cell signaling interactions 
important in reactive synaptogenesis.  Given that MMP gelatinase activity increases after UEC in 
rats, and acute attenuation of the immune response via minocycline dampens OPN, MMP 
activity, and the production of MMP-cleaved OPN fragments, we further evaluated the potential 
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Figure 3.11  Microglial Reactivity in WT and OPN KO Mice Following UEC.  Confocal 
IHC for microglia 2d postinjury shows transition from resting to activated form, and the 
notable migration of activated microglia to the border between the intact IML and 
deafferented OML in both WT and OPN KO strains (arrows).  This response is similar to that 
observed after rat UEC.  While OPN KO did not overtly alter microglial migration during the 
acute phase of reactive synaptogenesis, microglia of OPN KO mice exhibited different 
morphology, with longer, more interdigitated processes compared to WT mice.  Scale bar = 
50 µm. 
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for MMP/OPN interaction as a mechanism regulating synaptic reorganization.  We first 
examined the effect of injury on MMP activity in WT and OPN KO mice utilizing gelatin 
zymography to assay lytic activity of MMPs -2 and -9 (Fig. 3.12).  We paired this data with WB 
analysis of LCN2, a siderophore known to bind MMP-9 and persistently activate the enzyme 
(Fig. 3.13).  Following UEC, WT mice showed increased hippocampal MMP-2 (239.68 ± 45.92) 
and -9 activities (1534.45 ± 244.48, p<0.05) at 2d postinjury, however, only MMP-9 activity 
elevation was statistically significant compared to contralateral controls.  Similarly, injured OPN 
KO mice showed elevated MMP-2 (215.94 ± 36.33) and MMP-9 (679.65 ± 207.9, p<0.05) 
activities, with only MMP-9 differences significant.  Importantly, MMP-9 activity in OPN KO 
mice was significantly attenuated compared to WT animals (p<0.05), supporting an OPN/MMP 
interaction after trauma.  Moreover, remaining MMP-9 activity under conditions of OPN KO 
indicates that MMP-9 function after UEC is dependent upon other molecular signals in addition 
to OPN.  Parallel WB studies evaluating the WT and KO expression of LCN2 revealed two 
principal bands: a 130 kD form, representing MMP-9 bound LCN2 (Park et al., 2009), and a 55 
kD form (Fig. 3.13).  At 2d after UEC, both the 130 and 55 kD forms of LCN2 were 
significantly elevated in the injured hippocampus (827.88 ± 221.87, p<0.01; 237.55 ± 17.71, 
p<0.05) of WT mice compared to controls.  LCN2 was also elevated in the deafferented ML 
(336.7 ± 71.3, 151.1 ± 5.5; p<0.05), but these changes were significantly lower than within the 
whole hippocampus (p<0.05), suggesting LCN2/MMP-9 interaction may be occurring in both 
cell body and dendritic zones of dentate granule cells, but to a lesser degree in the deafferented 
zone.  For OPN KO mice, results were similar to WT animals, both LCN2 forms (130, 55 kD) 
were also significantly elevated compared to contralateral controls in each region (HC=271.84 
54.1, 183.39 ± 13.50; ML= 311.1 ± 60.8, 153.7 ± 14.0; p<0.05), however, there were no 
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Figure 3.12  OPN KO Attenuates Hippocampal MMP-9 Activity Following UEC.  At 2d 
postinjury, gelatin zymography shows an elevation in MMP-9, but not MMP-2 activity within 
the hippocampus of WT and OPN KO mice.  Injury-induced MMP-9 activity was reduced in 
OPN KO mice compared to WT controls.  Results are displayed in ROD and expressed as 
percent of control, with representative gel images shown below.  *p<0.05 relative to paired 
contralateral controls; §p<0.05. 
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Figure 3.13  UEC Induces Protein Expression in LCN2.  WB analysis of LCN2 protein in 
whole hippocampal and enriched ML extracts.  UEC induced a significant increase in LCN2 
compared to control hemispheres 2d postinjury in both WT and OPN KO mice.  Increases in 
hippocampal 55 kD LCN2 were modest, while the MMP-9 bound 130 kD form increased 
robustly compared to controls in WT mice.  Although both LCN2 bands were reduced in the 
KO mice, changes in the MMP-9 bound 130 kD form were much greater after OPN KO.  For 
the ML, no strain differences were seen, however, the 55 kD LCN2 signal did show a lower 
overall elevation in this region versus the whole hippocampus.  Results are expressed as 
percent of control, with representative blot images and cyclophilin A loading controls shown 
below.  *p<0.05, **p<0.01, relative to paired control cases; §p<0.05. 
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differences between regions.  Importantly, we did observe a significant reduction in 130 kD 
LCN2 response within the KO hippocampal extracts compared to WT mice (p<0.05).  This 
reduction parallels strain differences in MMP-9 activity seen in Fig. 3.12, supporting 
LCN2/MMP-9/OPN interaction during reactive synaptogenesis.  In parallel IHC experiments, we 
found increased LCN2 staining within the deafferented ML of injured WT and OPN KO mice 
(Fig 3.14 B, D), where an overall qualitative reduction in the staining intensity relative to WT 
was apparent for the injured OPN KO animals. 
 
DISCUSSION 
This study utilized OPN KO mice to remove OPN and evaluate its role during adaptive 
reactive synaptogenesis in the UEC model.  Three approaches were taken to assess how the 
absence of OPN alters successful regeneration.  First, using antibodies for separate molecular 
markers of cytoskeletal organization (MAP1B), synapse stabilization (N-cadherin), and 
presynaptic terminal integrity (synapsin 1), changes in postinjury protein expression and tissue 
distribution were mapped in WT and OPN KO animals subjected to UEC.  For these measures, 
focus was placed on the 2d postinjury interval where the rat studies of Chapter 2 showed 
maximal injury-induced OPN elevation.  Here, both whole hippocampal and enriched ML 
extracts were sampled to determine if OPN KO had different effects in the cell body or dendrite-
rich regions.  In a second set of experiments, the effect of OPN KO on cognitive functional 
outcome over the time frame of reactive synaptogenesis (4-28d postinjury) was determined using 
the NOR task.  This task has been successfully used in other mouse TBI models to assess 
hippocampal dysfunction as a consequence of controlled cortical impact injury or impact 
acceleration insult (Biegon et al., 2004; Tsenter et al., 2008).  In addition, since OPN can be
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Figure 3.14  IHC of LCN2 in WT and OPN KO Mice Following UEC.  Confocal IHC of 
LCN2 after UEC in both WT and OPN KO mice exhibited increased staining in the ML (B, 
D) compared to control hemispheres (A, C), supporting protein elevations in WB profiles.  
LCN2 injury-induced increase was attenuated in OPN KO mice (D), consistent with lower 
levels of LCN2 protein change in WB data, and paralleling KO effects on MMP-9 activity see 
again Fig. 3.10).  Scale bar = 50 µm. 
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cleaved by MMPs to generate integrin binding peptides for cell signaling, the effect of OPN KO 
on MMP lytic activity and OPN fragment generation was tested.  As a correlate to this 
MMP/OPN interaction, a novel MMP-9 ligand and activator, LCN2, was assayed in WT and 
OPN KO mice after UEC lesion.  Overall, results from WB molecular marker analysis showed 
that MAP1B, N-cadherin, and synapsin-1 expression were reduced at 2d postinjury in each strain 
when compared with contralateral controls.  However, of the three markers, only synapsin 1 
revealed effects of OPN KO and regional sample differences.  Notably, the attenuated reduction 
of 55 kD synapsin 1 expression in KO mice was consistent with the incomplete removal of 
presynaptic terminals found in the rat experiments of Chapter 2, where OPN expression was 
reduced with minocycline immunosuppression.  In addition, activated microglia in OPN KO 
mice subjected to UEC presented an altered morphology compared to WT mice.  These 
observations suggest that OPN plays a more prominent role in the presynaptic morphing during 
the early phases of reactive synaptogenesis.  When NOR task performance was evaluated, both 
uninjured WT and OPN KO mice recognized the novel object at significantly higher than chance 
levels.  Further, deficits in recognition were detected at 4, 7, 14, and 21d postinjury with OPN 
KO compared to injured WT cohorts.  Interestingly, injured OPN KO mice also showed 
reduction in MMP-9 lytic activity versus WT animals subjected to UEC, and this reduced MMP-
9 activity was correlated with attenuated expression of the MMP-9-bound form of LCN2.  
Together, these findings support OPN role in presynaptic terminal removal during the acute 
phase of synaptogenesis, involving integrin cell signaling through MMP-9/LCN2-mediated 
generation of OPN fragments.  Moreover, this process is critical for adaptive outcome during the 
regenerative phase of synaptogenesis since the NOR deficits are detected 4-21d postinjury when 
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OPN is absent.  From the present OPN KO results, new details have emerged regarding the 
importance of OPN in the acute molecular mechanisms supporting adaptive synaptic plasticity. 
 
Osteopontin, MAP1B, and Synaptic Cytoarchitecture 
One of the first cellular responses at the onset of reactive synaptogenesis is 
morphological reshaping of neurons and glia to allow clearance of degenerated presynaptic 
terminals.  Reactive glial cells become hypertrophic and extend their processes to degrade dying 
presynaptic terminals, while postsynaptic dendrites retract to reform their spine structure.  All of 
these processes require significant change in cytoskeletal proteins.  MAP1B belongs to a family 
of growth and cytoskeletal proteins, including MAP2 and tau, which regulates microtubule 
assembly underlying the structural integrity of glia and neurons (Emery et al., 2003).  This 
family of proteins is found in somata, axons, and dendrites, with extensive expression in 
developing axons of the immature brain (Yamanouchi, 2005; Riederer, 2007).  MAP1B is one of 
the first MAPs expressed during rat embryonic development, and can be found in a number of 
structures including the olfactory system, cerebellum, and spinal cord (Gonzalez-Billault et al., 
2004; Tortosa et al., 2011).  This intense developmental expression decreases with aging, and is 
nearly absent in the adult CNS, with the exception of sites which exhibit a high level of 
regenerative plasticity such as the hippocampus and olfactory system (Riederer and Matus, 1985; 
Safaei and Fischer, 1989).  MAP1B is a large protein with a molecular mass of 255 kD and, like 
many microtubule associated proteins, undergoes phosphorylation and/or cleavage to generate 
additional functional forms (Riederer, 2007).  Given that MAP1B can influence cell polarity and 
axonal outgrowth, its potential for facilitating regeneration in the adult CNS has been explored in 
neurological dysfunction and injury (Bates et al., 1993; Gai et al., 1996).  For example, MAP1B 
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is localized to Amyloid-β (Aβ) plaques and tau tangles in Alzheimer disease (Uchida, 2003), as 
well as visible in Lewy bodies of Parkinson disease (Gai et al., 1996).  Further, in vitro Aβ-
mediated apoptosis reduces MAP1B expression through calpain and caspase cleavage (Fifre et 
al., 2006).  By contrast, MAP1B also supports adult neuroregeneration, with documented 
increases in phosphorylated MAP1B during axon regrowth in trochlear neurons (Book et al., 
1996), sciatic nerve lesion (Bush et al., 1996; Soares et al., 2002), and SCI (Soares et al., 2007).  
These examples show the active participation of MAP1B in shaping the cytoskeleton of neurons 
during both degenerative and regenerative processes. 
 The active role of MAP1B in both neurodegeneration and regeneration highlights the 
importance of time-dependent MAP expression in neurological disease or following traumatic 
insult.  Rodent models of ischemia show that increased MAP1B expression does not occur until 
7d after MCAO, suggesting that it plays a predominant role in the regeneration associated with 
recovery (Popa-Wagner et al., 1999).  Other studies have also reported that reduction in MAP1B 
inhibits regenerative capacity, as demonstrated by delayed glial or MAP1B response as late as 
14-28d postinjury (Badan et al., 2003).  Together, these studies suggest that early reduction or 
loss of MAP1B may be linked to the structural disruption associated with early degeneration, but 
increased MAP1B would subsequently accompany regeneration as cytoarchitecture supports 
neuronal regrowth.  Interestingly, a recent report has linked such cytoskeletal growth to OPN, 
utilizing a yeast 2 hybrid study to demonstrate that intracellular OPN binds MAP1B in the rat 
substantia nigra SN and striatum (Long et al., 2012).  Given that MAP1B has the potential to 
bind OPN in the brain, is associated with glial-mediated regeneration after CNS injury, and the 
fact that moderate lateral fluid percussion injury induces MAP1B expression (Emery et al., 
2000), we posited that MAP1B/OPN interaction may be present during the acute phases of UEC 
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reactive synaptogenesis.  We evaluated MAP1B in its full length 220 kD, as well as cleaved 80 
and 35 kD forms.  In the rat studies of Chapter 2, UEC deafferentation induced cytoskeletal 
degradation and subsequent removal of the injured axons, a finding marked by a decrease in 
MAP1B expression at 2d postinjury.  This result was consistent with other reported injury-
induced MAP1B reductions within the hippocampus such as following gerbil forebrain ischemia 
(Tanay et al., 2006).  A similar pattern was observed in our WT and OPN KO mice, where 
MAP1B expression in the hippocampal extracts was significantly reduced for both the 220 and 
80 kD forms compared to controls.  Interestingly, only WT showed significant reduction of the 
hippocampal 35 kD MAP1B.  These changes in MAP1B expression are consistent with reported 
calpain- caspase-mediated proteolysis of MAP1B (Fischer et al., 1991; Fifre et al., 2006), and 
notably, these two enzymes are known to mediate neuronal damage following TBI (Saatman et 
al., 1996; Pike et al., 1998).  For ML enriched extracts the overall effect was reduction, however, 
the significance of this reduction varied with respect to MAP1B form and mouse strain. Both the 
220 and 80 kD forms of MAP1B tended to decrease in both the WT and KO animals, reaching 
significance for both forms in the WT, but only for the 80 kD in KO mice.   
Given that significant reductions in 80 kD MAP1B occur for both strains, and in both 
sampled regions, we interpret the 80 kD MAP1B as the principal form mediating trauma-induced 
cytoarchitectural rearrangement within the dendrites of the mouse dentate gyrus.  More 
importantly, regional comparisons indicated no significant differences between WT and KO 
strains, suggesting the intracellular form of OPN which associates with MAP1B is less likely to 
participate in the injury-induced structural reorganization at 2d after UEC.  This result supports 
our rat observations in Chapter 2, which point to little or no colocalization of MAP1B and OPN, 
and a more prominent role for secreted, cleaved, OPN in chemokine and astrokine signaling at 
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2d postinjury.  Interestingly, IHC staining for MAP1B in the two mouse strains did not show 
notable postinjury differences, however, the OPN KO mice appeared to show stronger MAP1B 
signal.  Since the WB results showed nearly identical strain and regional patterns for MAP1B 
expression, and the IHC label represents an aggregate of all three blot signals, it might be 
predicted that no gross staining differences would be observed.  Surprisingly, the clear shift in 
MAP1B distribution associated with dendritic retraction seen in the rat after UEC was not found 
in either mouse strain.  On the surface, this finding would suggest species differences in the role 
of MAP1B after UEC which remain to be explored.  Clearly, deafferentation in the WT mouse 
produces presynaptic terminal loss identical to the rat as evidenced by shifts in synapsin 1 
staining, but microtubule rearrangement must preferentially involve other MAPs in the mouse 
models.  Together, these studies indicate that while secreted OPN can act as an inflammatory 
cytokine during the acute degenerative phase of reactive synaptogenesis, the modification of 
cytoskeletal structure through intracellular OPN/MAP1B binding does not appear to play a 
significant role in the process.  Without OPN, we found no difference in the injury-induced 
change of MAP1B expression. 
 
Osteopontin, N-cadherin, and Stabilization of the Synaptic Junction 
Given that OPN did not appear to have overt effects on cytoskeletal integrity through 
MAP1B binding mechanisms during the degenerative phase of synaptogenesis, we next 
examined its potential influence on N-cadherin, a CAM important in the 
stabilization/destabilization of the synaptic junction.  N-cadherin belongs to a larger family of 
cadherins which are Ca
2+
-dependent CAMs important in stabilizing cell-cell interactions.  
Roughly 80 cadherins are expressed within the CNS, playing a role in development and 
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organization of the nervous system, including axonal outgrowth and synapse targeting (Doherty 
and Walsh, 1992).  Cadherins are often found at synapses where they are the major structural 
protein comprising the adherens junction (Yap et al., 1997), and have been more recently 
implicated in the modulation of synaptic plasticity in the adult brain (Huntley et al., 2002).  N-
cadherin engages in homophilic binding on either side of synapses, forming adhesion zippers 
which stabilize cell-cell interactions (Shapiro et al., 1995).  Synaptic plasticity during CNS 
development or following injury, requires the dissociation of pre and postsynaptic connections to 
permit the establishment of new contacts during synaptic reorganization, a process which 
inherently alters the expression of stabilization molecules such as N-cadherin (Shan et al., 2002).  
Interestingly, cadherins can be localized to specific synapse types, with N-cadherin found rather 
exclusively with excitatory synapses, such as those which are present on dentate granule cells of 
the hippocampus (Benson and Tanaka, 1998).  This location makes N-cadherin a critical 
mediator of the stabilization between the presynaptic terminals and postsynaptic spines affected 
in our UEC model of adaptive plasticity.  Time-dependent changes in N-cadherin expression 
occur following traumatic insult, being reduced during periods of acute synaptic degeneration 
and elevated later, when synapses regenerate (Takeichi and Abe, 2005; Warren et al., 2012).  
Specifically, at 2d following UEC-induced deafferentation in the rat, N-cadherin expression is 
significantly reduced (Warren et al., 2012), supporting its active role in synapse destabilization 
as degenerating terminals are removed to prepare dendritic sites for reinnervation.  Interestingly, 
OPN expression has been inversely correlated with E-cadherin expression in the plasticity 
associated with hepatocellular carcinoma, potentially mediating cellular and structural growth 
during cancer invasion through the ECM (Iso et al., 2005; Korita et al., 2008).  These findings 
suggest that the OPN increases we observed in Chapter 2 may be correlated with altered N-
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cadherin early after injury, and the process is a part of immune system control of synapse 
destabilization for the removal of injured terminals during the degenerative phase of reactive 
synaptogenesis. 
Similar to previously published studies in the rat model of UEC, N-cadherin levels were 
reduced in WT and OPN KO mice 2d postinjury.  However, no significant strain or regional 
differences were found, suggesting that loss of OPN did not alter the overall acute changes in N-
cadherin protein at this postinjury interval.  Nevertheless, compared to contralateral controls, 
some differences in profile between strains and region were suggested.  Both the 115 kD full 
length form and 35 kD cleaved fragments showed lower expression in the hippocampus and ML-
enriched fractions of WT mice subjected to UEC, however only the full length 115 kD 
reductions in N-cadherin reached significance.  For OPN KO mice, the 115 kD form showed a 
trend toward reduction in the hippocampus, while both forms were significantly reduced in ML.  
Parallel IHC for N-cadherin showed similar diffuse and cellular ML labeling as described for rat 
UEC at this time point, but no qualitative differences between control and injured WT mice were 
observed.  However, KO mice did show apparent increase in N-cadherin-positive cellular 
staining within the ML.  This elevated N-cadherin staining in the non-neuronal cells of the 
deafferented zone correlates with a trend toward greater reduction of N-cadherin fragment signal 
in the ML blot samples relative to those of the whole hippocampus, suggesting the possibility 
that higher IHC signal in the OPN KO may reflect an accelerated lysis of N-cadherin in reactive 
neuroglia.  Together, these results point to only minor differences in N-cadherin expression when 
OPN is absent during the acute UEC-induced immune response.  While additional studies will be 
required to explore N-cadherin processing in the OPN KO, the present findings do not support 
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modulation of N-cadherin and synapse stabilization as a major function of OPN during the early 
stages of hippocampal synaptic reorganization in mice. 
 
Osteopontin, Synapsin 1, and Terminal Integrity During the Acute Immune Response 
A third critical component of the acute phase of reactive synaptogenesis is the clearance 
of degenerating presynaptic terminals.  Immune-induced OPN response could play a role in 
facilitating this axonal clearance, a possibility supported by its localization in reactive microglia 
at the acute postinjury phase.  To investigate this potential OPN interaction, we again probed 
OPN KO mice, using the expression of the presynaptic terminal marker synapsin 1 to assay 
whether the removal of these terminals is altered when OPN is absent.   
Synapses are integral to the cell-cell transmission of information between neurons, 
principally through neurotransmitter release from synaptic vesicles.  One protein family essential 
to this process are the synapsins.  They are among the most abundant synaptic proteins present in 
the majority of nerve terminals (Goelz et al., 1981) and are specifically localized to the 
presynaptic compartment of synapses (De Camilli et al., 1983a; Fletcher et al., 1991; Ferreira et 
al., 2000).  Within presynaptic terminals, synapsins interact with the cytoskeleton, as well as 
contribute to synapse formation as evidenced by their high level of expression during 
developmental synaptogenesis (Lohmann et al., 1978; De Camilli et al., 1983a; Mason, 1986; 
Haas and DeGennaro, 1988; Melloni et al., 1994; Bogen et al., 2009) and LTP induction in the 
adult brain (Lynch et al., 1994; Sato et al., 2000).  Several different synapsin proteins exist, 
synapsin 1 being the first described, which is expressed as two nearly identical proteins in 86 and 
80 kD forms (De Camilli et al., 1979; De Camilli et al., 1983b).  As a protein functioning 
through  cytoarchitectural interaction, synapsin 1 is capable of undergoing extensive 
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phosphorylation by protein kinase A (PKA) and Ca
2+
/calmodulin-dependent protein kinase 
(CaMK), posttranslational modifications which modulate its ability to bind synaptic vesicles to 
the cytoskeleton  (De Camilli et al., 1983b; Cesca et al., 2010).  Synapsin 1 binds many structural 
components within the presynaptic terminal, including actin (Bahler and Greengard, 1987; 
Petrucci and Morrow, 1987), spectrin (Bennett et al., 1985; Krebs et al., 1987), microtubules 
(Baines and Bennett, 1986; Goldenring et al., 1986), and neurofilaments (Steiner et al., 1987).  
The shift in synapsin 1 phosphorylation and dephosphorylation underlies its role bundling 
structural filaments during synaptic vesicle aggregation or neurotransmitter release.  While 
synapsin 1 has historically been considered for its role in presynaptic vesicle release (Sudhof, 
1990; Bahler et al., 1990; Greengard et al., 1993),  evidence from recent in vitro and in vivo 
studies with suggest a role for synapsins in the formation of synaptic contacts (Lohmann et al., 
1978; Melloni et al., 1994; Ferreira et al., 2000) and presynaptic terminal formation (Han et al., 
1991).  Further, synapsin 1 mediates neurite elongation in postnatal development (Melloni et al., 
1994) within growth cones of cerebellar granule cells (Harada et al., 1990) and hippocampal 
neurons (Fletcher et al., 1991), providing support for a potential role in plasticity following CNS 
trauma.  Our current studies provide evidence that OPN and synapsin 1 interact to influence the 
progress and outcome of reactive synaptogenesis.  
 Previous studies have documented time-dependent alterations in synapsin 1 expression 
following CNS trauma.  The protein was reduced early following mTBI (Wu et al., 2011a) and 
CCI (Griesbach et al., 2009), which correlated with poor cognitive behavior assayed by MWM 
performance.  Following UEC deafferentation, there is a loss of synapsin 1 in the dentate ML (2d 
postlesion), marking the removal of damaged presynaptic terminals, while its expression 
reemerges during synapse regeneration (7d postlesion) when new terminals are generated by 
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collateral sprouting.  Interestingly, these early changes in synapsin 1 correlate with the acute 
OPN response to traumatic insult, and more recent studies have linked synapsin 1 to glutamate 
release in osteoblasts, a rich source of OPN, a process utilizing molecular mechanisms similar to 
synaptic neurotransmission (Bhangu et al., 2001).  Further, synapsins are implicated in the 
development of schizophrenia, and recent proteomic analyses of experimental models of 
schizophrenia-associated elevated OPN levels with alterations in the hypothalamic cytoskeleton, 
providing a potential functional link between OPN and synapsin 1 during aberrant synaptic 
organization in the brain (Guest et al., 2012).  Taken together, these published studies lend 
credence to the idea that OPN may interact with synapsin 1 after brain injury, mediating 
cytoskeletal breakdown and subsequent presynaptic terminal removal during the degenerative 
phase of reactive synaptogenesis. 
 Given that synapsin 1 plays a key role in the organization of presynaptic terminals, it’s 
potential to interact with OPN, and the prominent presynaptic terminal degeneration at 2d after 
UEC, we used synapsin 1 as marker to assess how OPN affects the presynaptic component of 
acute reactive synaptogenesis.  Following UEC, WB analysis of synapsin 1 showed significant  
reductions in the hippocampus and ML of both strains for the 80 kD full length form, as well as a 
functional 55 kD fragment, a predicted result for the 2d degenerative phase.  This pattern is 
consistent with cysteine protease cleavage (Bahler et al., 1989) and previous studies 
demonstrating interaction of synapsin fragments with cytoskeletal proteins such as spectrin 
(Sikorski et al., 1991; Sikorski and Goodman, 1991).  This overall reduction in synapsin 1 
reflected the UEC-induced clearance of presynaptic terminals seen in the rat studies of Chapter 
2.  In contrast to the MAP1B and N-cadherin studies, which did not show strain differences after 
injury, we did observe a significant attenuation of hippocampal 55 kD synapsin 1 loss compared 
 198 
 
to WT mice when OPN was absent.  This result suggests that the absence of OPN impairs 
synapsin 1 (and axonal terminal) clearance, which is, interestingly, quite similar to the effect of 
minocycline induced OPN reduction on synapsin 1 IHC signal in the rat studies of Chapter 2.  
While WT mice did not show regional differences in UEC-induced synapsin 1 expression, OPN 
KO mice did.  The 55 kD synapsin 1 reduction was significantly greater in the ML of OPN KO 
mice compared to hippocampus, consistent with a more critical OPN role in degenerating 
terminal removal in dendritic versus cell body enriched zones.  If this OPN influence on terminal 
removal is mediated through synapsin 1, it would be predicted that altered microglial migration 
and lower OPN expression in the ML would be correlated as well.  We did, in fact, see this 
correlation with synapsin 1-marked clearance of synaptic terminals following acute attenuation 
of the immune response in Chapter 2.  IHC staining for synapsin 1 in the dentate gyrus of WT 
and KO mice further supported poor removal of degenerating axon terminals when OPN 
expression is altered.  Loss of ML staining was incomplete in KO mice compared with paired 
WT animals, a finding similar to that of Chapter 2 rat studies following acute minocycline 
administration.  
Since both OPN reduction with minocycline and OPN KO attenuated the clearance of 
presynaptic terminals, and this clearance is dependent, in part, upon activation of ML microglia, 
we predicted that OPN KO mice would also show a different microglial response than WT after 
UEC.  As expected, IHC staining for activated microglia in uninjured hippocampus of WT and 
KO mice exhibited similar profiles of randomly distributed and ramified microglia.  After UEC, 
as in the rat model, microglia switched to an activated morphology and migrated to the border of 
the intact and injured dendrites, however KO microglia had longer processes with greater 
interdigitation between the dentate granule cell bodies, morphology similar to resting microglia.  
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While the postinjury pattern of microglial distribution was similar between strains, this 
difference in morphology suggests impaired ability to transform to full reactive state following 
deafferentation.  Similar reports of altered microglial morphology with increased process length 
compared to WT controls was previously reported by Maetzler and colleagues (2007) in MPTP 
models of PD. Attenuated synapsin 1 removal correlates with this altered microglia morphology 
in the KO,  also supporting OPN role in regulating microglial activation in the acute phases of 
trauma-induced synaptic plasticity.  In aggregate, our studies of synaptic markers from OPN KO 
mice subjected to UEC point to an instrumental role for OPN in mediating the efficacy of axon 
terminal removal in order to prepare the local environment for collateral sprouting and new 
synapse formation.  OPN achieves this role, in part, through its direction of microglial migration 
and activation during acute postinjury intervals.  The impact of these actions is to facilitate 
effective synaptic reorganization and return of function following CNS trauma. 
 
Osteopontin Knockout Mice and Cognitive Function 
In our examination of proteins marking the different components of injured synapses 
following UEC, synapsin 1 expression alone was found to be altered with OPN KO, while the 
loss of OPN failed to change postinjury expression of the cytoskeletal marker MAP1B or 
synaptic junction marker N-cadherin.  This attenuation of synapsin 1 degradation in the KO was 
consistent with reduced synapsin 1 removal at the intact and deafferented dendritic boundary of 
the rat UEC when OPN was suppressed by minocycline.  Further, OPN KO mice also showed an 
altered distribution of reactive neuroglia similar to that observed in Chapter 2 for the rat 
maladaptive TBI+BEC model, animals which have persistent cognitive deficits following 
deafferentation.  We interpret these findings as evidence that axotomized degenerating 
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presynaptic terminals are inadequately removed when OPN is lacking.  Since synapsin 1 is a 
molecule critical for both presynaptic terminal formation and neurotransmitter release, we 
reasoned that impaired removal of presynaptic terminals with ablation of OPN slows the 
necessary acute synaptic degeneration process, which delays new synapse formation, resulting in 
abnormal hippocampal connections and the associated cognitive deficits.  
To test whether OPN KO mice exhibited impaired cognitive function, we utilized the 
NOR test, a hippocampal-dependent task which takes advantage of rodents’ natural curiosity and 
exploratory behavior to test their capacity for long term memory recall.  NOR was first described 
in 1988 by Ennaceur and Delacour as a novel one-trial test to examine memory recall in rodents 
(Ennaceur and Delacour, 1988).  Here, animals are presented a series of 2-object sets which they 
are allowed to explore freely, and successful recall of an object results in a reduced exploratory 
time as this object is familiar and not as interesting.  Performance in this task is commonly 
calculated by the metric of RI.  This measure defines the percentage of time spent with the novel 
object divided by the total exploratory time.  A number of studies have demonstrated successful 
use of this paradigm, in TBI-induced damage, including assessment of hippocampal function 
following impact acceleration (Baratz et al., 2011; Siopi et al., 2012) or controlled cortical 
contusion (Han et al., 2011; Tong et al., 2013)  While OPN KO mice are considered to be 
developmentally normal, no studies have examined their behavioral characteristics pertaining to 
cognitive function, thus we first evaluated uninjured OPN KO mice to verify that their baseline 
behavior in the NOR task did not differ from paired WT control mice.  Uninjured naïve animals 
were capable of recalling the familiar object, with both strains spending 65-68% of their 
exploration time with the novel object.  While the uninjured WT animals, on average, spent more 
time with the novel object than the OPN KO animals, the RI values were not significantly 
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different, confirming that both strains had comparable hippocampal function in this test and no 
gross behavioral differences in attention, natural curiosity, or aversion to open field testing 
existed between the strains.  Following UEC injury, we focused on testing between 4-28d 
assaying behavioral status at the end of the OPN rich degenerative phase (4d), during the 
initiation of collateral sprouting (7d) and three times during the subsequent interval of synapse 
maturation and stabilization (14, 21 and 28d).   
At 4d postinjury, WT mice performed well, spending a significant amount of time with 
the novel object in order to perform above criterion performance at the task, and having an RI 
similar to WT uninjured animals.  This apparent behavioral compensation after UEC might be 
interpreted as an indication that the task was not sensitive enough to detect cognitive deficits in 
these mice.  An alternative, and more likely explanation, is that WT mice are able to generate 
sufficient activation for NOR behavior from the circuitry of the remaining intact contralateral 
hippocampal formation.  Interestingly, this result is consistent with more rapid and efficient 
cognitive recovery when entorhinal lesion is performed unilaterally versus bilaterally in the rat 
(Steward et al., 1977).  While OPN KO mice also spent more time with the novel object at 4d 
postinjury, RI values were significantly lower than WT animals, suggesting that the absence of 
OPN did alter functional status at the end of the acute degenerative phase of reactive 
synaptogenesis.  Moreover, this result supports the importance of the events occurring during the 
initial 1-4d postinjury period, including presynaptic terminal clearance and establishment of 
degenerative boundaries, each preparing the ECM for regeneration.  Importantly, we now have 
evidence that disruption of these events is temporally correlated with OPN loss and cognitive 
disruption.  During the 7-21 testing period several interesting differences in NOR RI measures 
were found.  WT mice continued to spend more than 50% of their time exploring the novel 
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object however, this group did show an interesting trend toward reduced RI at 21d of testing.  It 
is possible that this reduction in NOR for the WT mice  was caused by either shifts in  attention 
to the task at this time point, or alternatively, the extensive synaptic pruning and stabilization 
occurring in regenerated hippocampal circuitry at this postinjury interval.  The latter 
interpretation appears to be more likely since we found WT NOR performance at 28d had 
returned to a level equivalent to that of the 7d animals.  Interestingly, this reduction in task 
performance at 21d and rebound to higher RI at later time points, is similar to that reported after 
WT CCI, where mice with hippocampal damage showed improved NOR during the first two 
weeks after injury, reduction in performance at three weeks postinjury, and a return to higher RI 
values at four weeks postinjury (Han et al., 2011).  By contrast, OPN KO mice failed to reach 
criterion for NOR at 7d and, while they did show a trend toward better performance, the KO 
animals continued to fail at the task through the 21d testing period.  There was also no significant 
difference between the RI values of the two strains over 7-21d, likely the result of high variance 
in cognitive performance for the OPN KO group.  Interestingly, OPN KO mice did show 
recovery to above criterion performance at 28d postinjury, suggesting that the deficits in 
functional capacity can be compensated for by long term adjustments in hippocampal circuitry.   
The present NOR results, spanning degenerative-regenerative phases of synaptogenesis, 
indicate that loss of OPN does alter the reemergence of cognitive function typically observed 
during the first three weeks after UEC (Loesche and Steward, 1977; Steward, 1981).  
Performance is consistently lower than in paired WT cohorts subjected to UEC.  Our NOR data 
also suggest that rapid, extensive rise in OPN postinjury expression is critical to the timely 
evolution of functional synaptic reformation after CNS deafferentation.  Further, given our 
observations of reduced synapsin 1 degradation at 2d in the OPN KO, and the abnormal 
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persistence of synapsin 1 tagged presynaptic terminals in the rat when OPN is reduced, it is 
possible that change in OPN expression may underlie the NOR deficits seen at 4d compared to 
WT animals, and likely contribute to the slow, variable recovery of RI which follows.  This 
mechanistic link is plausible since the efficacy of LTP, one of the classic cellular templates for 
synaptic plasticity and memory formation, can be altered by the persistence of damaged synapsin 
1 containing presynaptic terminals (Sato et al., 2000).  In our OPN KO model, this may manifest 
itself in reduced hippocampal function at 4d postinjury, prior to synaptic sprouting.  The present 
results also show altered synapsin 1 levels in hippocampal tissue of KO mice, and associate a 
change in glial distribution with decreased hippocampal function in OPN KO mice.  These 
observations suggest that OPN direction of the cell-mediated immune response fostering proper 
synaptic terminal removal and ECM conditioning is critical to the generation of functionally 
adaptive reactive synaptogenesis.  Our NOR behavioral results are the first to demonstrate 
impaired cognitive function following CNS insult in OPN KO animals and is consistent with SCI 
studies which show that OPN null mice have impaired locomotor recovery compared to WT 
mice following crush injury (Hashimoto et al., 2007).  Clearly, OPN KO mice are a good tool for 
further probing the role of OPN in mediating axonal and dendritic response during trauma-
induced synaptic reorganization. 
 
Osteopontin and LCN2-Mediated MMP-9 Lysis of Osteopontin 
Previous results in Chapter 2 showed a correlation between the extent of trauma-induced 
MMP-9 activity and the postinjury level of the integrin binding 45 kD OPN.  Notably, acute 
minocycline administration attenuated UEC-induced OPN expression and reduced both MMP-9 
activity and 45 kD OPN.  Based upon these findings, we hypothesized that injured WT mice will 
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express elevated MMP-9 activity and, by contrast, OPN KO mice will have reduced enzyme 
activity.  We also posited that LCN2, a novel ECM regulator of MMPs, capable of binding 
MMP-9 to effect its persistent activation (Kjeldsen et al., 1993; Yan et al., 2001), will be 
increased in WT, and reduced along with MMP-9 activity in OPN KO mice.  To determine if 
LCN2-mediated MMP-9 activity contributes to generation of integrin binding OPN fragments, 
we utilized gelatin zymography and WB analysis to determine MMP-9 activity and LCN2 
expression in injured WT and OPN KO mice.  We found that, similar to rats, both mouse strains 
had elevated MMP-9 activity 2d after UEC.  While UEC-induced MMP-9 activity was 
significantly increased in both strains relative to contralateral controls, the elevation in KO mice 
was attenuated by 55% compared to that of WT mice, mimicking the effect of acute minocycline 
administration in Chapter 2.  These results suggest that, in the absence of OPN, MMP-9 activity 
is reduced, and further supports a role for MMP-9 in the processing of injury induced OPN.  It 
should be noted that, despite the significant reduction compared to WT mice, injury-induced 
MMP-9 changes in OPN KO mice remained significantly higher than controls, clearly indicating 
that MMP-9 is active in other proteolytic pathways besides that of OPN.  Since MMP-9 has been 
associated with oligodendroglial response after CNS insult (Kim et al., 2012; Seo et al., 2013), 
this MMP-9 inhibition in OPN KO mice suggests that MMP-9/OPN interaction may be 
important to the remyelination repair of damaged axons, as well as directing successful synaptic 
reorganization and axonal outgrowth.  While MMP-2 was elevated in both strains, it did not 
differ significantly from controls as was observed for rat UEC in Chapter 2, which again 
highlights species differences, and sample size effects.  
Given these differences in MMP activity between strains, we examined LCN2 response 
to injury in the same hippocampus and ML extracts evaluated for synaptic markers in order to 
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determine if MMP-9 binding to ECM LCN2 could regulate enzyme activity.  Recently, LCN2, 
an immune molecule which sequesters iron-containing pathogens, has been shown to contain not 
only a hydrophobic binding pocket, but also a ligand-binding domain for MMP-9 (see again Fig. 
3.1 C).  Specifically, LCN2 is capable of binding MMP-9 to persistently activate this protease 
within the ECM (Kjeldsen et al., 1993; Yan et al., 2001).  In our analysis, two principal WB 
signals at 130 and 55 kD were detected.  It is likely that the 130 kD band represents the MMP-
bound form of LCN2 (Park et al., 2009), and the 55 kD, a free form of LCN2.  Results showed a 
significant increase in both the 130 and 55 kD LCN2 within the hippocampus following UEC in 
WT and KO mice, however elevations in the OPN KO were significantly lower than that of WT 
mice.  Interestingly, this LCN2 reduction in the OPN KO hippocampus was proportional to the 
reduction in hippocampal MMP-9 activity, implicating involvement of LCN2-mediated MMP-9 
activation in the processing of OPN for effective synaptic reorganization.  Within ML-enriched 
extracts, WB analysis showed a significant increase of both LCN2 forms following UEC in both 
WT and OPN KO mice compared with controls, however alterations in LCN2 did not 
statistically differ between strains.  Interestingly, there were no regional difference in KO mice, 
but WT mice showed hippocampal LCN2 elevation which was significantly higher than that of 
the ML.  This finding suggests LCN2-mediated OPN function is not concentrated within the ML, 
but important in heavily OPN positive cellular laminae as well.  Further, IHC for LCN2 supports 
WB elevations within the hippocampus of WT and OPN KO mice, staining which is pronounced 
in the deafferented ML.  Together, these results suggest a time-dependent link between OPN, the 
immune response, and MMP-9 activity during acute postinjury intervals.  They also support 
LCN2-MMP-9 activation as a mechanism for processing of OPN signals which contribute to the 
generation of effective functional recovery.  
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SUMMARY 
The experiments of this chapter utilized the OPN KO mouse to test OPN involvement in 
the acute phase of reactive synaptogenesis, complementing the profiling of OPN elevation after 
hippocampal deafferentation discovered in Chapter 2.  Relative to injured WT control mice, 
OPN KO subjected to UEC exhibited an attenuated breakdown of synapsin 1, pointing to OPN 
role in presynaptic terminal removal during the acute degenerative phase of reactive 
synaptogenesis.  OPN KO IHC suggested this response is mediated through reactive microglia, 
and NOR behavioral testing revealed postinjury cognitive deficits when OPN is absent.  A final 
set of experiments support LCN2 activation of MMP-9 as a novel mechanism for generating 
integrin binding OPN fragments to signal these changes.  
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CHAPTER 4 
 
GENERAL DISCUSSION
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SUMMARY OF RESULTS 
In Chapters 2 and 3 we presented the mRNA and protein profile of full length OPN and 
MMP-processed lytic fragments within the rodent hippocampus following TBI.  The pattern of 
OPN response was contrasted between adaptive UEC, and maladaptive TBI+BEC  forms of 
synaptic plasticity, with expression compared between whole hippocampal and enriched extracts 
of the denervated ML.  Our results showed an elevation of OPN within 2d postinjury, having 
similar quantitative, but different qualitative changes in OPN for the two models.  In order to 
explore the specific role of OPN in the degenerative phase of adaptive synaptic plasticity, we 
administered minocycline to suppress the immune response and OPN production in rats, and 
utilized OPN KO mice to determine the effect of removing OPN on synaptic proteins critical to 
trauma-induced structural reorganization of hippocampal synapses.  Importantly, OPN 
deficiency altered the expression of synaptic proteins, as well as the reactivity of endogenous 
neuroglia and their tissue distribution, switching UEC adaptive synaptogenesis into a process 
similar to that of the maladaptive TBI+BEC model.  Interestingly, behavioral studies utilizing a 
hippocampal-dependent cognitive task confirm that OPN loss contributes to poor functional 
outcome after brain injury, and is correlated with these structural and cellular changes.  
Collectively, the studies of this dissertation show that OPN response is important to the success 
of the acute recovery phase induced by TBI deafferentation.  They specifically point to the 
production of OPN fragments by LCN2-mediated MMP-9 lysis, peptides that have the capacity 
to promote time-dependent chemotaxis and activation of both microglia and astroglia during the 
degenerative and regenerative phases of reactive synaptogenesis.  Therefore, we conclude that 
OPN may be a novel target for future therapeutics designed to improve the early stages of 
functional recovery following TBI. 
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 In Chapter 2, OPN protein was robustly elevated in the acute phase (1-2d) following 
UEC and TBI+BEC, highlighting the importance of its role as an inflammatory cytokine.  
Analysis of MMP-generated OPN fragments revealed precise temporal profiles associated with 
specific forms, suggesting multiple roles for OPN after trauma.  Specifically, a 45 kD fragment 
was elevated early (1d) after injury, while a 32 kD form was elevated later during sprouting (7d).  
These results suggest this 45 kD protein may be more important in clearance of degenerating 
presynaptic terminals, while the 32 kD form may play a role in synapse regeneration.  Further, 
IHC localization of OPN in reactive microglia and astroglia that demarcate the border between 
intact and injured dendrites, suggests that OPN/glial interaction is key for recruitment, migration, 
and phagocytic activation of additional glial cells.  This OPN/glial interaction was further 
supported by transcript localized to active microglia within the injured dentate, identifying these 
cells as a source of acute OPN.  Additional studies which showed minimal colocalization of OPN 
to proteins important in cytoarchitectural morphing such as MAP1B, suggests that this acute 
OPN response is less likely to be involved with structural reorganization during the acute phase 
(1-2d), but rather, indicates a more prominent role for OPN in chemotaxis and degeneration.  
Interestingly, while the comparison of the OPN/glial response between maladaptive TBI+BEC 
and adaptive UEC revealed similar OPN expression profiles, cellular analysis suggests that OPN 
mediates the more subtle changes of glial distribution to mark boundaries of tissue damage, a 
process that is disturbed with maladaptive conditions.  Finally, acute minocycline administration 
2d after UEC impaired trauma-induced OPN response, and altered the distribution of OPN-
containing glia, again producing conditions that mimic maladaptive TBI+BEC.  These OPN 
signals appear to involve specific MMP generated fragments since reduction of immune 
activation lowered MMP-9 activity and MMP-cleaved 45 kD OPN fragment production.   
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Taken together, this robust OPN elevation following trauma, which is localized to 
reactive glial cells within the injured zone, and is correlated with MMP-9 activity and generation 
of 45 kD integrin binding fragments, supports OPN as critical to the progress of the degenerative 
phase of reactive synaptogenesis.  The fact that acute attenuation of the immune response 
impaired this potentially beneficial OPN/glial interaction led us to investigate the effect of 
complete OPN ablation during trauma-induced synaptic regeneration utilizing OPN KO mice.  
Chapter 3 results further supported the importance of OPN efficient synaptic recovery after TBI 
as OPN KO mice had impaired hippocampal function compared to WT mice during the window 
of preparation for synaptic sprouting (4d postinjury).  While trauma-induced changes in 
cytoarchitectural (MAP1B) or junction stabilizing (N-cadherin) proteins did not differ between 
OPN KO and WT mice, there was a significant impairment in the breakdown of a protein 
marking presynaptic terminal removal during degeneration (2d) after UEC.  Synapsin 1 protein 
clearance was inhibited in OPN KO mice, a finding localized to the OML innervated by lesioned 
entorhinal neurons.  This impairment correlated with microglia of altered morphology, including 
longer cytoplasmic processes that mimicked a ramified state.  OPN KO mice also had reduced 
trauma-induced MMP-9 activity and LCN2-bound MMP-9, supporting known roles in 
LCN2/MMP-9 and MMP/OPN function.   
Collectively, these results suggest the following sequence of events after TBI: 1) 
hippocampal deafferentation induces the acute inflammatory response including activation of 
microglia, 2) microglia secrete extracellular OPN, 3) local activated MMPs cleave OPN into 
functional signaling fragments, 4) OPN signals cell migration in the acute degenerative phase to 
direct microglia in the removal of injured terminals, and 5) microglia signal recruitment of 
reactive astroglia during the initiation of sprouting, which then secrete factors important in 
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synaptic regeneration.  Further, our initial mechanistic studies suggest the generation of various 
OPN functional fragments is regulated upstream through LCN2 persistent activation of MMP-9 
within the local ECM, facilitating an adaptive, neuroregenerative, rather than maladaptive, 
attenuated recovery after CNS injury. 
 
OSTEOPONTIN AND THE INFLAMMATORY RESPONSE 
            These studies examining the role of OPN during synaptogenesis have widened our view 
of how this cytokine and the immune response as a whole may affect the recovery process 
following deafferentation induced by TBI.  Importantly, these studies highlight the role of acute 
inflammation in the preparation of synaptic sprouting during effective synapse repair.  UEC and 
TBI+BEC in rats, and UEC in mice, all resulted in acute, robust OPN response to 
deafferentation, which preceded molecular responses associated with the removal of injured 
terminals during degeneration.  OPN elevation was documented 1d after injury, and peaked at 2d 
following UEC and TBI+BEC rats, a response considered to be an early response with regard to 
the molecular mechanisms which occur during synaptic reorganization.  However, in other 
models of TBI, such as impact acceleration, cytokines such as chemokine CC ligand-2 (CCL2), 
also known as monocyte chemoattractant protein-1 (MCP-1), have been shown to increase as 
early as 4 hours after CHI, and peak at 12 hours postinjury, a much more acute and brief 
cytokine response.  These examples of varied cytokine response profiles point to the importance 
of: 1) the model or injury condition which induces the inflammatory response, 2) the type of 
cytokines which respond, and 3) the temporal span of the immune system response.  It is possible 
that focal deafferentation induces a very specific cytokine response related to synaptic repair, 
while more diffuse insults which induce global brain injury, including diffuse BBB disruption, 
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resulting in the nearly immediate cytokine release into local brain regions.  As our studies are 
focused on synaptic changes after injury, we did not evaluate time points earlier than 24 hours 
postinjury, however our observations of peak OPN postinjury expression strengthen the potential 
for different cytokines, or in this case, distinct OPN functional fragments, to act in different roles 
at different time points following deafferentation.  Given that results showed significant increase 
in the 45 kD OPN form 1-2 postinjury, it is possible that this functional fragment is specifically 
responsible for the cell signaling of the acute response during degeneration.  Since this fragment 
has an exposed RGD sequence, it is capable of interacting with integrin receptors such as 
vitronectin (αvβ3), a receptor which has been shown to modulate chemotaxis, and CD44, a 
receptor important in the inflammatory response.  Stroke models have documented the 
concurrent increase in αvβ3, CD44, and OPN, strengthening the possibility that OPN functions to 
signal microglial movement to the site of deafferentation during the acute immune response 
(Kang et al., 2008).  In addition, colocalization of these receptors with OPN also suggests that 
later elevations in the 32 kD form at 7d postinjury may permit OPN to function as an astrokine, 
as this fragment contains the highly conserved C-terminus.  This terminus has the potential for a 
number of functions within the ECM due to extensive posttranslational modification (Kazanecki 
et al., 2007a; Kazanecki et al., 2007b) and the ability to bind directly to the αvβ3 receptor 
(Christensen et al., 2012). 
While such results implicate a neuroprotective role for OPN following TBI 
deafferentation, consistent with studies in ischemia and SCI, they are in direct contrast to other 
studies in MS, PD, and AD which indicate OPN is a detrimental molecule, inducing 
neurodegeneration.  A variable potentially mitigating the differences in outcome following TBI 
expression is the temporal window during which OPN is expressed.  One characteristic shared by 
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AD, PD, and MS is the chronic nature of these diseases as opposed to the acute injury paradigm 
in ischemia, SCI, or TBI.  Previous studies have demonstrated persistent microglial activation in 
neurodegeneration, such as occurs with the development of PD (Block and Hong, 2005), 
suggesting chronic OPN expression may underlie the detrimental neurodegeneration seen in MS 
and PD, while acute robust OPN may be responsible for facilitating repair.  Given that OPN and 
microglia interact via integrin and CD44 receptors, it is conceivable that persistent OPN 
signaling leads to chronic microglial activation, and subsequent neurodegeneration seen in AD 
and PD.  Further, clinical evidence indicates OPN expression can be coupled with microglial 
activation in chronic CNS diseases, including PD and HIV-induced cognitive deficits (Burdo et 
al., 2008; Brown et al., 2011).  Together, these studies support the concept that the environment 
in which OPN cellular interaction occurs may determine whether OPN functions as a beneficial 
or detrimental molecule with respect to long term outcome following CNS injury or disease.  
 In contrast to the detrimental effects of OPN involved with chronic CNS disease, are 
models like ischemia, stroke, and SCI, which demonstrate that OPN may act in a reparative role 
during recovery and that OPN manipulation may promote recovery.  These studies have utilized 
cell culture and in vivo models with OPN KO mice to demonstrate that the absence of OPN 
results in larger infarct size and poor neurological recovery, a finding similar to our studies 
which showed OPN KO mice had delayed clearance of the injury site and worse hippocampal 
function at 4-21d postinjury.  Further, stroke studies have shown that postinjury administration 
of r-OPN can reverse the exacerbation of injury seen in KO animals, returning the injury profile 
to a state similar to that of WT animals.  Models of SCI have examined mechanisms underlying 
the greater core injury and worse locomotor recovery in OPN KO mice, suggesting OPN may 
modulate effective axon terminal and synaptic outgrowth.  Together, these models suggest OPN 
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may be beneficial in directing the immune response to facilitate effective synaptic recovery in 
acute traumatic conditions.  
Further evidence that the environmental conditions play a role in OPN immune effect on 
the neuronal outcome is seen with its potential for shifting a neuroprotective acute response into 
a detrimental neurodegenerative outcome.  Often TBI patients suffer polytrauma, such as that in 
a fall or motor vehicle accident, inducing multiple injuries including bone breaks.  More recent 
evidence indicates that multiple peripheral injuries could have worsening effects on TBI 
recovery.  OPN is a protein found in high levels within osteoclasts and osteoblasts during bone 
remodeling, and it is conceivable that TBI patients, who are often victims of polytrauma and/or 
skull fracture, may be subject to exacerbated CNS injury due to excessive OPN infiltration from 
multiple injury sites.  Bone breaks could prolong OPN response due to long term infiltration 
from other injury locations, and induce a chronic inflammatory response consistent with 
neurodegeneration.  For example, recent studies by Degos and colleagues indicate that when 
ischemic insult is compounded by tibial fracture,  CNS injury is exacerbated, inducing larger 
infarct volumes and excessive microglia in the periinfarct region (Degos et al., 2013).  As breaks 
far from the ischemia injury permit excessive glial cell localization to injury, local skull fracture 
may even further exacerbate pathology in human TBI cases, as mechanical stress in bone alone is 
capable of induce OPN expression in osteocytes (Denhardt and Noda, 1998; Terai et al., 1999; 
Nomura and Takano-Yamamoto, 2000).  When considered with our present results, these studies 
offer support for the importance of OPN/microglial interaction during immune signaling which 
directs the acute postinjury recovery period, suggesting further investigation into these, and other 
immune molecules may provide insight into novel therapeutics to treat TBI patients.  
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OSTEOPONTIN-MICROGLIAL INTERACTION DURING THE IMMUNE RESPONSE 
 Microglia are known to be key players during the acute CNS inflammatory response and 
chronic disease neuropathogenesis.  In our studies, OPN mRNA was localized to active 
microglia, and OPN protein prominently localized to these reactive cells at the border of 
deafferentation.  While our studies,  as well as others in ischemia and stroke, have demonstrated 
that microglia are indeed a source of OPN, it is likely that OPN and microglia also interact in the 
acute immune response to effect synaptic reorganization.  We have previously discussed the 
potential for exposed ligand binding sites on OPN permit interaction with αvβ3 or CD44 
receptors on microglia to facilitate chemotaxis and phagocytosis for debris clearance after injury.  
Interestingly, more recent descriptions of multiple microglial phenotype expression after CNS 
insult suggest that their role may be either beneficial or detrimental depending upon their specific 
phenotype.  Two microglia phenotypes are currently known to exist: 1) M1 classic macrophages, 
which are produced in reaction to proinflammatory cytokines, such as TNF-α and IL-1β, often 
associated with phagocytosis in neurodegeneration and cell damage, and 2) M2 microglia, which 
are an alternative form, reacting to ECM molecules to secrete factors such as transforming 
growth factor-β (TGF-β) and IGF-1 in neuroreparative mechanisms (Boche et al., 2013).  As an 
ECM molecule, it is possible that OPN promotes phenotype switching to the M2 type, directing 
microglia to facilitate chemotaxis and phagocytosis in repair and remodeling of the ECM as 
opposed to detrimental degeneration.  Porcine cell culture studies have shown that exogenous 
OPN alters microglial state, inducing proliferation and phagocytosis (Tambuyzer et al., 2012), 
two functions which are supported by our IHC results showing activated microglia colocalized 
with OPN near injured axon terminals.  In addition, these porcine studies demonstrated that OPN 
reduces super oxide production and NOS, supporting a switch to the M2 phenotype for 
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neuroprotection.  Published reports have documented the presence of different subsets of 
microglia after TBI (Hsieh et al., 2013), and that the proportion of M1/M2 microglia may affect 
neurological outcome after TBI, where aged rats who expressed an increased number of M1 
proinflammatory microglia exhibited poorer neurological function (Kumar et al., 2013).  Other 
studies which indicate inflammation can be persistent for years after TBI (Smith et al., 1997; 
Bramlett and Dietrich, 2002) also suggest targeting the ability of OPN to facilitate expression of 
beneficial microglial phenotypes may be of therapeutic benefit to improve synaptic recovery 
after TBI. 
 
OSTEOPONTIN AND SYNAPTIC PLASTICITY 
While OPN may function to facilitate a neuroprotective microglial phenotype, the exact 
mechanism by which this occurs in unknown, and the extent to which OPN mediates other cell 
types during synaptic recovery is not clear.  Several models of TBI have shown that 
inflammation alone can alter the generation of new neurons following insults (Das and Basu, 
2008; Bye et al., 2011), supporting broad effect of inflammatory molecules on regeneration.  Our 
results in Chapters 2 and 3 indicate that at least two functional fragments of OPN, generated 
through proteolytic processing, may be responsible for the pleiotropic function of OPN during 
TBI recovery.  During the acute degenerative phase, OPN can be localized in both microglia and 
astrocytes, however its transcription appears restricted to microglia.  Further, we have 
demonstrated trauma-induced ECM production of a MMP-generated 45 kD OPN fragment 
containing the RGD binding motif, as well as a 32 kD, C-terminus-containing peptide.  Given the 
acute (1-2d) elevation of this integrin binding 45 kD fragment, the protein may serve to 
selectively localize microglia at the site of injury and permit their recruitment of reactive 
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astrocytes to assist in matrix mediated synapse degradation (Fig. 4.1).  It may also enter damaged 
neurons, interacting intracellularly with either dendritic or axonal cytoskeleton to facilitate 
reorganization of injured postsynaptic spines or axon terminals in preparation for sprouting and 
synaptogenesis.  It is also possible that there is a delayed secondary OPN response as evidenced 
by elevation in the 32 kD form 7d postinjury.  Given that MAP1B staining returns at this time in 
the rat, regeneration may occur by interacting with this cytoarchitectural protein, or alternatively 
through signaling with astroglia as suggested by the late OPN response that colocalized with 
reactive astrocytes in stroke models. 
Contribution of OPN to microglial switching from a degenerative to a protective state 
may further direct a number of downstream beneficial processes.  For example, microglial 
phenotype switching may provide a signal that permits upregulation of 32 kD OPN, which 
further allows OPN to act as an astrokine.  Reactive astrocyte recruitment to the site of injury at 
later time points has been demonstrated in models of stroke and ischemia (Ellison et al., 1998; 
Ellison et al., 1999), and most recently in preliminary studies in our lab showing colocalization 
of OPN on GFAP positive cell bodies as late as 15d postinjury (see Appendix E).  In addition, 
these preliminary IHC studies have shown that CD44 colocalizes with these reactive astrocytes, 
further supporting the potential for OPN to act as an astrokine, facilitating regenerative repair 
mechanisms (Fig. 4.2).  As OPN has been correlated with neurite outgrowth in brain stab injury 
(Plantman, 2012), and a modulator of axonal outgrowth in sciatic nerve transection (Jander et al., 
2002), it is possible that alternative forms of OPN, yet to be explicitly identified, are expressed at 
later time points, facilitating the plasticity supporting the improved NOR performance seen in 
WT mice at 28d postinjury.  Astrocyte recruitment, and implementation of their functional role 
during recovery, may lie in the production of growth factors such as brain derived neurotrophic  
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Figure 4.1 Cytokine-Astrokine Signaling During Degeneration.  At 2d postinjury, 
microglia become activated, secreting OPN.  Lipocalin-mediated MMP lysis of OPN exposes 
functional ligands to permit interaction with integrin receptors such as those on astrocytes. 
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Figure 4.2  Cytokine-Astrokine Signaling During Regeneration.  At 2d postinjury, 
microglia become activated, secreting OPN.  Lipocalin-mediated MMP lysis of OPN exposes 
functional ligands to permit interaction with integrin receptors such as those on astrocytes. 
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factor (BDNF) (Quesseveur et al., 2013), nerve growth factor (NGF) (Goss et al., 1998), and 
IGF-1 (Madathil et al., 2013)  shown to promote neurogenesis and neurorecovery.  BDNF has 
been shown to increase in response to TBI (Hicks et al., 1997), and linked to improved cognitive 
functioning after injury as shown by performance in the MWM task (Griesbach et al., 2009).  
Together, these studies suggest that an alternative form of OPN may function to promote 
effective synaptic plasticity during sprouting 7d postinjury. 
 In addition to cellular signaling for astrocyte facilitation of synaptic repair, it is possible 
that microglial secreted OPN indirectly interacts with molecules like neuronal MAP1B as the 
dendritic cytoskeletal reemerges at 7d postinjury.  This is supported by the fact that we found 
some MAP1B/OPN colocalization within microglia at this regenerative phase.  However, due to 
the few number of microglia colocalizing with OPN, it is unlikely that this OPN pathway plays a 
major role regulating synaptic formation While other studies show that intracellular OPN can 
bind to MAP1B (Long et al., 2012), it seems unlikely that such OPN binding is critical during 
reactive synaptogenesis since we did not observe OPN/MAP1B interaction with IHC during 
periods of neuronal growth.  Nevertheless, our experiments were limited, and it remains possible 
that a specific OPN fragment which we do not have the tools to visualize, binds MAP1B, or that 
astroglia employ OPN to indirectly support cytoskeletal reorganization during sprouting and 
synapse stabilization.  Interestingly, one structure in the adult CNS which has abundant MAP1B 
expression is the olfactory bulb (OB), and recent studies in our laboratory have demonstrated 
that rodents subjected to central fluid percussion injury show altered OPN response in their 
damaged OBs.  While we have not yet probed MAP1B expression in this model, we do have 
evidence of OPN activation after injury in the OB during synaptic plasticity.  Following TBI, 
olfactory axons may stretch as a result of acceleration and deceleration forces, causing injury 
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which manifests in anosmia, a common complaint in TBI patients (Reiter et al., 2004; Costanzo 
et al., 2012).  In our mild-moderate fluid percussion injury in mice, we have demonstrated 
ultrastructural evidence of injured olfactory axons, as well as OB spectrin proteolysis.  
Interestingly, in this alternative deafferentation model, and within a different region of the CNS, 
OPN is also upregulated within the glomeruli and olfactory nerve layer of the injured OB at 3d 
after TBI.  OPN also colocalizes with IBA1 at this early time point, and is found within olfactory 
ensheathing cells (OECs), specialized OB glial cell types important in the turnover of new 
synaptic connections.  These data further support the importance of OPN interaction with 
reactive glial cells following TBI, again highlighting early glial interaction.  It is possible that 
MAP1B directly interacts with OPN in this MAP1B-rich environment during the turnover of 
olfactory synapses.  We also know that MMP-9 activity is elevated in the deafferented OB, from 
our own TBI results (Appendix D), as well as published studies (Bakos and Costanzo, 2011).  
This MMP change fits well with our working hypothesis that OPN is lysed to facilitate local cell 
signaling properties in different regions of the CNS undergoing neuroplasticity after TBI.  Our 
results in the deafferented hippocampus and OB emphasize the role of the environment in OPN 
mediation of synaptic recovery.  Mechanism of injury and location in the CNS are important 
factors which contribute to the time frame during which OPN is expressed and induces its 
subsequent effects. 
Taken together, our biochemical and morphological data indicates that the cytokine OPN 
affects recovery processes important in memory and cognition.  Interestingly, recent studies have 
shown that, even in the absence of trauma, immune molecules can alter cognitive function 
(Kipnis et al., 2012).  In the case of OPN, we found that loss of this cytokine did not produce 
deficits in NOR performance for uninjured mice, whose RI scores did not differ from uninjured 
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WT animals.  This result points to a less critical role for OPN in normal synapse stabilization, 
but rather an important role in CNS recovery following injury as suggested by studies in bone 
(McKee et al., 2011) and cardiovascular (Murry et al., 1994) repair.  Following deafferentation 
in our model, NOR deficits emerged in OPN KO mice, specifically associated with the transition 
between degenerative and regenerative phases (4-21d), while injured WT did not show such 
deficits.  The fact that NOR deficits evolved during this time frame further supports our posited 
role for OPN as a critical immune mediator of microglial and astroglial function during 
successful synaptic  recovery.  As a molecule which has the ability to recruit microglia and 
activate T-lymphocytes, OPN may be critical to immune-mediated synaptic reorganization as 
evidenced by studies which demonstrate that T-cells and microglia contribute to the acquisition 
of spatial memory in adult rodents (Ziv et al., 2006).  Further, studies have shown that the 
absence of specific cytokines, such as T-cell-derived IL-4, impairs cognitive performance in the 
MWM task (Derecki et al., 2010).  The role of the immune system in neurocognitive disease 
provides a potential target for therapeutic intervention in CNS injury and disease states, as 
various studies in patients and experimental models of SCI, neurological disease, and HIV-
associated dementia (Kipnis et al., 2008; Gensel et al., 2012; Derecki et al., 2013) have 
demonstrated a connection between the immune system and neuroprotective function.  Overall, it 
appears that OPN has minimal action as a baseline immune humoral defense in the rodent brain, 
but serves a highly important role when the brain is challenged with mounting an acute response 
to injury, supporting not only structural, but also functional recovery.  
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OSTEOPONTIN AS A PROMISING TARGET OF THERAPEUTIC INTERVENTION 
         Given its robust elevation after CNS trauma, OPN has potential as a marker to predict 
outcome or a target for therapeutic treatment, the latter of which might be achieved either 
directly or by manipulation of its upstream OPN regulatory pathways.  Several studies have 
proposed the use of OPN as a biomarker for head and neck cancer, and a marker of ongoing MS 
inflammation, but it has yet to be considered as an index of TBI outcome.  While a single 
molecule is unlikely to have a well-defined predictability for different treatment modalities, OPN 
could be one of multiple cytokines or chemokines used in screening panels in order to profile 
patients for specific treatments.  Several clinical studies in MS, PD, AD, and HIV, have 
correlated elevated OPN serum levels with active pathology or cognitive deficits, suggesting that 
those TBI patients who have long term, elevated OPN may be susceptible to excessive 
neurodegeneration.  While many have considered targeting OPN in treatment of these chronic 
diseases, none have addressed the importance of the temporal window in which OPN is 
expressed, or the extent of its activity.  OPN expression in short response windows may be 
beneficial, allowing the switch from M1 to M2 type microglia, promoting neuroprotection.  
Similarly, controlling the expression of OPN directly, or through upstream 
regulators such as MMPs and LCN2, may provide more precise treatment for the ongoing 
sequelae in TBI as opposed to globally removing or administering a molecule as a single therapy.  
Our studies indicate OPN/MMP interaction, and upstream LCN2 regulation of OPN proteolysis, 
may be alternative methods used to modulate the effects of OPN in the process of 
neuroplasticity.  As previously described, it is not likely OPN acts alone in the neurorepair, but 
contributes to a complex series of molecular events which result in the smooth transition between 
neurodegeneration and neuroregeneration.  Ultimately, combinatorial treatments which include 
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selective manipulation of the chronic inflammatory response, and inhibition of persistent MMP 
activation, may focus the OPN/MMP/LCN2 pathway in the acute phase, prohibiting detrimental 
neurodegeneration. 
 
FUTURE DIRECTIONS 
OPN is a promising molecule for targeting in TBI therapeutics and requires further 
investigation regarding its potential role as a cytokine which might predict TBI outcome. OPN 
activation during the acute and chronic inflammatory responses can direct both degeneration and 
repair, clearly a complex process involving numerous cell types and ECM proteins.  Due to the 
posited pleiotropic functions of OPN following CNS injury, additional studies utilizing OPN KO 
mice will be important in determining more specific details about postinjury molecular changes 
in the absence of OPN.  First, generation of a TBI+BEC mouse model would help identify 
differences between adaptive and maladaptive synaptic plasticity in the context of OPN KO, 
providing additional structural and functional outcome data.  Probing for various OPN fragments 
between these models may further delineate the specific OPN forms which direct different 
aspects of plasticity after TBI.  In addition, integrin receptors likely play a role in the action of 
these fragments, as described by previous ischemia studies demonstrating that antagonists to the 
integrin-binding GRGDS sequence inhibited OPN function and ischemic recovery, a process 
which can be rescued by r-OPN administration (Suzuki et al., 2010b).  Further, electron 
microscopy and electrophysiological analyses will provide a more precise understanding of how 
postinjury synaptic structure and function are affected by OPN ablation.  While these studies 
would be effective in addressing endpoints specifically related to synaptic recovery, generation 
of cytokine panel assays would extend our understanding of how OPN affects other 
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inflammatory molecules during deafferentation-induced plasticity.  Ultimately, performing 
additional cytokine and synaptic plasticity studies may link specific molecular components in the 
inflammatory response associated with neuroprotection following TBI.   
Extending our postinjury time course beyond 7d over all of these endpoints may be 
particularly insightful, as we observed a reduction in OPN KO NOR deficits at that time point, 
suggesting a shift in OPN influence on synaptic recovery with the progression of time.  Further 
characterization of OPN KO mice regarding the ultrastructural synaptic changes and tract tracing 
for collateral sprouting would also enhance our understanding of how OPN might operate to 
permit effective synaptic plasticity after injury.  Electrophysiological examination of LTP during 
recovery intervals where OPN appears most critical will provide additional insight as to what 
part of the synaptic recovery process underlies behavioral deficits observed in the absence of 
OPN.  In addition, given that other studies indicate OPN is an upstream regulator of other 
cytokines such as MCP-1 (Zhang 2010), cytokine assays over a more complete postinjury time 
course could be performed to broaden the view of how OPN affects the inflammatory process as 
a whole, and the subsequent downstream effects related to synaptic plasticity.   
Most importantly, examination of OPN and its regulation during the later stages of 
synaptic plasticity, including synapse stabilization and maturation, is critical.  Specifically, time 
points between 14 and 28d utilized in the present NOR testing would help determine if there are 
structural correlates which explain the WT drop in NOR performance at 21d, and rebound seen 
at 28d.  As the similarity between TBI+BEC and UEC rat OPN profiles were only determined 
during acute recovery, it is possible that OPN may respond differently in the maladaptive model 
at the later phases of sprouting and synapse stabilization.  It would also be interesting to contrast 
the two models in WT and OPN KO mice, particularly the investigation as to whether OPN 
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status would switch adaptive into maladaptive outcome or vice versa.  If loss of OPN indeed 
induces poor synaptic recovery, we anticipate the ultrastructure of synapses of OPN KO mice 
would look similar to synaptic disorganization in a mouse subjected to maladaptive TBI+BEC.  
Likewise, electrophysiological recordings in both TBI+BEC and OPN KO UEC mice might 
reveal common alterations in electrical signaling, correlating abnormal structure with impaired 
hippocampal function.  We have previously reported alterations in LTP formation following 
MMP inhibition, a finding which might be replicated in OPN KO UEC and TBI+BEC mice.  
Together, these studies would extend the temporal profile of OPN effects in synaptic 
reorganization following TBI, providing additional endpoints which might address structural and 
electrophysiological evidence of altered neuronal function in the absence of OPN. 
While removing OPN may help confirm the importance of this cytokine as beneficial to 
synaptic recovery after injury, further studies which demonstrate rescuing impaired function 
would also strengthen this hypothesis.  One approach would be to test r-OPN administration in 
OPN KO UEC or WT TBI+BEC mice as an attempt to convert a maladaptive animal into an 
adaptive model of synaptic plasticity.  Interestingly, several studies have already demonstrated 
that administration of OPN prior to or following ischemic injury, reduces infarct size, stabilizes 
the BBB, and improves neurological scores (Suzuki et al., 2010a; Wu et al., 2011b; Suzuki et al., 
2011).  Unfortunately, no studies have examined the effect of this treatment on hippocampal 
cognitive function or ultrastructural effects on dendritic morphology and improved synaptic 
plasticity after injury.   
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FINAL REMARKS 
In conclusion, the results from this dissertation study highlight the potential for OPN to 
modulate deafferentation-induced synaptic plasticity during both the degenerative and 
regenerative phases of reorganization, acting in the acute inflammatory response to condition the 
matrix for sprouting, and subsequently influencing the cellular and molecular pathways 
responsible for effective synaptic recovery.  Alterations in structural and functional recovery in 
rodents implicate that this cytokine has the ability to modify the ECM of the hippocampus to 
promote regeneration.  While previous studies have suggested that immune molecules may serve 
as future therapeutic targets in the treatment of CNS injury, this study is the first to provide 
evidence that a specific cytokine has the potential to direct the immune response within reactive 
neuroglia during neuroplasticity, as well as facilitate structural reorganization and cognitive 
recovery under conditions of TBI-deafferentation.  Overall, these results give greater insight into 
the relationship between the immune response and effective synaptic recovery following CNS 
injury.  Further characterization of OPN and its interaction with immune cells and matrix 
molecules following trauma may ultimately assist in the development of novel treatments which 
reduce persistent impairment and bolster effective recovery in TBI patients.
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Affymetrix Rat Genome Microarray Screening
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Table A-1  7d Rat OPN (SPP1) Microarray Values: Fold Change Over Paired Control 
 
 
 
 
UEC TBI+BEC 
Hippocampus 13.6 40.5 
Molecular layer 21.1 5.5 
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Novel Object Recognition Paradigm
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Specific Novel Object Recognition Apparatus Setup 
 For the NOR paradigm, we utilized a black Plexiglas box (DIMENSIONS 90 x 90 x 45 
cm
3
) divided into 4 identical quadrants (42 x 42 x 30 cm
3
) (Fig. B-1).  Each square served as an 
individual habituation/familiarization/testing chamber for a single animal at a single postinjury 
time point, allowing four animals to be run at once, and maximizing efficiency.  As described in 
Chapter 3, four groups were compared:  naïve WT, naïve OPN KO, WT subjected to UEC, and 
OPN KO subjected to UEC.  On the first habituation day, animals were randomly assigned to a 
quadrant, and habituated to the environment as described in Chapter 3.  This same quadrant was 
used for the animal in both familiarization and testing phases as described in Chapter 3 until the 
task was completed for the specific time point.  Starting with the upper left quadrant, and rotating 
clockwise, animals were placed in their designated quadrant, and five minutes of exploration 
recorded following a one minute delay to standardize data recording.  For each subsequent time 
point, animal placement was rotated clockwise to the next quadrant to avoid any inherent bias 
regarding the quadrant itself, or placement within the room.  To prevent bias induced by long 
term memory recall, animals were exposed to a different novel Lego® object at each time point 
by assigning each quadrant to specific sets of novel objects.  Ultimately, each animal was 
exposed to unique single quadrant-novel-object paradigm at a different time point, preventing 
any potential bias due to the novel object itself, quadrant placement, or time-point-specific 
quadrant-object paradigm. 
 
63d Novel Object Recognition Study 
 Prior to the 28d NOR study, a longer 63d study comparing the hippocampal function of 
WT C57BL/6 and OPN KO mice was  performed.  In this task, the parameters and methods used 
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were the same as the 28d study described above, with the exception that the familiar object 
consisted of Lego® shapes with alternative configurations as opposed to a 50 ml conical tube.  
Thus, the animals were challenged to discriminate between two Lego® configurations in 
performing the NOR task.  Throughout the 63d study, the RI of WT and KO animals was not 
significantly different from chance alone, nor were the RI measures between strains with or 
without injury.  The null results of this prior 63d study, using only Lego configurations, may not 
be surprising given that previous behavioral studies in  mice show that these rodents utilize a 
number of cues, including vision and whisker-mediated tactile response, as well as olfactory 
input, during typical exploratory behavior (Brown and Wong, 2007).  It is likely that the 
similarity of texture and composition outweighed the visually detected differences in the objects, 
resulting in a failure to detect experimental effect.  In fact, a recent comprehensive study of 
mouse behavioral testing shows that the extent of sensory utilization can vary considerably 
between mouse strains (Wong and Brown, 2006).  In our case, the C57BL/6 background strain 
was found to be efficient at utilizing the visual cues for which the NOR task relies, but still failed 
to show UEC related deficits, suggesting that object novelty was not adequate.  Together, our 
two NOR studies highlight the importance of choosing an appropriate task during behavioral 
analysis, particularly when evaluating transgenic mice for the first time.
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Figure B-1  Specific NOR Apparatus.  Screenshot of NOR apparatus with four identical 
quadrants and symmetrically placed familiar and novel objects. 
 297 
 
 
 
 298 
 
Appendix C 
 
 
 
Osteopontin Knockout Mouse Characterization
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Osteopontin Knockout Mouse Phenotypic Behavior 
 OPN KO mice appeared phenotypically normal, with the exception of a slightly lower 
weight around weaning age (21d).  To prevent differences in weight/growth which could induce 
surgical complications between strains, both WT C57BL/6 and OPN KO mice were given a 
special semi-soft DietGel® 76A (ClearH2O®, Portland, ME) ad libitum for 10 days following 
weaning (P21-31).  By 8 weeks of age, both strains average weight was within the normal range 
(25 g).  Physically, OPN KO mouse appearance includes a slightly greyer coat and thicker body 
compared to WT mice, which have a very sleek black coat and leaner form.  OPN KO and WT 
breeding rates appeared similar, however, OPN KO mothers did appear to give birth slightly less 
often than WT mice.  This may be due to a somewhat longer gestational time (which would 
support initial observations of impaired growth/development rates compared to WT mice), 
nonviable embryos, or a delay in conception due to behavioral characteristics.  The precise 
mechanism for the observed differences in litter birth rate was not investigated, as it posed no 
deleterious implications for our studies.  
 Slight differences in behavior were observed between WT and OPN KO mice.  In 
general, male WT mice appeared more interested in huddling together when sleeping, while 
OPN KO mice showed no preference for solitary or group sleeping arrangements.  This 
territorial mentality is also supported by observation that male OPN KO mice would fight with 
other siblings when returned to their home cage following open field events during NOR.  Very 
few WT mice exhibited this characteristic while almost all OPN KO mice had these aggressive 
tendencies after undergoing the NOR task assessment.  It is possible that absence of OPN alters 
limbic and/or hippocampal circuitry, affecting mood or emotion, as suggested by studies 
demonstrating the importance of immune molecules in synaptic plasticity and maintenance.  
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Despite these slight differences in strains, none of these observations appears to have affected the 
outcome of our studies.  
 
Western Blot Characterization 
 To ensure that OPN KO mice did not produce OPN protein, we compared WT and KO 
hippocampal extracts, probing for full length OPN in animals subjected to UEC lesion.  Here we 
show the graphical representation of this OPN WB analysis (Fig. C-1).  WT mice subjected to 
UEC showed a robust increase in hippocampal OPN expression ipsilateral to the lesion, which 
was significantly elevated over contralateral control at 2d postinjury, a result similar to that of 
rats in Chapter 2.  As anticipated, we did not detect full length OPN protein response in OPN KO 
mice subjected to UEC (for representative blot images, see again Fig. 3.3 B).  With Gene Tools 
software, we measured relative optical density of probed signal and blot background for each 
lane.  In this case, OPN KO samples subjected to UEC showed essentially no difference from 
their contralateral controls, each achieving only background non-specific signal density.  Thus, 
no protein signal for OPN was detected in OPN KO mice, with or without UEC lesion.  Clearly, 
the eighty fold elevation in OPN for lesioned WT was significantly greater than the absence of 
signal in the OPN KO after injury.  These quantitative measures further confirm the efficient KO 
of OPN in our mouse strain. 
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Figure C-1  Hippocampal OPN Protein Expression Following UEC in WT and OPN KO 
Mice .  WB analysis of full length 66 kD OPN protein in whole hippocampal extracts.  UEC 
induced an acute robust increase in OPN protein in mice, similar to rats.  No OPN protein 
response was detected in OPN KO mice, confirming proper expression of the SPP1 transgene 
and null OPN protein mutation.  Results are displayed as percent change over control.  
***p<0.001 relative to paired control cases; §p<0.05. 
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Appendix D 
 
 
 
Fluid Percussion Injury of Olfactory Bulb
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Olfactory Bulb 
Given the potential for OPN to mediate overall CNS synaptic plasticity following TBI-
induced deafferentation, we performed parallel pilot studies to investigate the role of OPN during 
reactive synaptogenesis in the injured olfactory bulb (OB).  Olfactory disturbances are common 
after human brain injury, with anosmia occurring in up to 30 % of victims (Costanzo and Zasler, 
1992) and correlating with MRI detected damage in olfactory bulbs and tracts (Yousem et al., 
1996).  Here we examined the effects of diffuse fluid percussion TBI on OB OPN response.  WB 
analysis showed significant elevation for both full length OPN and its 32 kD MMP-cleaved 
fragment 1 and 3 days postinjury, during the acute degenerative phase of reactive synaptogenesis 
(Fig. D-1).  Interestingly, we discovered a time-dependent difference in the pattern of these two 
OPN bands, with the full length form peaking early at 1d, and the MMP fragment peaking at 3d 
postinjury.  These differences, when compared with the OPN postinjury protein expression in 
deafferented hippocampus (see again, Chapter 2), support model and regional variation of OPN 
response during reactive synaptogenesis.   
 Parallel gelatin zymography experiments revealed a concurrent increase in OB MMP-9 
activity after TBI (Fig. D-2), pointing to prominent role for this enzyme in processing OPN 
within the injured olfactory bulb.  Finally, similar to hippocampal results in the of Chapter 2, 
confocal IHC showed OPN response at 3d postinjury associated with reactive microglia and the 
highly plastic OEC population in the glomerular synaptic regions (Fig. D-3).  The 3d postinjury 
astroglial response did not appear to involve detectable OPN expression, but likely influence 
synaptic plasticity given the interdigitation of their reactive processes among synaptophysin-
positive synapses (Fig. D-4).  Taken together, these WB and IHC results suggest that glial 
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OPN/MMP-9 interaction plays a role in ECM conditioning to facilitate effective synaptic 
recovery in the olfactory bulb following diffuse TBI. 
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Figure D-1.  Olfactory Bulb OPN Protein Expression Following Central Fluid 
Percussion Injury.  WB analysis of full length 66 kD OPN and its MMP-cleaved 32 kD 
fragment in olfactory bulb extracts.  Mild-moderate central fluid percussion injury (TBI) 
induced an increase in both full length and MMP-cleaved OPN at 1 and 3d postinjury.  The 
most robust change was in the full length OPN during the acute 1d postinjury time period.  
Results are displayed as percent change over control with representative blot images and 
cyclophilin A loading controls shown below.  *p<0.05 relative to paired control cases. 
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Figure D-2.  Olfactory Bulb MMP Activity Following Central Fluid Percussion Injury.  
At 1 and 3d after central fluid percussion injury, gelatin zymography shows injury-induced 
elevation in MMP-9, but not MMP-2 activity in the olfactory bulb relative to sham controls.  
Results are expressed as percent of control, with representative gel images shown below.  
*p<0.05 relative to paired contralateral controls. 
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Figure D-3.  IHC of OPN and Glial Cell Types in the Olfactory Bulb at 3d Following 
Central Fluid Percussion Injury.  Strong confocal OPN signal (green in left panels) is 
present in olfactory nerve layer (ON) and in periglomerular cell layers (PG).  OPN shows 
colocalization (arrows) with NgR-p75, a marker for OECs, and with IBA1, a marker for 
microglia, but fails to show colocalization with GFAP.  Scale bar = 30 μm.  
 311 
 
 
 
 
 
 
 312 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure D-4  IHC of Synaptophysin and GFAP 3d Following Central Fluid Percussion 
Injury.  Confocal imaging of  synaptophysin staining (green), a synaptic terminal marker, 
shows increased aggregation of signal with TBI relative to sham controls (D, A).  Astroglia 
(GFAP positive) labeled in red show an injury-induced increase in 3d TBI animals (E) 
compared to sham controls (B).  Confocal overlays demonstrate the increased number of 
astroglial processes interdigitated among synaptophysin positive synapses within the injured 
olfactory bulb after TBI (C).  Scale bar = 20 μm. 
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Delayed Osteopontin and CD44 Localization to Reactive Astrocytes 
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Figure E-1  IHC of OPN Colocalized with IBA1 or GFAP 15d Following UEC.   Confocal 
imaging of OPN (green) in combination with either IBA1 (red) or GFAP (red) is shown for 
the dentate ML during the stabilization and maturation phase of reactive synaptogenesis.  Low 
level of OPN signal is seen in reactive microglia of both control and injured sides (A, B), but 
non IBA1 positive cells contain significant OPN in processes and along the surface of their 
cell bodies (arrows in A, B).  When OPN is colocalized with GFAP, the cells with significant 
OPN signal are identified as reactive astrocytes (arrows in C, D).  Notably, similar GFAP 
positive reactive astrocytes have high density signal for OPN along their cell surfaces (D), 
regions where the OPN receptor CD44 can be localized (arrows in E). Scale bar = 30 μm in 
A-D; 10 μm in E. 
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